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Abstract
Jason M. Stevens
Total Synthesis of Irciniastatin A
(Under the direction of Professor Michael T. Crimmins)
The total synthesis of (+)-irciniastatin A (psymberin) is reported in 19 steps and 6% 
overall yield. Key reactions include a highly convergent enolsilane-oxocarbenium ion 
union to generate the C8-C25 fragment and a late-stage coupling of a hemiaminal 
and acid chloride to complete the synthesis. In addition, efforts toward a second 
generation formal synthesis are described.
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Chapter 1: Isolation, Bioactivity, and Biosynthesis of 
Irciniastatin A
1.1 The Isolation of Irciniastatin A and B by Pettit
! In 2003 Pettit first reported the isolation of two powerful (GI50 from 0.001 to < 
0.0001 μg/mL) murine and cancer cell growth inhibitors harvested from the Indo-
Pacific marine sponge Ircinia ramosa off the coast of Samporna Borneo, which were 
named irciniastatins A and B.1 The initial extraction of ~ 1 kg of wet sponge provided 
34.7 mg of irciniastatin A in 3.51 10-3 % yield and 2.2 mg of irciniastatin B in 2.23 x 
10-4 % yield. 
! The initial activity screens of both of these compounds showed significant 
cancer cell growth inhibition against murine P388 leukemia cell line and six human 
cancer cell lines with GI50 values of 10-3-10-4 μg/mL. These cell lines included 
BXPC-3 pancreas, MCF-7 breast, SF268 CNS, NCI-H460 lung, KM20L2 colon and 
DU-145 prostate cancers as well as P388 leukemia. What was particularly  intriguing 
is that although irciniastatin A and B only differ in the oxidation state at C11, 
irciniastatin B proved to be 10 times stronger than irciniastatin A against BXPC-3, 
MCF-7, and SF268 cell lines whereas irciniastatin A  was at least 10 times more 
active than irciniastatin B  against NCI-H460. In addition irciniastatin A was shown to 
exhibit powerful antivascular activity against human umbilical vein endothelial cells 
(HUVEC) and also displayed marginal antifungal and antimicrobial activities, with 
minimum inhibitory  concentrations of 16 μg/mL and 64 μg/mL against Cryptococcus 
neoformans and Neisseria gonorrhoeae, respectively. 
! The initial structural assignment of the irciniastatins by Pettit was elucidated 
by high resolution mass spectrometry and extensive 500 MHz 2D-NMR experiments, 
including APT, 1H-1H-COSY, TOCSY, HMQC, ROESY and NOESY in chloroform-d3. 
Pettit observed that irciniastatins A and B both contained a structurally  unusual 
dihydroisocoumarin moiety and only differed by one degree of unsaturation, which 
was determined to be the oxidation state at C11 (Figure 1.1.1). While the absolute 
stereochemical assignments of the 6 stereocenters embedded within the 
dihydroisocoumarin and tetrahydropyran fragments could be definitively assigned, 
the absolute stereochemical assignment of the 3 stereocenters of the acyclic 
hemiaminal side chain could not be assigned with certainty. Pettit postulated that the 
network of nOE correlations between the protons on each side of the hemiaminal 
linkage provided for an absolute assignment as 5S, 8R, and 9S while insufficient 
data precluded the absolute determination of the C4 stereochemistry.
2
1.2 The Isolation of Psymberin (Irciniastatin A) by Crews
! Less than one year following the report by Pettit, an independent report by 
Crews in 2004 disclosed the isolation of a nearly identical molecule.2 The compound, 
named psymberin, was isolated from an undescribed inconspicuous sponge 
Psammocinia sp. from the waters of Papua New Guinea. From an initial 18.6 kg of 
wet sponge a total of 17 mg of psymberin was isolated in a 9.1 x 10-5 % yield. Like 
irciniastatin A, psymberin was also found to be a potent cancer cell growth inhibitor 
against a selection of NCI cell lines including SK-MEL-5 melanoma, MDA-MB-435 
breast cancer, and HCT-116 colon cancer. Remarkably, psymberin showed > 104 
fold activity differential against similar colon cancer cell lines. This astounding cell 
line specific activity  proved especially exciting as it may possibly indicate that 
psymberin binds to a distinct cellular target.
! The structural assignment of psymberin was elucidated by high resolution 
mass spectrometry and extensive 500 MHz 2D-NMR experiments, including 1H-1H-
COSY, DEPT, HMBC, HSQMBC and NOESY in methanol-d4. The absolute 
stereochemistry  of the 6 stereocenters of embedded in the dihydroisocoumarin and 
tetrahydropyran fragments could be determined by nOE enhancements and 
evaluation of coupling constants. However, as with irciniastatin A, the absolute 
assignment of the C1-C8 side chain could not be definitively assigned (Figure 1.2.1). 
Crews noted that psymberin shares very similar structural architecture to both the 
pederin and the mycalamide family of natural products. Examination of the coupling 
constant data from these molecules against the data for psymberin lead to the 
assignment of 5S, 8S, and 9S, while C4 could not be definitively assigned. This 
3
assignment contradicted the C8 assignment proposed for irciniastatins A and B and 
at the time it was unclear whether the two molecules shared the same absolute 
stereochemistry, although Crews postulated that the two molecules were identical. 
The following year Crews proposed structure was proven to be correct and the 
identity of the C4 stereocenter was first established as the (S)-configuration through 
Williams substructure NMR shift correlation3  then by Floreancigʼs natural product 
degradation analysis,4 and ultimately the first total synthesis by DeBrabander.5
4
1.3 Biosynthesis of Irciniastatin A
! A total of thirty four pederin-like molecules have been reported in the 
literature. Of them, the irciniastatins are the only molecule lacking the pendant oxane 
ring or 1,3-dioxane and the only  structures that feature a dihydroisocoumarin 
fragment. In the initial report, Crews suggested that the biosynthesis of pederin and 
irciniastatin A are similar and that irciniastatin A is likely  produced from a sponge 
microsymbiont as opposed to the Paederus blister beetle symbiont responsible for 
the biosynthesis of pederin. In 2009, five years after their initial report, Crews 
reported the isolation of biosynthetic gene clusters from Psammocinia aff. bulbosa 
that are responsible for the biosynthesis of irciniastatin A, which also showed 
compelling evidence that they were bacterial in origin.6  Several domains of the 
polyketide synthase domain architecture were nearly identical to counterparts of 
onnamide and pederin PKS domain architecture while others shared little similarity. 
These correlations provided that the onnamides, pederins, mycalamides and 
irciniastatins are synthesized through similar biosynthetic machinery,7  and allowed 
for Crews to propose a biosynthesis for irciniastatin A that also explained the lack of 
the pendant oxane and the incorporation of the dihydroisocoumarin moiety (Figure 
1.3.1). Crews proposed that irciniastatin A is assembled in a linear fashion starting at 
C1 and building toward C25 through a series of predominantly acyl transferase and 
keto reductase operations. While the biosynthesis appears straightforward there are 
several interesting aspects and may hold implications for future synthetic efforts. The 
first is that the synthesis of the tetrahydropyran is formed through an oxy-Michael 
addition. While a number of 6-exo-dig cyclizations have been used to form the 
5
tetrahydropyran in the synthetic campaigns that will be described, none have used 
this biomimetic approach to form that carbon oxygen bond. The other interesting 
aspect is that the biosynthesis of the dihydroisocoumarin occurs through tricarbonyl 
6
condensation, which also has not been explored as a synthetic avenue for the 
construction of this fragment
1.4 Biological Activity of Irciniastatin A and Irciniastatin Analogs
! The identity of the cellular target and the specific mode of action for 
irciniastatin bioactivity remain unknown as of 2010. While the pederin family of 
natural products are uniformly potent protein synthesis inhibitors,8  the unique 
structure of irciniastatin A and cell line specific cytotoxicity that is not observed for 
pederin natural products suggest a unique mode of action. Support for this was 
garnered through the preparation of an analog of irciniastatin A, psympederin 23 
(Figure 1.4.1).9  This analog contained the side chain and tetrahydropyran functions 
but the dihydroisocoumarin moeity was substituted for the 1,2-dimethoxy terminus 
common to pederin natural products. This analog showed a 1000 fold reduced 
activity  compared to natural irciniastatin thereby revealing its important role in 
bioactivity  of irciniastatin A (Table 1.4.1). Similarly, psympederin, which was also a 
pederin/mycalamide analog, revealed that the acyclic side chain results in a 300 fold 
reduction in antiproliferative activity when compared with mycalamide A that contains 
the cyclic pederate side chain. These data suggest a unique mode of action for 
irciniastatin A while also underscoring the need for reliable synthetic avenues to 
access additional material for biological evaluation.
! To further probe the structural factors responsible for the cell line specific 
cytotoxicity  of irciniastatin A, a number of analogs have been prepared by the groups 
of DeBrabander,9 Schering-Plough,10  and Watanabe 11 (Figure 1.4.2). It was 
determined by  Watanabe that irciniastatin is not a chemical reagent and that an 
7
enantio-differential recognition event occurs at the cellular binding site, as (-)-
irciniastatin A (22) showed no cytotoxicity against HeLa cells, whereas (+)-
irciniastatin A was highly  active (Table 1.4.1). As stated previously it is also known 
that completely removing the dihydroisocoumarin shows a 1000 fold reduction in 
8
activity. However, aside from that one example there havenʼt been any further 
studies to investigate the role of that subunit more thoroughly. Most of the analogs 
currently known have focused on probing the side chain function. What has been 
discovered about the role of the side chain is that loss of unsaturation at C1 
produces a marked drop in cytotoxicity  as observed for 24, however, if the alkene is 
substituted for either an alkyne 25, or arene 26, the activity is diminished but not 
quite as drastically. It has also been demonstrated that both the C4 and 
Cell 
Line KM12 PC3 SKMQ-5 T98G HOP62 ACHN MB231 SW620 HeLa
8 0.45 0.98 2.29 1.37 0.42 0.76 0.27 0.82 0.20
22 >1000
23 710.00 821.00 >1000 >1000
24 200.00 >1000
25 1.20
26 32.00 615.00
27 >1000 >1000
28 126.00 347.00 763.00 187.00
29 37.10 200.00 352.00
30 3100.00 4600.00 6800.00 4200.00
31 2.90 3.00 8.70 5.30 6.10
32 0.07 0.06 0.27 0.14 0.16
Table 1.4.1. Comparison of Ircinastatin A and Irciniastatin A Analogs
C5 stereocenters are required for cytotoxicity. The analog 27 that lacks substitution 
at these positions showed a 100 fold reduction in cytotoxicity when compared with 
26, and the 4-epi-irciniastatin A analog 28 showed significant reduction in activity 
9
compared to irciniastatin A. Similarly, the C8-aminal epimer 29 was also less active 
while the corresponding 8,9-epi-irciniastatin A 30 showed the highest overall 
reduction in cytotoxicity among tested analogs. Lastly, it was found that the C11 
stereochemistry  does not play a key role in the bioactivity  of irciniastatin A. The 
analogs 8-epi-11-deoxy-irciniastatin A 31 retained most of the potency of irciniastatin 
A, however, the analog 11-deoxy-irciniastatin A 32 was actually more potent than the 
natural product. 
10
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Chapter 2: Previous Syntheses and Structural 
Determination of Irciniastatin A
! After the two initial independent isolation reports it still remained unclear if 
irciniastatin A and psymberin were stereochemically  identical. This stereochemical 
uncertainty  as well as challenge of designing a strategy to gain access to a new and 
unexplored molecular framework was certainly enough to pique the interest of the 
synthetic community. If not reason enough already to initiate a synthetic campaign 
toward this novel structure, the unprecedented potency and selectivity of these 
cytotoxins prompted over a dozen publications related to stereochemical 
identification,1,2  total3,4,5,6,7  and formal8  synthesis, fragment synthesis9,10,11,12  and 
several analog syntheses13,14,15 from 2005 to 2010.
! Two independent syntheses of the psymberate side chain were disclosed in 
20051-2 to address the unresolved side chain stereochemistry of the natural product 
although these studies did not address the C8 stereochemical uncertainty. The first 
total synthesis was reported by DeBrabander3 shortly thereafter in 2005, which 
proved that irciniastatin A and psymberin were in fact identical compounds, and that 
the structure proposed by  Crews was indeed correct. Shortly thereafter in 2005 
Floreancig9 reported the synthesis of the N7-C25 fragment of irciniastatin A, and 
after a quiet year, Williams8 reported a formal total synthesis in 2007 and the second 
total synthesis was reported by Schering Plough.4 In 2008 Smith5 disclosed the third 
total synthesis followed nine months later by our6 efforts in 2009 and the most recent 
total synthesis by Watanabe7 in 2010. In addition to the mentioned fragment and 
total syntheses, several other reports concerning small fragment syntheses10-12 and 
analog syntheses13-15 have appeared in the literature and will not be discussed in 
this chapter. This section of the chapter will cover all of the total syntheses to date 
and only fragment and formal syntheses that are relevant to this work and to those 
seeking to initiate future synthetic studies toward the ircinastatins or related 
molecules.
2.1 Williams Synthesis of the Psymberate Side Chain
! The potent and selective nature of the irciniastatins as well as their intriguing 
structure prompted efforts to determine the absolute stereochemistry of the acyclic 
side chain. In 2005 Williams1 reported the synthesis of both syn and anti isomers of 
the irciniastatin amide side chain (Scheme 2.1.1).16  Their approach compared the 
NMR spectral data for the irciniastatin side chain with the spectral data of the syn 
and anti isomers of a structurally similar model compound. This method is based on 
the hypothesis that the 1H and ¹³C  NMR signatures of stereoclusters are inherent to 
the specific arrangement of the stereogenic carbons and are virtually  context 
independent.17,18,19,20,21  Toward this end the mannitol derived aldehyde 33 was 
subjected to a stereodivergent methallylation, wherein methylation of the resultant 
carbinols 34 afforded methyl ether diastereomers 35 and 36 that were then 
separated. The anti (4S, 5S) isomer was subjected to acidic dioxolane deprotection, 
followed by reprotection of the diol as the bis-TBS ethers and then selective 
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deprotection of the primary TBS ether to give carbinol 37. A two step oxidation 
protocol gave glycolic acid 38 that was carried forward over four steps to 
glycolamide 39. The syn (4R, 5S) glycolamide diasteromer was then prepared using 
an analogous sequence.! The criteria for structural assignment based on 
comparison of spectral data with simple models is that the difference between the 1H 
chemical shift difference is < 0.05 for 1H and < 0.50 for ¹³C. The correlation of the 
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anti (4S, 5S) isomer 39 with irciniastatin A showed that the chemical shift differences 
for the 1H is < 0.05 ppm and < 0.5 ppm for the ¹³C  spectrum, indicating good 
correlation. Conversely the correlation of the syn (4R, 5S) isomer 42 with irciniastatin 
A showed > 0.25 ppm for the 1H signals and > 1.0 ppm for the ¹³C signals on 
average, indicating significant a deviation from the unknown system. Based on the 
chemical shift correlation as well as the correlation between the observed coupling 
constants between the model anti (4S, 5S) isomer 39 and the psymberate side 
chain, Williams proposed the side chain of irciniastatin A was anti (4S, 5S). While 
this provided clarity on the nature of the C4 and C5 stereocenters the absolute 
configuration of the C8 stereocenter remained unresolved.
2.2 Floreancig Synthesis of the Psymberate Side Chain.
! Within 3 months of the report by Williams, Floreancig reported a supporting 
analysis of the configuration of the C4 and C5 stereocenters on the psymberate side 
chain through degradation studies.2 Floreancig hypothesized that the acidic 
methanolysis of the hemiaminal of irciniastatin A would produce a tetrahydrofuran 
product. It would then be possible to generate a chromatographic signature for this 
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degradation product and make a comparison against all 4 possible stereoisomers of 
the degradation product of known configuration (Scheme 2.2.1). 
! The synthesis of the 4 tetrahydrofuran diastereomers began from diol 47, 
prepared from D-serine.22  The primary alcohol was selectively protected as the 
TBDPS ether and the vacant secondary  alcohol was protected as the PMB ether 48. 
Reduction of methyl ester 48 to the aldehyde allowed for a Felkin-Anh 
stereocontrolled addition of methallyl trimethylsilane with 4:1 dr to give the resultant 
alcohol,2324 which was then alkylated to give methyl ether 49. The acid 50 was then 
obtained through silyl ether deprotection followed by  a two step oxidation sequence. 
Acid 50 was converted to the acid chloride and subjected to a methyl imidate 
coupling followed by imine reduction to give hemiaminal 52. Removal of the PMB 
ether and acidic methanolysis then provided tetrahydrofuran 44, while also 
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demonstrating the feasibility  of acidic degradation of the hemiaminal irciniastatin A 
without epimerization. Tetrahydrofuran 46 was prepared through an enantiomeric 
synthesis starting from L-serine. 
! To access the syn tetrahydrofuran isomers, ester 48 was reduced to the 
resultant aldehyde and subjected to chelation controlled methallylmagnesium 
chloride addition to give syn isomer 53 with only modest stereocontrol.25 Methylation 
of alcohol 54 was followed by silyl ether deprotection and a two step oxidation 
protocol that afforded acid 54. A more straightforward synthesis of syn 
tetrahydrofuran 45 was carried out through methyl esterification of acid 54, PMB 
deprotection and acidic methanolysis, also without any observed epimerization. 
Tetrahydrofuran 43 was prepared through and enantiomeric synthesis starting from 
L-serine.
! With all four tetrahydrofuran diastereomers in hand, a chromatographic 
analysis method was developed using chiral gas chromatography that clearly 
resolved each isomer. A sample of natural irciniastatin A was provided by  Professor 
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Crews and was subjected to acidic methanolysis and the degradation product 
corresponding to 45 was observed by GC and exhibited and identical fragmentation 
pattern by GC-MS. Thus the anti (4S, 5S) configuration of the psymberate side chain 
was assigned based on the degradation studies and supported the NMR correlation 
study conducted by Williams.
! After two separate isolations and two separate reports of structural 
determination studies the C8 stereochemistry remained an unresolved issue. The 
structural determination studies confirmed the side chain stereochemistry matched 
the known stereochemistry of the structurally related pederin and mycalamide 
natural products. This information lead to a consensus that the C8 stereochemistry 
was likely  that of the S configuration. However, there was no definitive spectroscopic 
data to confirm this assumption and it still had yet to be determined whether 
irciniastatin A  and psymberin shared the same absolute configuration. At this stage, 
it seemed that total synthesis was the only way to solve this current ambiguity.
2.3 DeBrabander Total Synthesis
! With a clear need for total synthesis to resolve conflicting stereochemical 
assignments DeBrabander reported the first total synthesis of Irciniastatin A in 
2005.3 Importantly, DeBrabander devised a stereodivergent endgame strategy that 
would provide access to both C8 stereoisomers. This strategy provided for 
installation of the psymberate side chain at a late stage through a non-selective 
coupling of the methoxyimidate derived from amide 56 with acid chloride 55. This 
tactic, although non-selective, would provide for the isolation of both C8 isomers for 
comparison to both natural products and settle the conflicting reports for the 
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configuration at this carbon. Additionally, this would allow for installation of both the 
syn and anti side chain isomers that would then absolutely resolve the identity of the 
side chain stereochemistry  at C4. Amide 56 would be prepared from nitrile 57, the 
product of a boron mediated aldol reaction between aldehyde 58 and ketone 59, a 
reaction that will be utilized in several subsequent syntheses. The aldol coupling 
strategy would prove to be a convergent means for the union of the 
dihydroisocoumarin and tetrahydropyran fragments, however the increased 
convergence would come at the expense of diastereoselectivity and modularity of 
the synthesis.
! DeBrabanders synthesis of the psymberate side chain was very similar to the 
previous report by  Williams, starting from the chiral pool (4R)-2,2-dimethyl-1,3-
dioxolane-4-carbaldehyde (33), available from Aldrich for $100 per gram. A 
diastereoselective methallylation afforded alcohol 34 in 20:1 dr, a significant 
improvement to the previously reported 4:3 dr by Williams.26  Methylation of alcohol 
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34 followed by deprotection of the 1,2-diol acetonide afforded 1,2-diol 60. The 
protection strategy was then adjusted over a three step  sequence to give the free 
primary carbinol 61 with the secondary carbinol protected as the benzyl ester. A two 
step oxidation protocol revealed carboxylic acid 62 (8 steps, 46% yield), which is 
readily converted to the acid chloride coupling partner 55.
! While the chiral pool approach served well for the synthesis of the acid 
chloride fragment, DeBrabander chose to construct the tetrahydropyran fragment 
utilizing a series of enantio- and diasteroselective allylation reactions. Starting from 
aldehyde 63 prepared over 3 steps in 68% yield from isobutyraldehyde, an 
enantioselective Leighton allylation provided homoallylic alcohol 64 in 69% yield and 
94% ee while also unmasking the protected aldehyde.27 A  second Leighton allylation 
gave the C2-symmetric 1,3-diol 65 in 17:1 dr. Desymmetrization of diol 65 through a 
mono-TBS protection was followed by ozonolysis of both the terminal alkenes with 
concomitant cyclization to give the lactol, which was then protected to deliver lactol-
acetate 66. A Kobayashi diethylzinc addition28  gave secondary alcohol 67, which 
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was oxidized to ketone 59 after displacement of the acetate with TMSCN, 
completing the synthesis of the tetrahydropyran core (11 steps, 19% overall yield).
! The dihydroisocoumarin functionality  of irciniastatin A is a structurally distinct 
subunit that has not been observed in other natural products. Therefore, the 
preparation of this fragment provided an opportunity to utilize the wealth of reactions 
available for constructing and functionalizing aromatic rings. DeBrabander chose a 
directed metallation approach for the preparation of the aryl portion of the 
dihydroisocoumarin. Starting from 1,3-dimethoxyresorcinol (71), a known three step 
protocol was followed to deliver aldehyde 72 in 40% yield.29 The aldehyde was then 
converted to the diethyl amide directing group over two steps to give amide 73. A 
directed ortho-metallation/allylation gave terminal alkene 74, representing the carbon 
nucleus of the dihydroisocoumarin.30 ,31  Removal of the methyl ether protecting 
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groups and conversion of the diethylamide to the methyl ester gave catechol 75, 
which was reprotected to give the bis-PMB protected catechol 76. The target 
aldehyde 58 was then accessed through a dihydroxylation-oxidative cleavage 
sequence to completing the fragment synthesis (10 steps, 17% yield).
! Having accessed their three fragments, the union of the tetrahydropyran and 
the dihydroisocoumarin was investigated. Treatment of the (Z)-chlorophenylboryl 
enolate derived from ketone 59 with aldehyde 58 yielded the major syn-aldol product 
in 12:1 dr, as predicted from enolate facial bias imposed by the β-alkoxy 
substituent.32  The C15 stereochemistry  was then set through a catecholborane 
mediated chelation controlled reduction33 and basic work-up to generate the lactone, 
which upon treatment with TBAF then gave diol 77. The amide function was 
revealed through hydrogenation of the nitrile with the platinum(II) catalyst of Ghaffar 
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and Parkins to yield amide 78.34  Hydrogenolysis of the PMB ethers gave the fully 
deprotected N7-C25 fragement 79 that was subjected to global reprotection to give 
tetraacetate 56. The second key coupling, a strategy successfully  employed in the 
synthesis of pederin,35  was executed by first preparing the methoxyimidate using 
Me3OBF4 and immobilized pyridine and then adding a solution of acid chloride 55 
and Hünigs base. The coupled product was then treated with an ethanolic solution of 
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NaBH4, wherein after work-up  the crude products were saponified to afford a 71:29 
ratio of irciniastatin A (21 steps, 6% overall) to 8-epi-irciniastatin A. The synthetic 
material of known (4S, 5S, 8S) configuration exactly matched the 1H and 13C  NMR 
spectral data previously  reported for both irciniastatin A (CDCl₃) and psymberin 
(MeOD). Additionally, the optical rotation of synthetic irciniastatin A ([α]D = +25.2, c = 
0.11, MeOH) agreed with those reported for natural irciniastatin A ([α]D = +24.4, c = 
0.55, MeOH) and natural psymberin ([α]D = +29, c = 0.02, MeOH).
2.4 Floreancig Advanced Fragment Synthesis
! The report following the first total synthesis by DeBrabander was from 
Floreancig in 2005.9 Floreancigʼs strategy  was distinct from the strategy executed by 
DeBrabander although the target N7-C25 fragment 81 closely resembled 
Debrabanderʼs late stage amide 56 (Scheme 2.4.1). The target amide would be 
prepared from terminal alkene 82 that would arise from a Mukaiyama aldol reaction 
between enolsilane 84 and aldehyde 83. 
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! Floreancigʼs approach toward the precursor to the C9-C14 fragment utilized 
an enantioselective Leighton allylation36 of aldehyde 85, in the presence of a ketone 
(Scheme 2.4.2). The homoallylic alcohol 86 was then protected as the TES ether 
and the ketone was subsequently converted to enolsilane 84 to complete the 
fragment synthesis.
! To synthesize the aromatic portion of irciniastatin A, Floreancig chose to use 
methodology developed by Langer,37  utilizing the cycloaddition of allene 8838 and 
diene 87 (Scheme 2.4.3).39 This strategy provided the fully decorated aromatic ring 
89 in three steps from commercially available material. Most importantly the 
chemistry was run on 12 g scale, providing rapid access to multi gram quantities of 
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this valuable synthetic intermediate. Protection of catechol 89 followed by a 
chemoselective reduction of the benzylic ester to the corresponding aldehyde that 
was subjected to an enantioselective Brown crotylation gave homoallylic alcohol 90 
in 64% over 3 steps and 90% ee.40 Protection of the hydroxyl and ozonolysis of the 
terminal alkene afforded aldehyde 83 to finish the synthesis of the 
dihydroisocoumarin fragment (5 steps, 44% overall from catechol 89)
! The Mukaiyama aldol coupling of enolsilane 84 with aldehyde 83 (Scheme 
2.4.4) employed by Floreancig could occur with either α- or β-stereodirection from 
the substituents at C16 and C17. The α-directed Felkin-Anh41,42,43 approach of the 
nucleophile would provide the desired syn,syn-product, whereas β-direction from the 
β-silyloxy group would yield the anti,syn-product. Consistent with Evans44 
observations that α-direction prevails when bulky nucleophiles are employed, the 
Mukaiyama aldol between 84 and 83 provided the aldol product 82 with modest 
selectivity for the syn,syn-product through a Felkin-Anh approach. This strategy 
provided an excellent method for the union of the dihydroisocoumarin and 
tetrahydropyran frameworks, although it requires that the tetrahydropyran must be 
formed at a late-stage. A chelation controlled reduction using the alcohol handle 
proceeded to give the single syn-isomer in 74% yield.45  The tetrahydropyran was 
then formed by  ozonolysis of the terminal alkene with concomitant ring closure to 
give the lactol, which was followed by diacetylation to give lactol acetate 92. The 
synthesis of the advanced fragment was then completed by substitution of the 
acetate using TMSCN and hydrolysis of the resultant nitrile to give amide 81 (11 
steps, 14% overall yield from catechol 89). It was particularly curious that the total 
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synthesis was not completed as the late-stage intermediate was so similar to 
DeBrabanderʼs amide 59, and that this work would represent a significant 
improvement over DeBrabanderʼs synthesis. The notable differences are that the 
lactone of the dihydroisocoumarin had yet to be installed and that aryl ether 
protection strategy was different. Both of differences would prove to be critical issues 
in subsequent synthetic campaigns.
2.5 Williams Formal Synthesis of Irciniastatin A
! After a year without any publications concerning the synthesis of ircinastatin A 
or any of its fragments, one of the most interesting and unique syntheses was 
disclosed. In 2006 Williams8 reported the formal synthesis of irciniastatin A that 
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accessed DeBrabanderʼs late stage amide 563 (Scheme 2.5.1). In this synthetic 
effort, Williams sought to access the target amide 56 through protected carbinol 93, 
which was derived from the nucleophilic addition of the aryl homoenolate from 94 to 
the advanced aldehyde 95. Aldehyde 95 would arise from the alkyne 96 that is 
generated from a spirodiepoxide opening. This strategy was particularly interesting 
as it still stands as the only synthetic effort that couples the tetrahydropyran and the 
dihydroisocoumarin in this fashion. Furthermore, this synthesis highlights the utility 
of spirodiepoxide opening reactions toward the synthesis of complex 
tetrahydropyrans.
! Williams synthesis of tetrahydropyran 96 started with 2,2-dimethyl-1,3-
propane diol (98) that was monoprotected and oxidized to aldehyde 99, which was 
then subjected to an Ohira-Bestmann46 reaction to give alkyne 100 (Scheme 2.5.2). 
After acylation of the acetylide derived from 100 with amide 101, the resulting 
alkynone 102 was reduced under Noyori47  conditions to give the enantioenriched 
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propargylic alcohol 103. The chiral allene 104 was accessed through Myers48 
procedure and deprotection of PMB ether. Alcohol 104 was converted to ynone 105, 
which served well as a substrate for the diasteroselective CBS reduction to access 
the spirodiepoxide precursor 97 with 10:1 dr.49,50  Subjecting allene 97 to DMDO 
provided the desired spirodiepoxide opened product 106 as a single isomer in 72% 
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yield. What was especially remarkable about this transformation was the variety of 
function groups present on the product. Tetrahydropyranone 106 featured fully 
differentiable alcohol, ketone, terminal alkyne, and protected alcohol functional 
groups, which demonstrated the utility of this chemistry for building complex 
molecules outward from a core tetrahydropyran structure. The power of accessing 
these complex structures with differentiable protecting groups was exemplified as 
Williams performed a reduction of the α-hydroxy ketone to provide the anti-1,3-diol51 
that was subsequently converted to the epoxide 108. The selective opening of 
epoxide 10852  and protection of the resultant carbinol provided MOM ether 96. 
Lastly, the terminal alkyne that remained idle throughout these manipulations, was 
reduced with borane in the presence of 2-methyl-2-butene to reveal the advanced 
aldehyde 109. 
! Williams synthesis of the arene subunit of irciniastatin A proved to be one of 
the most concise (Scheme 2.5.3). The commercially available dimedone 110 was 
aromatized53  under acidic conditions and subsequently formylated with Zn(CN)2/
HCl54  to provide arene 111, which was carried forward to aryl ester 94 through 
standard protecting group and oxidation state manipulations. 
! With the two core fragments available, aldehyde 109 was converted to the 
desired coupling partner 95 through and Evans syn-aldol with subsequent removal 
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of the chiral auxiliary (Scheme 2.5.4). The two fragments were then united upon 
exposure of the homoenolate of 94 to aldehyde 95 to produce the coupled product 
93 in 63% yield with 3:1 dr. Although the yield and diastereoselectivity  were modest, 
the utility of the coupling can be taken from the ease with which the 
dihydroisocoumarin was generated at a late stage that could provide quick access to 
a variety  of dihydroisocoumarin modified irciniastatin analogs. To access the target 
amide 56, the MOM and TES protecting groups were replaced with the requisite 
acetate protecting groups of DeBrabanderʼs intermediate. Finally, the TBDPS ether 
of peracetylated 114 was converted over 4 steps to amide 56 (27 steps overall). 
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2.6 Schering Plough Total Synthesis
! In 2007, a group from Schering Plough reported the second total synthesis of 
irciniastatin A.4 Their synthetic approach differed significantly from the earlier work 
by DeBrabander. The Schering group sought to install the hemiaminal functionality 
while closing the tetrahydropyran ring from N-acyl enamine 115 using their BAIB 
mediated oxidative cyclization (Scheme 2.6.1). While this novel method for 
generating N-acyl hemiaminals from enamides was both unique and substantially 
different from the DeBrabander methoxyimidate-acid chloride coupling, it was not 
clear whether this method would provide improved stereoselective entry to the C8-
aminal over the methoxyimidate method. Enamide 115 would be generated from 
Buchwald coupling of amide 116 and vinyl iodide 117 to couple the psymberate side 
chain and tetrahydropyran subunits. The union of the dihydroisocoumarin and the 
tetrahydropyran carbon framework would arise from a substrate controlled 
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Mukaiyama aldol reaction to connect C14-C15 that was similar to Floreancigʼs 
strategy.
! As with all the previous reports for the synthesis of the psymberate side 
chain, the Schering group utilized a chiral pool strategy (Scheme 2.6.2). Starting 
from TBS protected (R)-glycidol 120, regioselective epoxide opening with 
isopropenylmagnesium bromide gave a secondary alcohol that was protected as the 
methyl ether 121. As the terminal alkene would not be tolerated for their late stage 
oxidative cyclization to form the hemiaminal, it was masked at this stage by 
hydroboration and protection the resultant alcohol as the benzyl ether. Deprotection 
of the TBS group followed by Swern oxidation provided aldehyde 122. A unique 
method to install the C5 carbinol stereochemistry  was used through 
diastereoselective cyanohydrin formation using TMSCN and AlCl3, although only 
poor selectivity  was observed, giving a 2:1 ratio of alcohol diastereomers. The 
desired carbinol isomer was protected as the TIPS ether and the nitrile was 
hydrolyzed55 to give amide 116 (9 steps, 27% overall yield).
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! The late stage formation of the tetrahydropyran as outlined by Schering, set 
two of the three stereocenters of the tetrahydropyran core after the carbon 
framework of this fragment was to be coupled to the dihydroisocoumarin unit. As a 
result, the synthesis of the C9-C13 fragment was concise (Scheme 2.6.3). An 
enantioselective Masamune aldol reaction of silylenol ether 124 with aldehyde 123 
set the single stereocenter of this fragment with > 50:1 er.56  Protection of the 
resultant alcohol as the TBS ether was followed by ketone formation directly from 
the ester with trimethylsilylmethyl lithium57 and then conversion to enolsilane 127 (4 
steps, 89% overall). 
! Similar to the strategy  employed by DeBrabander, the Schering group sought 
to access the dihydroisocoumarin subunit by  elaborating a commercially available 
aromatic ring as opposed to de novo synthesis (Scheme 2.6.4). Starting from phenol 
128, available over 2 steps in 46% yield from commercially available 2,4,6-
trimethoxytoluene,58 conversion to the aryl triflate was followed by a Stille coupling to 
give alkene 129. Removal of the methyl ether protecting groups and reprotection as 
TIPS ethers gave bis-TIPS protected catechol 130. The terminal alkene was 
converted over two steps to the corresponding aldehyde, which was then subjected 
to an enantioselective Brown crotylation reaction to provide syn-131 with excellent 
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diastereoselectivity (> 50:1) and enantioselectivity (90% ee).40 At this stage the 
lactone was closed under acidic conditions and the terminal alkene was converted to 
the corresponding aldehyde 118 (10 steps, 24% overall).
! With all three fragments available, the union of enolsilane 127 and aldehyde 
118 was realized through a substrate controlled aldol reaction to give ketone 132 in 
76% yield as the desired isomer (Scheme 2.6.5).59 This reaction demonstrates the 
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power of the Mukaiyama aldol reaction for coupling complex fragments in a 
diastereoselective fashion. It is also noteworthy that this represents the only  union of 
the dihydroisocoumarin and the tetrahydropyran framework with a preformed lactone 
of the dihydroisocoumarin. A  chelation controlled reduction utilizing catecholborane 
to set the C13 stereocenter gave carbinol 133 with 15:1 dr.33 The syn-1,3-diol was 
protected as the diacetate and the primary  benzyl ether was deprotected to allow for 
a Dess-Martin oxidation to the aldehyde that was subjected to a Takai olefination60 to 
give vinyl iodide 117 (E/Z = 5:1).
! With the successful union of the dihydroisocoumarin and the tetrahydropyran 
framework and elaboration to vinyl iodide 117, the novel endgame strategy of 
Buchwald amidation and oxidative cyclization to form the tetrahydropyran and N-acyl 
hemiaminal could be investigated (Scheme 2.6.6). The coupling of vinyl iodide 117 
and amide 116 was realized using CuI to give the protected N-acyl enamine 115 in 
excellent yield.61 At this stage the C13 carbinol required deprotection so the carbinol 
could participate in the oxidative cyclization event. Deprotection of the acetate 
protecting groups was accompanied by removal the O21 TIPS protecting group, 
which was subsequently reacetylated. The PhI(OAc)2 mediated oxidative 
cyclization62  reaction occurred to give a mixture of all four possible isomers in a 
42:42:8:8 ratio, giving a 30% yield of the desired isomer 135. Although this 
represented a new method for the construction of hemiaminals, a severely under 
explored functionality, the lack of compatibility with the terminal alkene of the 
psymberate side chain and the lack of stereocontrol severely weakened the 
effectiveness of this strategy. With the carbon skeleton of the natural product in 
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place, the alkene of the psymberate side chain would need to be revealed. The C15 
alcohol was protected as the acetate and the primary benzyl ether was deprotected 
to give alcohol 136. A two step selenium mediated dehydration was followed by 
global deprotection to provide synthetic irciniastatin A (8) (21 steps longest linear, 
8% overall).
2.7 Smith Total Synthesis
! The third total synthesis of irciniastatin A came from the Smith group  in 2008.5 
Their approach carried some similar elements to the syntheses from DeBrabander 
and Floreancig, while offering a new and unique approach to the tetrahydropyran 
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and the only stereospecific installation of the N-acyl hemiaminal. According to their 
retrosynthetic analysis, irciniastatin A would arise from a late stage installation of the 
side chain and N-acyl hemiaminal, an approach that was common to both earlier 
reports (Scheme 2.7.1). The N-acyl hemiaminal 138 would arise from the Curtius 
rearrangement of the corresponding carboxylic acid. This strategy represents a 
significant improvement over previous endgame approaches as it would be the first 
to gain stereospecific entry to the C8 hemiaminal. In similarity to DeBrabanderʼs 
approach, a Paterson boron mediated aldol between aldehyde 139 and ketone 140 
would install the C16 and C17 stereocenters. Aldehyde 140 would be prepared using 
Floreancigʼs strategy, while a series of catalytic reagent controlled reactions would 
be employed to generate the tetrahydropyran precursor 141. The advantage of this 
tactic would be rapid access to a wide variety of stereochemically diverse 
congeners, simply  by changing the enantiomer of the catalyst, thereby avoiding 
significant strategy redesign to access analogs.
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! Smithʼs synthesis of the psymberic acid side chain followed a chiral pool 
approach that was nearly identical to DeBrabanderʼs and Williamʼs strategy (Scheme 
2.7.2). The 1,2-diol acetonide 35, known from DeBrabanderʼs work, was deprotected 
to give the resultant diol that was selectively  protected at the primary  alcohol to give 
pivalate ester 142. Protection of the secondary alcohol as the SEM ether and 
removal of the temporary pivalate ester gave alcohol 143. A two-step  oxidation 
sequence afforded carboxylic acid 137 that could be converted to the mixed pivalate 
anhydride 144 required for the late stage side chain installation.
! The synthesis of the tetrahydropyran fragment began with commercially 
available 2,2-dimethyl-1,3-propane diol (98) that was mono-TBS protected and 
oxidized to give aldehyde 145. A vinylogous Mukaiyama aldol reaction63  with silyl 
ketene acetal 146 using the oxazaborolidinone 147 promoter gave carbinol 148 as a 
single enantiomer in 66% yield. The resultant alcohol was protected as the TBS 
ether and the allylic alcohol 149 was revealed through i-Bu2AlH reduction of the 
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corresponding methyl ester. A Sharpless asymmetric epoxidation64 gave the epoxide 
150 in 88% with a 13:1 dr, which was followed by TEMPO oxidation to furnish the 
carboxylic acid that was methylated using TMSCH2N2 to give methyl ester 151. 
Selective removal of the primary TBS ether with subsequent Parikh-Doering 
oxidation of the resultant alcohol completed the construction of aldehyde 152. The 
final elaboration toward alcohol 141, the requisite tetrahydropyran precursor, 
entailed treatment of 2-butanone with (-)-DIPCl and Et3N according to the Paterson 
method,6566 followed by addition of the aldehyde 151 to give the aldol adduct 141 in 
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86% yield in 5:1 dr. Treatment of 141 with catalytic CSA in CH₂Cl₂ gave the desired 
tetrahydropyran in 74% yield, which after methylation of the free hydroxyl completed 
the synthesis tetrahydropyran fragment 140 (13 steps, 23% overall).
! The last of the three fragments employed a slight derivation of the Langer 
method previously employed by Floreancig (Scheme 2.7.4). Using the 1,3-bis
(trimethylsiloxy)-1,3-diene 15467  derived from methylpropionyl acetate rather than 
ethylpropionyl acetate, the Diels-Alder reaction occurred in an improved 83% yield 
over the previously reported 70% yield, although the authors did not provide an 
explanation or procedure to shed light on these improvements. Aldehyde 139 was 
then accessed over two steps in 65% yield to complete the last remaining fragment.
! With all three fragments in hand, Smith investigated the union of the 
tetrahydropyran and dihydroisocoumarin fragments (Scheme 2.7.5). Similar to the 
DeBrabander coupling, the (Z)-chlorophenylboryl enolate derived from ketone 140 
with aldehyde 139 yielded the major syn-aldol product in 20:1 dr, invoking substrate 
control to explain observed stereodirection.32 Again in similar fashion, a 1,3-chelation 
controlled reduction45 was employed to generate the 1,3-syn-diol, which upon 
exposure to lithium hydroxide effected hydrolysis of the methyl ester and 
concomitant lactonization to provide dihydroisocoumarin 156. Employing a Curtius 
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degradation strategy that had been successful in their total syntheses of (+)-
zampanolide and (+)-dactylolide,68 the Teoc-protected hemiaminal 138 was isolated 
after TBS protection of the free hydroxyl. To finish the total synthesis all that 
remained was to form the N7-C6 bond. Smith explicitly  stated the difficulty they 
encountered while exploring this union, however a detailed account of these 
difficulties was not provided. Nevertheless, they were able to execute the coupling 
using LiHMDS as the base and the mixed pivalate anhydride 144 as the coupling 
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partner, which after a two-stage deprotection afforded synthetic irciniastatin A (8) (21 
steps, 6% overall). 
2.8 Watanabe Total Synthesis
! In 2010 Watanabe reported the fifth total synthesis of (+)-irciniastatin A, which 
also included the separate enantioselective synthesis of (-)-irciniastatin A and the 
synthesis of a single analog.7 Their overall disconnection strategy closely resembled 
Smithʼs strategy although they provided a novel approach to the psymberate side 
chain (Scheme 2.8.1). Comparable to the Crimmins and Smith strategies, Watanabe 
sought to access irciniastatin A (8) through a late-stage installation of the side chain 
and hemiaminal through a Curtius rearrangement followed by a hemiaminal 
acylation sequence. Hemiaminal 157 would be derived from the product of a boron 
enolate aldol reaction of known aldehyde 158 and ketone 159, which was nearly 
identical to strategy reported by Smith. The ketone coupling partner 159 would arise 
from the manipulation of epoxide 160.
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! The hallmark of the synthesis reported by Watanabe was their concise and 
scalable approach toward the psymberate side chain (Scheme 2.8.2). Starting with 
the copper(I) chloride promoted coupling of methallybromide 161 and propargyl 
alcohol 162,the internal alkyne product 163 was then converted to the allylic alcohol 
that was enantioselectively epoxidized under Sharpless conditions to give epoxide 
165. A regioselective epoxide opening of under Lewis acidic conditions with 
methanol provided diol 60 in 94% yield with 18:1 regioselectivity.69  A series of 
protecting group  manipulations provided primary  alcohol 143 that was oxidized 
directly to the carboxylic acid70  to complete the enantioselective synthesis of the 
psymberate side chain (8 steps, 22% overall), which could then be converted to 
Smithʼs pivalate anhydride 144 required for coupling.
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! While Watanabeʼs synthesis of the psymberate side chain offered a concise 
and unique approach to that fragment, their synthesis of the tetrahydropyran was 
quite the opposite (Scheme 2.8.3). The synthesis of this piece was longer than all 
current total syntheses of the natural product and utilized an epoxide opening to 
form the tetrahydropyran that was very similar to that of Smith. Starting from known 
epoxide 16671 the protection of the free alcohol and subsequent acetylide addition 
into the epoxide72 to give alcohol 168 was followed by deprotection and oxidation to 
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aldehyde 169. The C13 stereocenter was then set through a diastereoselective 
allylation73  that was followed by several protecting group manipulations to provide 
propargyl alcohol 170. Reduction of the alkyne to the allylic alcohol using Red-Al 
allowed for a Sharpless epoxidation of the resultant alkene to give epoxide 160. 
Epoxide 160 was then subjected to a sequence of protection, deprotection-
cylclization and methyl etherification to give tetrahydropyran 172 in a manner very 
similar to Smithʼs. Having constructed the key tetrahydropyran their sights were set 
on converting the terminal alkene to the requisite ethyl ketone. This effort began with 
reprotection of the silyl ether that was lost during the cyclization step and oxidative 
cleavage of the terminal alkene to reveal aldehyde 173. The ethyl ketone was then 
installed through Grignard addition to the aldehyde and an ensuing oxidation to 
ketone 174. To complete the synthesis of the desired coupling partner 159 the 
primary BOM ether was converted to itʼs corresponding benzyl ester over three 
steps (20 steps, 16% overall from 166).
! Having devised synthetic routes to both the psymberic acid and 
tetrahydropyran fragments, Watanabe utilized DeBrabanderʼs method for the 
synthesis of Crimmins aldehyde 158,6 and the endgame strategy commenced 
(Scheme 2.8.4). The union of aldehyde 158 and the boron enolate of 159 was again 
utilized in this work giving a 68% yield and > 20:1 dr of alcohol 175, further 
demonstrating the power of the Paterson aldol in complex molecule synthesis.32 The 
aldol adduct was then subjected to chelation controlled β-hydroxy carbonyl reduction 
to give the 1,3-syn diol74  that was lactonized and TBS protected to give silyl ether 
176. The hemiaminal 157 was then revealed through hydrogenolysis of the benzyl 
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ester and Curtius degradation75  of the resultant carboxylic acid. In accord with the 
two previous syntheses that featured a late stage hemiaminal acylation, Watanabe 
described significant difficulty achieving this transformation. The union was achieved 
using the conditions reported by  Smith albeit in 24% lower yield even though the 
only difference between the two separate reports were the TIPS protecting groups 
on the aromatic ring as opposed to the SEM ethers used by Smith. Lastly, global 
deprotection using TASF in DMF gave irciniastatin A (28 steps, 2% overall from 166)
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Chapter 3: Total Synthesis of Irciniastatin A
! Irciniastatin A, a unique member of the pederin family of natural products, 
caught our attention through its challenging molecular structure and its remarkable 
anti-proliferative activity. The array of potential aldol disconnections observed in the 
natural product would provide an opportunity  to extend the breadth of the Crimmins 
aldol reactions to a new class of natural products that have yet to be explored in our 
laboratory, the pederins and mycalamides. Our goal was to develop a modular and 
highly convergent synthetic strategy toward irciniastatin A that would also be suitable 
for analog preparation. Ultimately, our efforts culminated in the most step  efficient, 
modular, and highly convergent synthesis of irciniastatin A, which will be discussed 
in this chapter.1
3.1 Retrosynthetic Analysis
! Retrosynthetically, (+)-irciniastatin A (8) was envisioned to arise from two key 
disconnections (Scheme 3.1.1). A late-stage attachment of the psymberic acid chain 
would be accomplished by coupling of acid chloride 189 with hemiaminal 190, the 
product of a Curtius rearrangement of the carboxylic acid derived from the 
corresponding benzyl ether of 191. This tactic would allow for a highly 
stereocontrolled entry to the C8 hemiaminal and efficient incorporation of the side 
chain. Tetrahydropyran 191 would arise from the stereoselective addition of 
enolsilane 192 to the oxocarbenium ion derived from acetate 193. These two key 
disconnections segregate the three major subunits of irciniastatin A (8), each of 
similar size and complexity and accessible in a highly stereocontrolled fashion from 
standard aldol synthons.
3.2 Synthesis of the Psymberic Acid Side Chain of Irciniastatin A
! Until recently,2,3  all reported syntheses of the psymberate side chain have 
relied on functionalizing commercially available chiral pools4,5,6,7,8,9  or enzymatic 
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resolutions10,11 (Scheme 3.2.1). In addition, analogue studies2,12,13,14 have shown the 
side chain to be required for high activity. Therefore, an enantioselective and highly 
tunable synthesis of the side chain would be ideal for further investigation of side 
chain function. We reasoned that an oxazolidinethione asymmetric glycolate aldol 
reaction15,16 would allow for enantioselective entry to the psymberate side chain as 
well as provide sufficient opportunities for derivatization and congener synthesis.
! The synthesis of acid chloride 189 (Scheme 3.2.2) began with the known17 anti-
aldol reaction of glycolate 195 and 3-methyl-but-3-enal (196) to give aldol adduct 
198 in 64% and 87:2:11 dr. The auxiliary  was subsequently  removed by methanol 
substitution to give β-hydroxy methyl ester 199. Methylation of alcohol 199 required 
the use of the Meerwein reagent to avoid β-elimination side products to furnish 
methyl ether 200 in 80% yield. While the allyl substituted glycolyloxazolidinethione 
has been shown to deliver the highest selectivity and yield for the anti-aldol reaction, 
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the subsequent removal of the allyl protecting group can often be cumbersome.18 It 
was found that Wilkinsonʼs catalyst could isomerize the allyl group to the 1:1 mixture 
of E/Z-enol ethers 201 in the presence of the disubstituted alkene giving a 42% yield 
and 38% recovered starting material when the reaction was stopped at 50% 
conversion. The 1:1 mixture of E and Z- enol isomers were subjected to acidic 
methanolysis to afford the alcohol that was reprotected to give silyl ethers 202-204. 
Unfortunately, at the last step  of our synthetic route it was found that both the TES 
and TBS ethers 202 and 203 did not survive the hydrolysis conditions, particularly 
the mildly  acidic work-up, and the ester with the α-TIPS ether 204 was exceedingly 
resistant to hydrolysis. The inability to access the desired acids 205-207 from the 
methyl ester and the inefficient allyl deprotection prompted the investigation of an 
alternative strategy to access the protected psymberic acid side chain.
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! The previous route toward the psymberic acid side chain demonstrated that 
the anti-aldol strategy was effective for gaining enantioselective entry  to the carbon 
skeleton of psymberic acid skeleton. However, attempting to maintain the ester 
oxidation state at C6 throughout the synthetic sequence limited the methods 
available for the allyl ether deprotection and the required hydrolysis of the ester 
limited the tolerance for silicon protecting groups at C5. It was reasoned that having 
C6 at the alcohol oxidation state in the form of a protected alcohol would allow more 
latitude for the allyl deprotection step and would also allow entry to the desired acid 
through an alcohol deprotection-oxidation sequence. Additionally, the previous effort 
demonstrated that TES, TBS and TIPS ethers were not suitable protecting groups at 
the glycolyl oxygen and that a less acid labile SEM ether could serve as a suitable 
replacement. Toward these ends, the anti-aldol adduct 198 was carried forward to 
the primary  TIPS ether 208 using known procedures from our laboratory (Scheme 
3.2.3).17 Methylation of the alcohol was followed by removal of the allyl protecting 
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group under Kulinkovich conditions19  to give alcohol 210 in much improved yield 
over the previous sequence. Protection of alcohol 210 as the SEM ether was 
followed by selective removal of the primary TIPS ether and oxidation of the primary 
alcohol to the carboxylic acid 137 over two steps. At this stage it was demonstrated 
that the acid 137 (9 steps, 28% overall) could be converted to acid chloride 189 for 
the final coupling.
3.3 Synthesis of the Tetrahydropyran Precursor of Irciniastatin A
! As the tetrahydropyran represents the core of irciniastatin A, both the 
dihydroisocoumarin and psymberic acid fragments will need to be coupled to this 
core fragment, thereby highlighting the need for an efficient and tunable synthesis to 
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accommodate two separate coupling strategies. A survey of all the strategies 
employed in total synthesis or advanced fragment synthesis have formed the 
tetrahydropyran through a cyclization of the C13 alcohol onto C9 in various fashions 
(Scheme 3.3.1).3-7,9 Our approach sought to construct the tetrahydropyran 
framework in the opposite direction by cyclizing a C9 alcohol onto C13 through a 
straightforward lactonization. The chiral pool 2-deoxy-D-ribose contains a significant 
portion of the highly oxygenated carbon skeleton of the target lactol-acetate 193 
including 2 of the 3 stereocenters, and would provide an ideal starting point toward 
the synthesis of this fragment. Although the chiral pool approach would lack 
modularity for subsequent analog synthesis, the structural homology between 2-
deoxy-D-ribose with our desired fragment would provide rapid and scalable access 
to acetate 193 that would meet our immediate goal toward the synthesis of 
irciniastatin A.
! The synthesis of lactol acetate 193 (Scheme 3.2.2) began from known p-
methoxybenzylidine acetal 21120,21  available from 2-deoxy-D-ribose (194) in two 
steps. Methylation of alcohol 211 was followed by a dihydroxylation-oxidative 
cleavage sequence to reveal aldehyde 212. A catalyst-controlled Kiyooka22  aldol 
reaction of aldehyde 212 and enolsilane 12423 provided carbinol 213 in 84% yield 
and 9:1 dr. Protection of alcohol 213 to give TBS ether was followed by 
hydrogenolysis of the p-methoxybenzylidine acetal and acid promoted lactonization 
to afford lactone 214 over 3 steps. Protection of the primary alcohol as the benzyl 
ether and reduction of the lactone with diisobutylaluminum hydride allowed for 
protection of the resultant lactol, giving lactol-acetate 193 over 3 steps. While the 
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yield of every step  of this sequence exceeded 80%, we felt the total of 11 synthetic 
steps from commercially  available material could be optimized to provide an even 
shorter and more efficient sequence. 
! To improve the step economy, several one-pot procedures were investigated 
(Scheme 3.3.3). The deprotection of the p-methoxybenzylidine acetal with 
concomitant lactonization was realized in a one-pot fashion by simply using dilute 
HCl in methanol to give a 10:1 mixture of lactone 214 and the corresponding diol, 
which was completely  converted to lactone 214 by exposure to trifluoroacetic acid. 
Protection of the primary alcohol gave benzyl ether 215 and subsequent one-pot 
reductive acetylation24 ,25  afforded acetate 193 in quantitative yield. These 
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improvements shortened our route by two steps and have provided access to multi 
gram quantities of acetate 193 (9 steps, 34% overall from 2-deoxy-D-ribose).
3.4 Synthesis of the Dihydroisocoumarin of Irciniastatin A
! The dihydroisocoumarin subunit of irciniastatin A  was a previously unknown 
structural element of natural products and therefore its efficient preparation would 
need to be addressed during the course of a synthetic campaign. Previous efforts 
have chosen to either functionalize an aromatic system,6,8 generate an aromatic 
system from its respective aliphatic skeleton,26 or to directly construct9,27 the desired 
aromatic ring (Scheme 3.4.1). In seeking to incorporate as much versatility as 
possible into our synthesis for the benefit of potentially straightforward analog 
syntheses down the road, we chose to construct the aryl portion of irciniastatin A 
using a Diels-Alder aromatization/aryl methylation strategy. This tactic would allow 
for efficient construction of the aromatic ring with the ability to selectively  install a 
variety of functionality at the C20 position.
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! The synthesis of the aromatic ring of the dihydroisocoumarin fragment began 
with a Diels–Alder aromatization reaction of diene 21628  and alkynoate 21729 
through the extrusion of 2-methylpropene (Scheme 3.4.2). This method for directly 
constructing the aromatic ring was quite efficient and reliable, requiring only 30 min 
in the microwave while giving less than 3% variation in yield over 10 runs. However, 
the major drawback of this strategy is that the maximum capacity for the microwave 
reactor is only  2 g, which severely limited the scalability of the synthesis, although a 
total of 8 g of 218 have been prepared using this method. The Diels–Alder product 
218 was protected as the bis-MOM ether and selectively brominated with N-
bromosuccinimide to give aryl bromide 219. Extensive investigation revealed that the 
MOM ethers were required for a successful Suzuki reaction. If TBS or TIPS ethers 
were employed the reaction simply turned black and only gave decomposition 
products. It is thought that the bulky nature of the TBS and TIPS groups hinders the 
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critical oxidative addition step while the less sterically encumbering MOM ethers are 
less intrusive. Thus the C20 methyl substituent of arene 220 was installed through 
the an sp2-sp3 Suzuki coupling30 of aryl bromide 219 with trimethylboroxine. As an 
alternative to the Suzuki coupling, a lithium-halogen exchange31  could also be 
employed to prepare arene 220 by generating the corresponding aryl anion of aryl 
bromide 219, which could undergo alkylation with MeI. While this offered a both 
cheaper and more abundant metal and alkyl source, the need for extreme cryogenic 
temperatures and the variable amounts of the inseparable reduced starting material 
weakened the utility of this method. Following the Suzuki reaction, acidic removal of 
both MOM ethers was followed by TIPS protection of the intermediate catechol 221, 
and hydrogenation of the benzyl ether furnished alcohol 222. A Swern oxidation of 
the resultant alcohol then provided the target aldehyde 158. While the synthesis of 
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aldehyde 158 over the 8 steps proceeded with excellent yields, specifically  all yields 
after the cycloaddition exceeding 90%, Floreancigʼs report of the synthesis of a 
nearly  identical aldehyde was only  a mere 3 steps, and had been run on 12 g scale 
(Scheme 2.4.3).27 Although our synthesis offered greater opportunity  for 
derivatization through the use of the Suzuki reaction, the brevity of Floreancigʼs 
synthesis would best serve our immediate goal of synthesizing irciniastatin A.
! The revised synthesis of aldehyde 158 and subsequently enolsilane 192 began 
from known catechol 8932 that was prepared by the cycloaddition of allene 8833,34 
and diene 87 (Scheme 3.4.3).35 Protection of catechol 89 as the bis- TIPS ether was 
followed by selective ester reduction to give aldehyde 158 in 78% yield over 2 steps. 
An asymmetric propionate aldol36 ,37,38  reaction of aldehyde 158 and propionyl 
thiazolidinethione 197 afforded the Evans-syn-aldol adduct 223 in 94% yield and 
>20:1 dr. A direct displacement of the chiral auxiliary  with Weinrebʼs amine was 
followed by acid promoted lactonization to give the dihydroisocoumarin 224 that was 
converted to methyl ketone 225 (6 steps; 63% overall from catechol 89). An initial 
attempt to convert the methyl ketone to the TMS enolsilane 227 surprisingly  formed 
significant amounts of trimethylsilyl protected acetal 228 in addition to the desired 
enolsilane 227. This unfortunate intramolecular attack was likely due to a 
combination factors. The first was that the excess TMSOTf Lewis acid required for 
the soft enolization was likely activating the lactone toward nucleophilic attack. The 
second possible factor was the conformational rigidity imposed by the 
dihydroisocoumarin, which positions the ketone directly underneath the lactone, 
inviting intramolecular attack by the enolsilane. The solution to this problem proved 
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to be stopping the reaction at ~60% conversion, which allowed for isolation of clean 
product before significant quantities of the byproduct formed. Alternatively, the 
corresponding TBS enolsilane 229 prepared with the less Lewis acidic and bulkier 
TBSOTf could be prepared without any observed side products in excellent yield.
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! In addition to enolsilanes 227 and 229, their non-lactonized counterparts could 
be accessed through an analogous sequence (Scheme 3.4.4). A direct displacement 
of the chiral auxiliary with Weinrebʼs amine was followed by protection of the 
secondary alcohol as a TBS ether to deliver silyl ether 230, which was subsequently 
converted to methyl ketone 231 (6 steps; 66% overall from catechol 89). In stark 
contrast to ketone 226 featuring the dihydroisocoumarin moiety, the conversion of 
ketone 231 to the TMS enolsilane 232 did not occur with any side products. This is 
likely  due to a combination of the increased conformational flexibility of the non-
lactonized substrate and the overall lower electrophilicity of esters compared with 
lactones. In addition, ketone 231 could also be converted to enolsilane 192 in 
excellent yield.
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3.5 Diastereoselective Coupling of the Enolsilane and Lactol-Acetate 
Fragments
! The union of the tetrahydropyran and the dihydroisocoumarin subunits have 
been critical to the successful synthesis of irciniastatin A. This has been a 
challenging endeavor due to the dense array of chiral centers at the juncture of 
these two fragments. All synthetic approaches to this union have utilized aldol 
chemistry, specifically  the Mukaiyama aldol39,7,27 and the Paterson aldol,3,6,9,40,41 to 
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address this problem (Scheme 3.5.1). While these methods took advantage of 
stereodirection from the dihydroisocoumarin fragment, we sought to develop  a more 
direct coupling that would capitalize on tetrahydropyran controlled stereodirection. 
We felt the observed substitution pattern about the tetrahydropyran would allow for a 
highly diastereoselective union of these two densely functionalized subunits.
! Having devised highly stereocontrolled routes to all three key fragments, the 
union of acetate 193 and the enolsilanes 227,229,232 and 192 were investigated 
(Scheme 3.5.2). Rigorous experimentation revealed that BF₃·OEt₂ was the optimum 
Lewis acid and that the TBS enolsilanes 229 and 192 performed better than their 
corresponding TMS enolsilanes 227 and 232 for the formation of the tetrahydropyran 
products. It was also observed that the yields employing the open-chain enolsilanes 
232 and 192 were consistently higher than those observed for enolsilanes 227 and 
229 with the lactone appendage. Most intriguing, however, was that addition of a 
solution of enolsilane 192 to a premixed solution of 193 and BF₃·OEt₂ at -40 °C was 
required for efficient coupling, yet this did not improve the efficiency of the coupling 
of enolsilane 232 and acetate 193. In all cases, the union proceeded with high 
diastereoselectivity, giving tetrahydropyrans 233 and 234 as the only detectable 
diastereomer in each case, which represents the most highly selective coupling of 
the tetrahydropyran and dihydroisocoumarin subunits.
! The high diastereoselectivity can be rationalized by well precedented 
pseudoaxial addition of the nucleophile along path C to the highest populated 
oxocarbenium conformer B, proceeding through a favorable chair like conformation 
as opposed to the disfavored path D that would proceed through a high energy  twist-
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boat. (Scheme 3.5.3). 42  Conformer B would also be expected to be favored as a 
result of through-space stereoelectronic stabilization of the oxocarbenium ion by the 
axially positioned C11 ether, whereas no such stabilization is present in conformer 
A. While nucleophile path A would be disfavored as a result of proceeding through a 
high energy twist-boat, path B that proceeds through a chair like conformation would 
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also be disfavored due to the developing high energy syn-pentane interaction in the 
product 
3.6 Completing the Total Synthesis of Irciniastatin A
! Having coupled the dihydroisocoumarin with the tetrahydropyran, conditions to 
set the C15 stereocenter were investigated (Scheme 3.6.1). Standard achiral 
reducing agents proved to be nonselective or were completely  selective for the 
undesired diastereomer in the case of i-Bu2AlH. At initial glance it would seem as 
though there werenʼt any synthetic handles available to direct the reduction. 
However, Evans has reported the use of TBS ethers to direct 1,3-carbonyl 
reductions, which was exactly what was present in our system.43 It was found that by 
slightly  modifying the reported conditions, a modest 3:1 selectivity could be obtained 
with 91% overall yield to give alcohol 235 in 70% isolated yield. The major isomer 
was carried forward to the 1,3-diol acetonide 240 whose ¹³C spectrum showed the 
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characteristic acetonide chemical shifts indicating the desired syn-1,3 relationship.44 
After protection of the secondary  alcohol as its TBS ether and cleavage of the benzyl 
ether, carbinol 236 was oxidized over 2 steps to carboxylic acid 237. Initial studies 
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into a one pot Curtius reaction with (O,O)-diphenylphosphoryl azide45 were found to 
be ineffective, providing significant quantities of inseparable carbamoyl azide 
impurity.46,47,48 Therefore, Weinstockʼs procedure49,50 was employed to generate the 
intermediate isocyanate, which under mild conditions using copper(I) chloride 
afforded Teoc-protected hemiaminal 238.51,52  Much to our dismay, a screen of 
reported conditions for acylation of structurally related intermediates never yielded 
N-acyl hemiaminal 239.9,53,54,55,56
!  A survey of all of the previous syntheses of irciniastatin A at the time revealed 
that all feature a late stage aminal and side chain incorporation with a preformed 
lactone of the dihydroisocoumarin (Scheme 3.6.2). In addition, DeBrabander had 
observed a close spatial relationship between these two regions of the molecule in 
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his synthesis of the analog psympederin 23.12 To lend further support that the 
dihydroisocoumarin was spatially close to the hemiaminal, the selectivity of the 
methoxyimidate coupling was completely reversed when comparing irciniastatin A 
(8) with the dihydroisocoumarin intact, and psympederin (23) that lacks the 
dihydroisocoumarin. Albeit unlikely that such remote functionality should have any 
effect on the hemiaminal coupling, the limited number of available options warranted 
pursuit of this lead.
! Having been presented with the necessity  to modify our current endgame 
strategy, it proved to be an ideal time to reinvestigate the C15 reduction (Scheme 
3.6.3). It was found that the (R)-CBS agent57,58 was completely selective for desired 
isomer 235 while also providing high and consistent yields. Strategically, after the 
ketone reduction, the lactone was formed concomitantly with removal of the TBS 
ether to give 243, adding only one synthetic step over the original plan. An 
analogous sequence of TBS protection of the C15 carbinol and hydrogenolysis of 
the benzyl ether gave carbinol 244, which was elaborated over two steps to acid 
245. Acid 245 was subjected to the previously established Curtius conditions to give 
hemiaminal 190. With hemiaminal 190 featuring the lactonized dihydroisocoumarin, 
it was found that i-PrMgCl, a base not previously used for this transformation, 
successfully  effected reaction with acid chloride 189 in a remarkable 87% yield. 
While this doesnʼt conclude that having the preformed lactone of the 
dihydroisocoumarin is requisite for a coupling of this type, it certainly lends strong 
support that that portion of the molecule does have a considerable influence. What 
was particularly interesting was that our advanced hemiaminal 190, which only 
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differs from Smithʼs hemiaminal 138 in the aryl ether protection (Crimmins TBS vs 
Smith SEM), was a completely ineffective coupling partner under Smithaʼs reported 
conditions using his pivalate anhydride 144. The role of the seemingly remote aryl 
protecting groups in the late-stage hemiaminal acylation was highlighted further in 
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the subsequent synthesis by Watanabe (TIPS aryl ethers), which was 25% less 
efficient than Smith (SEM aryl ethers). These discrepancies clearly  highlight a need 
to gain further insight on the structures of these advanced intermediates while also 
underscoring the pressing need to develop new technology for installing N-acyl 
hemiaminal functionality  in complex structures. Finally, to complete the total 
synthesis, a global deprotection with TASF in DMF at 50 °C provided (+)-irciniastatin 
A (8) in 94% yield.
	
 In summary, the total synthesis of (+)-irciniastatin A (8) was completed in 19 
steps with a 6% overall yield from 2-deoxy-D-ribose. The successful application of 
this strategy  allowed for rapid assembly of the three key fragments with high 
diastereocontrol. The 5 mg of synthetic irciniastatin A procured through these 
synthetic efforts has allowed for collaboration with the Lineberger Comprehensive 
Cancer Center to further evaluate the anti-tumor activity of irciniastatin A.
3.7 Second Generation Retrosynthetic Analysis
! After the completion of the most step efficient and convergent synthesis of 
irciniastatin A, our attention turned to streamlining our previous synthesis to add 
increased scalability and modularity. By strengthening these aspects of our 
synthesis it would be possible to rapidly assemble the parent natural product as well 
a library of analogues without significant changes to the synthetic route. 
Furthermore, a synthetic route with increased scalability  would provide additional 
irciniastatin A for screening against additional cell lines and  provide an opportunity 
to install an affinity probe to identify the cellular target.
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! Retrosynthetically, the psymberate side chain would be installed at a late 
stage as it was for our previous synthesis through the coupling of acid chloride 189 
with hemiaminal 190 (Scheme 3.7.1). The hemiaminal would arise from the Curtius 
degradation of carboxylic acid 247, which would arise from the coupling between 
enolsilane 192 and acyl dioxanone 248. This strategy would eliminate the need for 
late stage protecting group and oxidation state manipulations. Acyl dioxanone 248 
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would be prepared through a combination of Crimmins acetate aldol59 and glycolate 
anti-aldol reactions.15 By switching from a chiral pool approach to an iterative aldol 
approach toward the tetrahydropyran fragment, the preparation of analogs of this 
fragment could be prepared by varying either the aldehyde or enolate component in 
these reactions. The fully protected carbon skeleton of the psymberate side chain 
was envisioned to arise through a direct anti-acetal aldol reaction, that would 
drastically streamline the synthesis of this fragment by eliminating redundant 
oxidation state and protecting group manipulations. Lastly, enolsilane coupling 
partner 192 would be prepared as it was previously through a diene-allene 
cycloaddition, although our previously  developed enoate-diene cycloaddition would 
allow entry to C20 analogs should the need arise.
3.8 Efforts Toward the Second Generation Synthesis Toward Irciniastatin A
! The second generation synthesis of the tetrahydropyran core of irciniastatin A 
began through the acetate aldol reaction of known aldehyde 25360,61  and 
acetylthiazolidinethione 254, giving the aldol adduct 255 in 87% yield and a modest 
4:1 dr (Scheme 3.8.1). While it was anticipated that using Crimmins mesityl 
thiazolidinethione chiral auxiliary  would provide superior selectivity, the ease of 
preparation of the benzyl thiazolidinethione 254 auxiliary and the facile separation of 
the product diastereomers provided that this avenue would be ideal for initial 
investigations. The alcohol 255 was protected as the TBS ether and reductive 
removal of the chiral auxiliary provided aldehyde 249. With aldehyde 249 in hand, 
the Crimmins anti-aldol reaction was then investigated. Much to our surprise, the 
major product of the anti-aldol appeared to be a mixture of products resulting from a 
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Prins-type cyclization as indicated by the presence of new CH2 protons, carbinol and 
alcohol protons, and lack of terminal alkene protons in the 1H NMR. In fact, the TIPS 
protected β-hydroxy aldehyde 257 provided the impurity in 87% yield as a single 
isomer upon exposure to 2 equivalents TiCl4 at -78 °C  over 10 min. The required use 
of at least 2 equivalents of the TiCl4 Lewis acid for the anti-aldol and that the gem-
dimethyl groups likely create a significant Thorpe-Ingold effect, the rearrangement 
was perhaps not that surprising. The molecular weight and incorporation of a 
chlorine atom were confirmed by mass spectrometry. Based on the known molecular 
formula and the 1H NMR data, alcohol 258 is likely the rearranged product, however 
more data would be needed for a definitive structural assignment. 
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! Having discovered an unfortunate, although interesting, Prins-cyclization, our 
efforts turned to shutting down the byproduct reaction pathway. The TiCl4 Lewis acid 
responsible for activating the addition of the alkene to the aldehyde is required for 
the Crimmins anti-aldol and efforts to address this aspect of the problem were likely 
to be unfruitful. Similarly, installing the gem-dimethyl group after the anti-aldol would 
likely  require significant changes to our synthetic route. Instead, our attention 
focused on modifying the olefin component of our substrate that was responsible for 
undesired intramolecular nucleophilic addition to the aldehyde. The most 
straightforward modification that would require only small alterations to our current 
route would be to exchange the nucleophilic terminal alkene for an enoate, which 
would render the Prins cyclization electronically  unfavorable. Toward this end 
aldehyde 26062 is a known compound prepared over 3 steps from isobutyraldehyde 
(Scheme 3.8.2). While the known route is quite concise, it wasnʼt clear if it would 
meet our scalability needs. Therefore, a new route employing simple chemistry that 
used cheap and abundant starting materials was devised. Starting from 2,2-
dimethyl-1,3-propane diol (98), a mono-acetate protection and oxidation sequence 
provided aldehyde 259, which was subjected to a Horner-Wadsworth-Emmons 
reaction, ethanolysis and oxidation to arrive at the desired aldehyde 260. The 
scalability of this route was exemplified by the ability  to prepare 100 mmol of the 
alcohol precursor to aldehyde 260. An acetate aldol reaction of aldehyde 260 with 
the titanium enolate of acetylthiazolidinethione 254 provided a slightly improved 5:1 
dr and 90% yield over the previous sequence, which was also displayed scalability 
as it was run on 35 mmol scale. The protection of the β-hydroxy alcohol was 
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followed by a two-step reduction and oxidation sequence as the direct reduction of 
the auxiliary to the aldehyde was not possible in the presence of the enoate ester. 
The modified aldol substrate 262 was subjected to the Crimmins anti-aldol reaction 
and found to produce the desired product 263 with a mediocre 3.5:1:0.75 dr 
although with a 58% yield of the desired isomer. Indeed, the installation of an enoate 
moiety had electronically disabled the undesired Prins reaction, although itʼs 
subsequent removal proved exceedingly  difficult. A survey of transition metal 
catalyzed oxidative cleavage reactions resulted in either oxidation of the sulfur atom 
of the chiral auxiliary, or no reaction, as was observed for OsO₄. Similar problems 
were also encountered with ozonolysis reactions as oxidation of the 
oxazolidinethione to the oxazolidinone competed with enoate oxidation. Efforts to 
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completely oxidize the both oxazolidinethione and the enoate were only moderately 
successful but experienced further setbacks as the removal of the oxazolidinone 
was exceedingly difficult. The best results were obtained by adding a 
substoichiometric amount of ozone followed by  a triphenylphosphine quench and 
imidazole promoted cyclization to give acyl dioxanone 248 in a one-pot fashion in 
38% yield. 
! Having accessed the elusive acyl dioxanone 248, itʼs ability to participate in 
as an electrophilic coupling partner was explored (Scheme 3.8.3). It was initially 
found that the reaction of methallyltrimethylsilane 264 with acyl dioxanone 248 was 
unproductive using BF₃·OEt₂ or TMSOTf as the Lewis acid at temperatures below 
-25 °C. In fact, the desired coupling product was only  isolated when BF₃·OEt₂  was 
used as the Lewis acid at 0 °C, a temperature that would definitely  be too high to be 
compatible with our Lewis acid sensitive enolsilane coupling partner. The silver lining 
was that although the conditions were unfavorable at this stage, the oxocarbenium 
ion was forming and dioxanone 248 was participating in a productive coupling 
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reaction. It was thought that the coupling with dioxanone 248 was reluctant 
compared with our previous lactol-acetate 193 due to the loss in entropic driving 
force for the reaction as the leaving group was now tethered to our substrate. A 
potential solution for this problem was to employ a Lewis acid that could 
accommodate two ligands to give bidentate chelation of Lewis acid between the 
carboxyl and α-methoxy groups, which might provide a longer lifetime for the 
oxocarbenium ion. Also, a Lewis acid of this type, when doubly ligated would also 
lose a counter anion that could also stabilize the oxocarbenium ion. This hypothesis 
was supported by our experiments that showed a much improved reaction at lower 
temperatures by using SnCl4 or TiCl4. While the initial results for our model coupling 
were exciting, it was found that when these conditions were extended to our desired 
coupling reaction with enolsilane 192, the major product was deprotection of the C17 
TBS ether of the enolsilane in both cases. At this stage it was felt that the difficulty in 
accessing dioxanone 248 and its reluctance to participate in even simple coupling 
reactions warranted exploring other options.
! One of the significant drawbacks to installing the enoate in our previous 
fragment was that its oxidation to the aldehyde/lactol was particularly challenging. 
The main problem with the ozonolysis was that the oxazolidinethione was 
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undergoing competitive oxidation to the oxazolidinone, which was incredibly difficult 
to remove and cyclize to form the dioxanone 248. This problem could be alleviated 
by removing the auxiliary prior to the ozonolysis via esterification. Thus our sites 
were set on the synthesis of a more familiar lactol-acetate with a C7 ester instead of 
the dioxanone. Toward this end the aldol adduct 263 was directly  esterified to give 
methyl ester 267 that was subjected to a much improved ozonolysis and then 
acetylated to give lactol-acetate 268 (Scheme 3.8.4).
! With our modified coupling partner 268 in hand, its ability to function as an 
electrophilic coupling partner in our desired reaction was investigated (Scheme 
3.8.5). It was initially found that while lactol-acetate 268 showed improved reactivity 
at lower temperatures with BF₃·OEt₂ than dioxanone 248, the reactivity at lower 
temperatures was drastically increased by adding acetonitrile to the reaction. One 
possibility for the improved reactivity  could be that the polar acetonitrile solvent is 
stabilizing the oxocarbenium ion, which might otherwise be anchimerically stabilized 
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by the carbonyl of the methyl ester resulting in lower reactivity. The conditions were 
applied to our desired coupling of enolsilane 192 and acetate 268 giving a 24% yield 
of the tetrahydropyran 270, and recovery of most of the starting materials. While the 
coupling still required optimization, it was exciting that this was the first time we had 
achieved a productive coupling with C7 in the correct oxidation state. What was 
particularly interesting in this case was that our optimized conditions for our original 
coupling that required premixing that lactol acetate and BF₃·OEt₂  prior to enolsilane 
addition actually led to a decreased yield of 12% in the present case.
! Before extensive optimization of our coupling reaction, the remaining 
chemistry of the endgame sequence was explored (Scheme 3.8.6). In accord with 
our previous endgame the (R)-CBS agent provided a single carbinol diastereomer, 
whose identity would be confirmed upon completing the formal synthesis. A 
deprotection-lactonization reaction then afforded dihydroisocoumarin 272. A global 
reprotection as TBS ethers was then followed by an attempted hydrolysis of the 
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methyl ester, which unfortunately resulted in deprotection of the aryl TBS ethers to 
give 278 with the methyl ester still in tact.
! Although our previous endgame had failed at the last step  we believed the 
general template for our endgame strategy had a solid foundation from which to 
improve. The most pressing issue aside from the low-yielding coupling, was certainly 
the hydrolysis of the methyl ester, which could be alleviated by employing a benzyl 
ester that could be removed under more compatible hydrogenolysis conditions. This 
would then lead to the revised lactol acetate fragment 275 that would be prepared in 
an analogous fashion to the previous methyl ester 268 (Scheme 3.8.7). In addition, 
our previous endgame approaches suffered from a low yielding deprotection-
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lactonization reaction, which was followed by a redundant reprotection. By 
employing a modified enolsilane coupling partner featuring a benzyl protected ether 
at the C17 position it would then be possible after the coupling, and C15 carbonyl 
reduction-protection sequence, to hydrogenolyze both the benzyl ester and benzyl 
ether while forming the desired lactone. The successful implementation of this 
strategy would solve the current problem of ester hydrolysis and improve our original 
endgame sequence by 3 steps.
! With a revised strategy  in place our efforts began with the synthesis of lactol-
acetate 275 starting with esterification of aldol adduct 263 to provide benzyl ester 
278 (Scheme 3.8.8). In an improvement over the previous protocol, a one-pot 
ozonolysis-lactolization-acetate protection sequence was carried out to give the 
desired lactol acetate 275 in a remarkable 86% yield
! Future work on this project will focus on the development of an efficient 
coupling reaction between acetate 275 and enolsilane 274 as well as the 
subsequent endgame chemistry. Our revised synthesis of the tetrahydropyran 
precursor will allow for the synthesis tetrahydropyran analogs to be screened for 
biological activity alongside the additional synthetic irciniastatin A prepared through 
our research efforts. 
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Chapter 4: Experimental Procedures and NMR 
Spectra
4.1 Materials and Methods
! Infrared (IR) spectra were obtained using a Jasco 460 Plus Fourier transform 
infrared spectrometer. Nuclear magnetic resonance (¹H, ¹³C, COSY, NOESY) 
spectra were recorded on Bruker model Avance 400 (¹H at 400 MHz; ¹³C  at 100 
MHz) and Bruker model Avance 500 (¹H at 500 MHz; ¹³C  at 125 MHz) instruments. 
Chemical shifts are reported relative to chloroform (δ 7.26), benzene (δ 7.15) or 
methanol (δ 4.78) for ¹H NMR spectra and chloroform (δ 77.23), benzene or (δ 
128.0) methanol (δ 49.3), for ¹³C  spectra. ¹H NMR data are reported as follows: 
chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet), coupling constants (Hz), and integration. Optical rotations were 
determined using a Jasco P1010 polarimeter. Mass spectra were obtained using a 
Bruker BioTOF II mass spectrometer with electrospray ionization (ESI).  Thin layer 
chromatography (TLC) was conducted on silica gel F254 TLC plates purchased from 
EMD Chemicals Inc. Visualization was accomplished with UV light and/or aqueous 
ceric ammonium molybdate solution followed by heating unless otherwise noted. 
Flash column chromatography was carried out using Ultra Pure Silica Gel Silia-P (40 
to 63 µm) purchased from SiliCycle Inc.  Dichloromethane (CH₂Cl₂), diethyl ether 
(Et₂O), tetrahydrofuran (THF), and toluene (PhCH₃) were dried by passage through a 
column of neutral alumina under argon immediately prior to use.    All alkylamines, 
2,6-lutidine, benzene, pyridine, and chlorotrimethylsilane (TMSCl) were distilled from 
calcium hydride immediately prior to use.  Boron trifluoride-diethyl etherate was 
distilled from calcium hydroxide immediately  prior to use.  Iodomethane was distilled 
prior to use. Anhydrous N,N-dimethylformamide (DMF) was purchased from Aldrich 
chemical company in 1L Sure/SealTM bottles. Dess-Martin periodinane was 
prepared according to literature procedures and stored at -20 ºC. Procedures calling 
for pH = 4 buffer employed Fisher Scientific Buffer Solution pH 4.00 (0.05 M 
potassium biphthalate buffer). Sodium hydride, 60% oil dispersion, was washed with 
pentanes under positive argon pressure prior to use. All other reagents and solvents 
were used as received from the manufacturer.  All air and water sensitive reactions 
were performed in flasks flame dried under positive flow of argon and conducted 
under an argon atmosphere. Yield refers to isolated yield of analytically  pure material 
unless otherwise noted.
4.2 Experimental Procedures
(-)-Methyl Ether To a 0 °C  slurry  of 60% NaH oil dispersion (128 mg, 3.19 mmol) in 
THF (10 mL) was added a solution of alcohol (910 mg, 2.66 mmol) in THF (3.5 mL) 
over 2 min followed by a THF rinse (3.5 mL). The reaction was stirred at 0 °C for 20 
min and was then treated with iodomethane (0.25 mL, 3.98 mmol), stirred at 0 °C  for 
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5 min, then the white slurry was warmed to room temperature. After 1 h the 
transparent reaction was quenched with saturated aqueous NH4Cl (12 mL), the 
layers were separated, and the aqueous layer was extracted with EtOAc (3 × 10 
mL). The combined organic layers were washed with brine (10 mL), dried over 
Na2SO4, filtered, and concentrated. Purification by column chromatography (5% 
EtOAc/Hexanes) gave (-)-methyl ether (905 mg, 2.53 mmol) as a clear oil in 96% 
yield. [α]23D = -4.94 (c = 0.26, CH2Cl2); IR (film) 3076, 2942, 2866, 1647, 1382, 1327, 
1246, 1107, 1012, 996, 919, 883, 796, 682, 659; ¹H NMR (400 MHz, CDCl₃) δ 1.04 
(m, 21 H), 1.79 (s, 3H), 2.30 (m, 2H), 3.40 (s, 3H), 3.55 (m, 2H), 3.79 (m, 2H), 4.17 
(m, 2H), 4.80 (m, 2H), 5.14 (dd, J = 1.6, 10.2 Hz, 1H), 5.26 (dd, J = 1.6, 17.2 Hz, 
1H), 5.92 (m, 1H); ¹³C NMR (100 MHz, CDCl₃) δ 11.9, 18.0, 22.8, 38.5, 57.9, 63.2, 
72.0, 80.1, 80.7, 112.24, 116.3, 135.5, 143.2; MS (ESI+) for C20H40O3Si [M+Na] calc 
379.2644 found 379.2639.
(+)-Alcohol 210 To a 0 °C  solution of (-)-allyl ether (905 mg, 2.54 mmol) in ether (25 
mL) was added titanium(IV) isopropoxide (0.75 mL, 2.53 mmol) to give a yellow 
solution, which was treated with 2.0 M n-BuMgCl in ether (3.17 mL, 6.344 mmol) 
over 1 h via syringe pump. Immediately following the addition the dark orange 
solution was quenched with water (3 mL), filtered through celite, and rinsed with 
EtOAc (50 mL). The layers were separated and the aqueous phase was extracted 
with EtOAc (3 × 10 mL). The combined organic layers were washed with saturated 
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NH4Cl, dried over Na2SO4, filtered, and concentrated. Purification by column 
chromatography (5% EtOAc/Hexanes) afforded (+)-alcohol 210 (690 mg, 2.18 mmol) 
as yellow oil in 86% yield. [α]25D = +15.3 (c = 0.25, CH2Cl2); IR (film) 3459, 2942, 
2867, 1462, 1104, 1066, 883, 800, 682, 660 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.10 
(m, 21H), 1.79 (s, 3H), 2.30 (m, 2H), 2.52 (d, J = 4.0 Hz, 1H), 3.40 (s, 3H), 3.45 (m, 
1H), 3.67 (m, 1H), 3.80 (m, 2H), 4.81 (d, J =  7.2 Hz, 2H); ¹³C NMR (100 MHz, 
CDCl₃) δ 11.9, 17.9, 22.9, 38.4, 58.0, 63.8, 72.9, 80.1, 112.6, 142.9; MS (ESI+) for 
C17H36O3Si [M+Na] calc 339.2272 found 339.2096.
(-)-SEM Ether To a solution of alcohol (+)-210 (220 mg, 0.690 mmol) in CH₂Cl₂ (2.22 
mL) was added i-Pr2NEt (0.97 mL, 5.55 mmol) followed by SEMCl (0.49 mL, 2.78 
mmol). The reaction was heated to 30 ˚C  and stirred for 1 h giving an orange 
solution. The reaction was poured into ice cold aqueous NaHCO3, the layers were 
separated, and the aqueous extracted with CH₂Cl₂ (3 x 5 mL). The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, and concentrated. 
Purification by column chromatography (3% EtOAc/Hexanes) gave (-)-SEM ether 
(268 mg, 0.600 mmol) as clear oil in 86% yield. [α]23D = -14.1 (c = 0.28, CH2Cl2); IR 
(film) 2943, 2867, 1463, 1375, 1248, 1105, 1030, 883, 860, 835, 682 cm-1; ¹H NMR 
(500 MHz, CDCl₃) δ 0.01 (s, 9H), 0.93 (t, J = 8.5 Hz, 2H), 1.06 (m, 21H), 1.78 (s, 
3H), 2.23 (dd, J = 4.0, 14.5 Hz, 1H), 2.29 (dd, J = 9.5, 14.5 Hz, 1H), 3.39 (s, 3H), 
3.60 (m, 2H), 3.66 (m, 1H), 3.73 (dd, J = 5.5, 9.5 Hz, 1H), 3.83 (m, 2H), 4.80 (m, 
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4H); ¹³C NMR (125 MHz, CDCl₃) δ -1.4, 11.9, 18.0, 18.1, 22.7, 38.3, 57.9, 63.07, 
65.1, 78.1, 79.9, 95.2, 112.3, 143.1; MS (ESI+) for C23H50O4Si2 [M+Cs] calc 
579.2302 found 579.2332.
(+)-Alcohol To a 0 ˚C  solution of (-)-TIPS ether (500 mg, 1.12 mmol) in THF (3.63 
mL) was added 1.0 M TBAF in THF (2.23 mL, 2.23 mmol).  The reaction stirred for 
15 min at 0 °C and the reaction was poured into saturated aqueous NH₄Cl (3 mL), 
the layers were separated and the aqueous layer was extracted with EtOAc (3 x 3 
mL). The combined organic layers were washed with water (2 mL) and brine (2 mL), 
dried over Na2SO4, filtered, and concentrated. Purification by column 
chromatography (20% EtOAc/Hexanes) afforded (+)-alcohol (265 mg, 0.91 mmol) as 
clear oil in 82% yield. [α]20D = +38.7 (c = 0.25, CH2Cl2); IR (film) 3462, 2952, 1647, 
1375, 1249, 1107, 1057, 1024, 860, 835, 693 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 
0.01 (s, 9H), 0.96 (t, J = 8.8 Hz, 2H), 1.77 (s, 3H), 2.20 (dd, J = 5.2, 14.0 Hz, 1H), 
2.32 (dd, J = 8.0, 14.0 Hz, 1H), 3.25 (dd, 4.4, 8.0 Hz, 1H), 3.39 (s, 3H), 3.49 (m, 1H), 
3.59 (m, 2H), 3.69 (m, 3H), 4.76 (m, 4H); ¹³C NMR (125 MHz, CDCl₃) δ -1.5, 18.1, 
22.7, 39.3, 58.3, 62.3, 65.7, 80.8, 82.1, 95.3, 112.8, 142.4; MS (ESI+) for C14H30O4Si 
[M+Na] calc 313.1181 found 313.1806.
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(-)-Aldehyde (-)-Aldehyde was prepared from (+)-alcohol according to literature 
procedures. Smith, A. B.; Jurica, J. A.; Walsh, S. P., Org. Lett. 2008, 10, 5625. [α]19D 
= -7.6 (c = 0.26, CH2Cl2); IR (film) 3078, 2953, 2891, 2826, 2724, 1732, 1644, 1377, 
1249, 1109, 1059, 1027, 937, 860, 834 cm-1; ¹H NMR (500 MHz, CDCl₃) δ -0.09 (s, 
9H), 0.81 (m, 2H), 1.61 (s, 3H), 2.20 (dd, J = 7.0, 14.0 Hz, 1H), 2.26 (dd, J = 6.5, 
14.0 Hz, 1H), 3.31 (s, 3H), 2.42 (ddd, J = 7.0, 10, 10.0 Hz, 1H), 3.62 (m, 2H), 4.03 
(s, 1H), 4.70 (m, 2H), 4.74 (s, 2H), 9.56 (s, 1H); ¹³C NMR (100 MHz, CDCl₃) δ -1.5, 
18.0, 22.5, 38.7, 57.8, 65.8, 81.6, 82.3, 95.3, 114.1, 141.5, 202.0; MS (ESI+) for 
C14H28O4Si [M+Na] calc 311.1655 found 311.1622.
(-)-Acid 137. A solution of (-)-aldehyde (146 mg, 0.506 mmol) in t-BuOH (23 mL) and 
2-methyl-2-butene (1.29 mL, 12.15 mmol) was treated with a solution of NaClO2 
(687 mg, 6.07 mmol) in 0.05 M potassium biphthalate pH 4 buffer (23 mL) in one 
portion. The yellow solution was stirred for 1 h, gradually  turning clear.  The reaction 
was then poured into brine (50 mL) and EtOAc (50 mL).  The layers were separated 
and the aqueous layer was extracted with EtOAc (4 x 20 mL) and the combined 
organic layers were dried over Na₂SO₄, filtered, and concentrated. Purification by 
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column chromatography (25% EtOAc/Hexanes to 40% EtOAc/Hexanes) gave (-)-
acid 137 (146 mg, 0.48 mmol) as a clear oil in 95% yield, that was stored frozen in 
benzene. [α]22D = -6.2 (c = 0.26, CH2Cl2); IR (film) 3076, 2953, 1725, 1443, 1376, 
1249, 1190, 1158, 1111, 1061, 891, 860, 835, 758, 693 cm-1; ¹H NMR (400 MHz, 
C₆D₆) δ -0.02 (s, 9H), 0.93 (m, 2H), 1.70 (s, 3H), 2.50 (m, 2H), 3.21 (s, 3H), 3.65 (m, 
2H), 3.84 (m, 1H), 4.45 (d, J = 3.2 Hz, 1H), 4.65 (q, J = 8.5, 19.5 Hz, 2H), 4.86 (s, 
1H), 4.93 (s, 1H); ¹³C NMR (100 MHz, C₆D₆) δ -0.4, 19.1, 23.9, 40.2, 58.9, 67.0, 
77.7, 82.3, 96.0, 114.5, 143.3, 177.5; MS (ESI+) for C14H28O5Si [M+Na] calc 
327.1604 found 327.1586.
(-)-Methyl Ether To a 0 °C solution of alcohol (8.80 g, 35.16 mmol) and MeI (4.36 
mL, 42.19 mmol) in THF (122 mL) and DMF (12.2 mL) was added NaH 60% oil 
dispersion (2.02 g, 84.38 mmol). The reaction mixture was stirred for 30 min at 0 °C 
and 1 h at room temperature then quenched with saturated aqueous NH₄Cl. The 
layers were separated and the aqueous layer was extracted with EtOAc (5 x 50 mL). 
The combined organic layers were dried over Na₂SO₄, filtered and concentrated. 
Purification by column chromatography (Hexanes to 10% EtOAc/Hexanes) afforded 
(-)-methyl ether (8.50 g, 32.15 mmol) in 91% yield as clear oil. [α]22D = -44.03 (c = 
0.55, CH2Cl2); IR (film) 3074, 2934, 2836, 1615, 1517, 1250, 1102, 1034, 827 cm-1; 
¹H NMR (500 MHz, CDCl₃) δ 2.42 (ddd, J = 7.5, 7.5, 14.5 Hz, 1H), 2.65 (m, 1H), 3.24 
(ddd, J = 5.0, 9.5, 9.5, 1H), 3.43 (s, 3H), 3.56 (t, J = 11.0 Hz, 1H), 3.64 (m, 1H), 3.81 
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(s, 3H) 4.42 (dd, 5.0, 11.0 Hz, 1H), 5.12 (dd, J = 2.0, 10.0 Hz, 1H), 5.16 (dd, J = 2.0, 
17.0 Hz, 1H), 5.43 (s, 1H), 5.99 (dddd, 7.5, 7.5, 10.0, 17.0 Hz, 1H), 6.89 (d, J = 9.0 
Hz, 2H), 7.41 (d, J = 9.0 Hz, 2H); ¹³C NMR (125 MHz, CDCl₃) δ 36.2, 55.3, 58.1, 
69.0, 73.9, 80.1, 100.9, 113.6, 117.2, 127.4, 130.5, 134.4, 160.0; MS (ESI+) for 
C15H20O4 [M+Cs] calc 397.0416 found 397.0423.
(-)-Aldehyde 212 To a solution of (-)-alkene (6.48 g, 24.5 mmol) in THF (48 mL) and 
water (48 mL) was added NMO (6.12 g, 52.24 mmol) followed by a 20 mg/1.0 mL 
solution of OsO₄ in water (0.64 mL, 0.05 mmol). The reaction mixture was stirred for 
16 h and was quenched with solid Na₂S₂O₃  (3.2 g) and stirred for 1 h.  The layers 
were separated and the aqueous layer was extracted with CH₂Cl₂ (3 x 50 mL). The 
combined organic layers were concentrated and taken on to the next step without 
purification. 
! To a 0 °C biphasic solution of the crude diol (7.36 g, 24.5 mmol) in 0.05 
potassium biphthalate pH 4 buffer (66 mL) and CH₂Cl₂ (66 mL), was added NaIO₄ 
(7.82 g, 36.56 mmol). The mixture stirred for 5 min at 0 °C  and was then warmed to 
room temperature for 2 h. The reaction mixture was quenched with aqueous 
Na₂S₂O₃, the layers were separated and the aqueous layer was extracted with 
CH₂Cl₂ (3 x 50 mL). The combined organic layers were dried over MgSO₄, filtered 
and concentrated to crude oil. Purification by column chromatography (5% EtOAc/
Hexanes to 20% EtOAc/Hexanes) afforded (-)-aldehyde 212. (6.3 g, 23.7 mmol) in 
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97% yield over 2 steps. [α]26D -41.2 (c 0.46, CH2Cl2); IR (film) 2935, 2837, 1725, 
1615, 1518 cm-1; 1H NMR (CDCl3, 400 MHz); δ 2.71 (ddd, J = 2.4, 7.6, 16.4 Hz, 1H), 
2.83 (ddd, J = 2.4, 4.8, 16.4 Hz, 1H), 3.21 (ddd, J = 5.2, 9.6, 19.2 Hz, 1H), 3.36 (s, 
3H), 3.56 (dd, J = 10.4, 10.4 Hz, 1H), 3.76 (s, 3H), 4.12 (ddd, J = 4.4, 7.6, 9.2 Hz, 
1H), 4.43 (dd, J = 5.2, 11.2 Hz, 1H), 5.48 (s, 1H); 6.86 (d, J = 8.8 Hz, 2H), 7.35 (d, J 
= 8.8 Hz, 2H), 9.78 (s, 1H); 13C  NMR (CDCl3, 75 MHz) ppm 46.3, 55.2, 57.7, 68.9, 
74.0, 75.5, 101.0,  113.5, 127.3, 129.7, 199.8, 160.0; MS (ESI+) calc for C14H18O5 (M
+H) 267.12, found 267.2.
(-)-Alcohol 213 To a stirring solution of N-Ts-(L)-valine (2.89 g, 10.6 mmol) in CH2Cl2 
(100 mL) at 0 ºC was added BH3•THF (10.6 mL of a 1.0 M solution in THF, 10.6 
mmol) in portions over 0.5 h. After the reaction mixture was cooled to -78 ºC neat 
silyl ketene acetal 124 (3.82 g, 20.2 mmol) was added and stirred for 5 min. (-)-
Aldehyde 212 (2.7 g, 10.1 mmol) was added and stirred for 2 h. The reaction mixture 
was quenched by the addition of a 10% aqueous solution of NaHCO₃  (20 mL) and 
the layers were separated. The aqueous layer was extracted with CH₂Cl₂  and the 
combined organic layers were dried over MgSO₄, filtered and concentrated. 
Purification by  column chromatography (10% to 25% EtOAc/Hexanes) gave (-)-
alcohol 213 (3.24 g, 8.47 mmol) in 84% yield as a 9:1 mixture of diastereomers. [α]
18D -39.5 (c = 0.55, CH2Cl2); IR (film) 3535, 1726, 1615, 1519 cm-1; 1H NMR (CDCl3, 
400 MHz); δ 1.17 (s, 3H), 1.14 (s, 3H), 1.22 (dd, J = 7.2, 7.2 Hz, 3H), 1.63 (m, 1H), 
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2.03 (m, 1H), 3.25 – 3.19 (m, 2H), 3.39 (s, 3H), 3.54 (dd, J = 10.4, 10.4 Hz, 1H), 
3.76 (s, 3H), 3.81 (ddd, J = 9.2, 9.2, 2.4  Hz, 1H), 4.16 – 4.05 (m, 3H), 4.41 (dd, J = 
10.8, 4.8 Hz, 1H), 5.44 (s, 1H), 6.83 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H); 13C 
NMR (CDCl3, 75 MHz) ppm 14.1 20.4, 21.0, 33.8, 47.0, 55.2, 57.9, 60.5, 69.0, 74.5, 
75.9, 81.5, 101.0, 113.6, 127.3, 129.6, 160.1, 177.8; MS (ESI+) calc for C20H30O7 (M
+H) 383.45, found 383.3.
(-)-Silyl Ether To a solution of (-)-alcohol 213 (3.00 g, 7.83 mmol) in CH2Cl2, (50 mL) 
at 0 ºC was added 2,6-lutidine (2.28 mL, 19.7 mmol) followed by TBSOTf (2.72 g, 
10.3 mmol).The reaction stirred for 1 h at 0 °C and warmed to room temperature and 
stirred for 1 h. The reaction mixture was quenched with saturated aqueous NaHCO₃, 
the layers were separated, and the aqueous layer was extracted with CH₂Cl₂ (3 x 10 
mL). The combined organic layers were washed with brine (5 mL), dried over 
MgSO₄, filtered and concentrated. Purification by column chromatography (10% 
EtOAc/Hexanes) gave (3.47 g, 7.00 mmol) of (-)-silyl ether in 89% yield as a clear 
oil. [α]26D -36.0 (c = 0.53, CH2Cl2); IR (film) 1730, 1616, 1518 cm-1; 1H NMR (400 
MHz, CDCl₃); δ -0.06 (s, 3H), 0.05 (s, 3H), 0.83 (s, 9H), 1.11 (s, 3H), 1.17 (s, 3H), 
1.23 (dd, J = 8.0, 8.0 Hz , 3H), 1.64 (ddd, J = 13.6, 8.0, 4.0 Hz, 1H), 2.19 (ddd, J = 
14.8, 5.2, 5.2 Hz, 1H), 3.07 (ddd, J = 9.6, 9.6, 4.8 Hz, 1H), 3.55 – 3.46 (m, 2H), 3.39 
(s, 3H), 4.05 (dd, J = 14.4, 7.2 Hz, 2H), 3.78 (s, 3H), 4.23 (dd, J = 4.8, 4.8  Hz, 1H), 
4.37 (dd, J = 10.8, 4.8 Hz, 1H), 5.35 (s, 1H), 6.85 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.4 
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Hz, 2H); 13C NMR (75 MHz, CDCl₃) ppm -5.1, -3.9, 14.0, 18.1, 20.3, 21.2, 25.9, 38.2, 
48.3, 55.2, 57.9, 60.3, 69.0, 73.2, 76.1, 78.6, 101.1, 113.4, 127.5, 130.3, 159.9, 
177.0; MS (ESI+) calc for C26H44O7Si (M+H) 497.28, found 497.4.
(-)-1,3-Diol.  To a flask containing (-)-p-methoxybenzylidine acetal (533 mg, 1.072 
mmol) added Pd(OH)2/C (275 mg) followed by THF (2 mL). The reaction was 
degassed under reduced pressure, charged with hydrogen, and stirred under a 
balloon of hydrogen for 5 h. The reaction was filtered through Celite®, washed with 
THF (75 mL), concentrated to clear oil and taken on crude to the next step. [α]18D = 
-9.8 (c = 0.27, CH2Cl2); IR (film) 3446, 2932, 2857, 1720, 1472, 1387, 1362, 1256, 
1093, 836, 776 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.08 (s, 3H), 0.14 (s, 3H), 0.89 (s, 
9H), 1.11 (s, 3H), 1.19 (s, 3H), 1.27 (t, J = 2.8 Hz, 3H), 1.60 (m, 1H), 1.82 (m, 1H), 
2.29 (s, 1H), 2.41 (m, 1H), 2.81 (m, 1H), 3.07, (m 1H) 3.44 (s, 3H), 3.81 (m, 4H), 
4.14 (m, 3H); ¹³C  NMR (100 MHz, CDCl₃) δ -4.50, -3.91, 14.00, 18.12, 19.03, 23.24, 
25.89, 38.05, 47.72, 57.66, 60.70, 69.76, 74.11, 83.36, 177.58; MS (ESI+) for 
C18H38O6Si [M+Cs] calc 511.1492 found 511.1479.
(-)-Lactone 214 Crude (-)-diol, dried azeotropically with toluene, was dissolved in 
CH2Cl2 (5 mL), cooled to 0 °C, then treated with TFA (40 μL, 0.536 mmol). The 
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reaction was stirred for 5 min at 0 °C then stirred at room temperature for 5 h. The 
reaction was quenched with saturated aqueous NaHCO3 (1.5 mL) and the aqueous 
phase was extracted with CH2Cl2 (3 × 5 mL), dried over Na2SO4, filtered and 
concentrated to clear oil. Purification by column chromatography (25% EtOAc/
CH₂Cl₂) afforded pure (-)-lactone 214 (315 mg, 0.946 mmol) in 88% yield over 2 
steps as clear oil.  [α]18D = -36.6 (c = 0.22, CH2Cl2); IR (film) 3450, 2930, 1731, 1471, 
1391, 1257, 1162, 1131, 1088, 835, 776 cm-1; ¹H NMR (500 MHz, CDCl₃) δ 0.05 (s, 
3H), 0.06 (s, 3H), 0.86 (s, 9H), 1.24 (s, 3H), 1.25 (s, 3H), 1.80 (m, 1H), 2.11 (s, 1H), 
2.22 (t, J = 12.3 Hz, 1H), 3.50 (s, 3H), 3.52 (m, 1H), 3.70 (m, 1H), 3.65 (m, 1H), 3.79 
(s, 1H), 4.76 (dd, J = 3.3, 7.5 Hz, 1H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.6, 18.0, 
22.9, 25.7, 26.1, 28.2, 44.2, 59.5, 60.9, 73.1, 76.7, 82.7, 176.8; MS (ESI+) for 
C16H32O5Si [M+Cs] calc 465.1073 found 465.1120.
(-)-Benzyl Ether 215. To a flask containing sodium hydride 60% oil dispersion (220 
mg, 5.73 mmol), washed with pentanes, was added THF (3.5 mL) and cooled to 0 
°C. The resulting slurry was treated with a room temperature solution of alcohol (-)-
lactone 214 (763 mg, 2.29 mmol), tetrabutylammonium iodide (170 mg, 0.45 mmol), 
and benzyl bromide (0.41 mL, 3.44 mmol) in THF (4.9 mL) over 10 min. The reaction 
mixture was stirred for 45 min at 0 °C and then warmed to room temperature and 
stirred for 5 h. The reaction was cooled to 0 °C and quenched with a saturated 
solution of aqueous NH₄Cl (7 mL) followed by dilution with ethyl acetate (7 mL) and 
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water (2 mL). The layers were separated and the aqueous phase was extracted with 
ethyl acetate (3 x 7 mL). The organics were combined and washed with brine (5 
mL), dried over Na2SO4, filtered and concentrated to orange oil. Purification by 
column chromatography (5% EtOAc/Hexanes to 25% EtOAc/Hexanes) to afforded 
(-)-benzyl ether 215 (865 mg, 2.04) in 89% yield as clear oil. [α]21D = -27.3 (c = 0.27, 
CH2Cl2); IR (film) 2929, 2857, 1734, 1462, 1390, 1257, 1164, 1092, 1031, 1016, 835, 
776 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.03 (s, 3H), 0.05 (s, 3H), 0.85, (s, 9H) 1.23 
(s, 3H), 1.25 (s, 3H); 1.75 (dt, J = 4.4, 4.4, 14.0 Hz, 1H), 2.26 (m, 1H), 3.46 (m, 4H), 
3.54, (m, Hz, 1H); 3.78 (m, 1H), 3.78 (m, 1H), 4.50 (s, 2H), 4.82 (m, 1H), 7.30, (m, 
5H); ¹³C NMR (100 MHz, CDCl₃) δ -5.2, -4.7, 17.8, 22.8, 25.6, 25.7, 27.1, 44.0, 59.3, 
68.6, 73.0, 73.4, 76.7, 81.0, 127.5, 127.6, 128.2, 137.7, 176.6; MS (ESI+) for 
C23H38O5Si [M+Cs] calc 555.1543 found 555.1550.
(-)-Lactol. To a -78 °C solution of (-)-lactone 215 (865 mg, 2.0 mmol) in ether (20 
mL) added 1.0 M solution of diisobutylaluminum hydride in hexanes (3.58 mL, 3.58 
mmol), dropwise, over 5 min. The reaction stirred for 2 h at -78 °C and was 
quenched with a saturated solution of Rochelleʼs salt (10 mL) at -78 °C. The mixture 
warmed to room temperature and stirred for 2.5 h. The aqueous phase was 
extracted with EtOAc (4 x 10 mL) and the combined organics were washed with 
brine (5 mL), dried over Na2SO4, filtered, and concentrated to clear oil. The oil was 
purified by  column chromatography (10% EtOAc/Hexanes to 25% EtOAc/Hexanes) 
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to give (-)-lactol (844 mg, 1.99 mmol) as an inseparable 5:1 mixture of anomers that 
were carried forward to the anomerically stable lactol-acetate for characterization.
(-)-Lactol-Acetate 193 To a solution of (-)-lactol (561 mg, 1.321 mmol) in pyridine 
(1.6 mL) was added acetic anhydride (1.25 mL, 13.21 mmol) over 1 min and stirred 
for 16 h. The reaction mixture was diluted with CH2Cl2 (25 mL) and quenched with 
saturated aqueous sodium bicarbonate (2 mL). The layers were separated and the 
aqueous was extracted with CH2Cl2 (3 × 10 mL). The combined organics were 
washed with brine (5 mL), dried over Na₂SO₄, filtered, concentrated to yellow oil. 
Purification by  flash column chromatography (10% EtOAc/Hexanes) gave (-)-lactol-
acetate 193 (565 mg, 1.21 mmol) in quantitative yield as clear oil. [α]21D = -33.4 (c = 
0.27, CH2Cl2); IR (film) 2929, 2857, 1753, 1473, 1457, 1391, 1364, 1226, 1058, 835, 
775 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.03 (s, 3H), 0.04 (s, 3H), 0.88 (s, 3 H), 0.09 
(s, 9H), 0.098 (s, 3H), 1.54 (dt, J = 2.7, 2.7, 14.0 Hz, 1H), 1.92 (m, 1H), 2.09 (s, 3H), 
3.48 (m, 5H), 3.61 (dd, J = 3.2, 9.8 Hz, 1H), 3.67, (t, J = 2.7 Hz, 1H), 4.10 (ddd , J = 
2.7, 4.7, 11.7 Hz, 1H), 4.52 (s, 2H), 5.75 (s, 1H), 7.29 (m, 5H); ¹³C NMR (100 MHz, 
CDCl₃) δ -5.1, -4.6, 18.0, 18.6, 21.0, 21.6, 25.8, 30.6, 38.6, 58.8, 70.0, 72.1, 73.4, 
75.0, 82.0, 96.1, 126.8, 127.4, 128.2, 128.6, 138.3, 169.6; MS (ESI+) for C25H42O6Si 
[M+Cs] calc 599.1805 found 599.1801.
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(-)-Lactone 214 To a solution of benzylidine acetal (1.00 g, 2.01 mmol) in methanol 
(5 mL) at 0 °C was added a 0 °C  solution of 0.01 M HCl in methanol (10 mL, 0.10 
mmol). The reaction was stirred for 1.25 h at 0 °C and was quenched with saturated 
aqueous NaHCO3 (16 mL) the layers were separated, and the aqueous phase was 
extracted with CH2Cl2 (3 × 60 mL). The combined organic layers were washed with 
water (10 mL) and brine (10 mL), dried over Na2SO4, filtered and concentrated to oil. 
Purification by column chromatography (25% EtOAc/CH₂Cl₂) afforded pure (-)-
lactone 214 (470 mg, 1.40 mmol) in 70% yield as white solids, as well as diol (-)-1,3-
diol (47 mg, 0.124 mmol) in 7% yield as clear oil. (-)-1,3-Diol (47 mg, 0.124 mmol) 
azeotroped with toluene, was dissolved in CH2Cl2 (5 mL), cooled to 0 °C, then 
treated with TFA (40 μL, 0.536 mmol). The reaction was stirred for 5 min at 0 °C  then 
stirred at room temperature for 5 h. The reaction was quenched with saturated 
aqueous NaHCO3 (1.5 mL) and the layers were separated. The aqueous phase was 
extracted with CH2Cl2 (3 × 5 mL) and the combined organic layers were dried over 
Na2SO4, filtered and concentrated to white solids. Purification by column 
chromatography (25% EtOAc/CH₂Cl₂) afforded pure (-)-lactone 214 (41 mg, 0.124 
mmol) in quantitative yield, for a combined 77% yield. [α]18D = -36.6 (c = 0.22, 
CH2Cl2); IR (film) 3450, 2930, 1731, 1471, 1391, 1257, 1162, 1131, 1088, 835, 776 
cm-1; ¹H NMR (500 MHz, CDCl₃) δ 0.05 (s, 3H), 0.06 (s, 3H), 0.86 (s, 9H), 1.24 (s, 
3H), 1.25 (s, 3H), 1.80 (m, 1H), 2.11 (s, 1H), 2.22 (t, J = 12.3 Hz, 1H), 3.50 (s, 3H), 
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3.52 (m, 1H), 3.70 (m, 1H), 3.65 (m, 1H), 3.79 (s, 1H), 4.76 (dd, J = 3.3, 7.5 Hz, 1H); 
¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.6, 18.0, 22.9, 25.7, 26.1, 28.2, 44.2, 59.5, 
60.9, 73.1, 76.7, 82.7, 176.8; MS (ESI+) for C16H32O5Si [M+Cs] calc 465.1073 found 
465.1120.
(-)-Benzyl Ether 215 To a flask containing sodium hydride 60% oil dispersion (220 
mg, 5.73 mmol) was added THF (3.5 mL) and cooled to 0 °C. The resulting slurry 
was treated with an orange room temperature solution of (-)-alcohol 214 (763 mg, 
2.29 mmol), tetrabutylammonium iodide (170 mg, 0.45 mmol), and benzyl bromide 
(0.41 mL, 3.44 mmol) in THF (4.9 mL) over 10 min.  The reaction mixture was stirred 
for 45 min at 0 °C  and then was warmed to room temperature and stirred 5 h. The 
reaction mixture was cooled to 0 °C  and quenched with a saturated solution of 
aqueous NH₄Cl (7 mL) followed by  dilution with ethyl acetate (7 mL) and water (2 
mL). The layers were separated and the aqueous phase was extracted with ethyl 
acetate (3 x 7 mL). The organic layers were combined, washed with brine (5 mL), 
dried over Na2SO4, filtered and concentrated to orange oil. Purification by column 
chromatography (5% EtOAc/Hexanes to 25% EtOAc/Hexanes) afforded (-)-benzyl 
ether 215 (865 mg, 2.04) in 89% yield as clear oil. [α]21D = -27.3 (c = 0.27, CH2Cl2); 
IR (film) 2929, 2857, 1734, 1462, 1390, 1257, 1164, 1092, 1031, 1016, 835, 776 
cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.03 (s, 3H), 0.05 (s, 3H), 0.85, (s, 9H) 1.23 (s, 
3H), 1.25 (s, 3H), 1.75 (dt, J = 4.4, 4.4, 14.0 Hz, 1H), 2.26 (m, 1H), 3.46 (m, 4H), 
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3.54, (m, 1H), 3.78 (m, 1H), 3.78 (m, 1H), 4.50 (s, 2H), 4.82 (m, 1H), 7.30 (m, 5H); 
¹³C NMR (100 MHz, CDCl₃) δ -5.2, -4.7, 17.8, 22.8, 25.6, 25.7, 27.1, 44.0, 59.3, 
68.6, 73.0, 73.4, 76.7, 81.0, 127.5, 127.6, 128.2, 137.7, 176.6; MS (ESI+) for 
C23H38O5Si [M+Cs] calc 555.1543 found 555.1550.
(-)-Lactol-Acetate 193 To a -78 °C solution of (-)-lactone 215 (546 mg, 1.29 mmol) 
in CH₂Cl₂ (8.3 mL) was added a 1.0 M solution of DIBAL in hexanes (3.2 mL, 3.23 
mmol), dropwise, over 10 min.  The solution stirred for 2 h at -78 °C and was treated 
with pyridine (0.39 mL, 4.85 mmol) over 5 min, a solution of DMAP (395 mg, 3.23 
mmol) in CH₂Cl₂ (1.0 mL) over 5 min, and Ac₂O (1.0 mL, 10.34 mmol) over 5 min, 
respectively. The yellow solution stirred at -78 °C  for 14 h and was warmed to 0 °C 
over 5 h. The reaction mixture was quenched with saturated aqueous NH₄Cl (5 mL) 
and stirred for 1 h. The layers were separated and the aqueous layer was extracted 
with CH₂Cl₂ (3 x 10 mL). The combined organic layers were dried over Na₂SO₄, 
filtered, and concentrated. Purification by column chromatography (10% EtOAc/
Hexanes) afforded (-)-lactol-acetate 193 (600 mg, 1.29 mmol) in quantitative yield as 
pale yellow oil. [α]21D = -33.4 (c = 0.27, CH2Cl2); IR (film) 2929, 2857, 1753, 1473, 
1457, 1391, 1364, 1226, 1058, 835, 775 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.03 (s, 
3H), 0.04 (s, 3H), 0.88 (s, 3 H), 0.09 (s, 9H), 0.098 (s, 3H), 1.54 (dt, J = 2.7, 2.7, 
14.0 Hz, 1H), 1.92 (m, 1H), 2.09 (s, 3H), 3.48 (m, 5H), 3.61 (dd, J = 3.2, 9.8 Hz, 1H), 
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3.67 (t, J = 2.7 Hz, 1H), 4.10 (ddd , J = 2.7, 4.7, 11.7 Hz, 1H), 4.52 (s, 2H), 5.75 (s, 
1H), 7.29 (m, 5H); ¹³C  NMR (100 MHz, CDCl₃) δ -5.1, -4.6, 18.0, 18.6, 21.0, 21.6, 
25.8, 30.6, 38.6, 58.8, 70.0, 72.1, 73.4, 75.0, 82.0, 96.1, 126.8, 127.4, 128.2, 128.6, 
138.3, 169.6; MS (ESI+) for C25H42O6Si [M+Cs] calc 599.1805 found 599.1801.
Bis-phenol 218 To a microwave vial containing a stir bar was added with alkynoate 
217 (1.0 g, 4.58 mmol) and bis-silylenol ether 216 (2.76 g, 9.42 mmol) and then 
microwaved at 300 W  and 220 °C  30 min. The reaction mixture was cooled to room 
temperature, diluted with i-PrOH (6 mL) followed by 5% HCl (aq)/i-PrOH (2 mL) and 
stirred for 5 min. The biphasic solution was further diluted with water (5 mL) and 
ether (30 mL). The layers were separated and the aqueous layer was extracted with 
ether (3 × 10 mL).The combined organics were dried over MgSO4, filtered and 
concentrated to orange oil. Purification by column chromatography (25% EtOAc/
Hexanes) afforded bis-phenol 218 (1.01 g, 3.34 mmol) as off-white solids in 73% 
yield. IR (film) 3266, 2952, 2865, 1653, 1619, 1436, 1321, 1260, 1194, 1169, 1108; 
¹H NMR (400 MHz, CDCl₃) δ 3.20 (t, J = 7.2 Hz, 2H), 3.64 (t, J = 7.2 Hz, 2H) 3.85 (s, 
3H), 4.52 (s, 2H), 5.25 (s, 2H), 6.27 (d, J = 2.8 Hz, 1H), 6.31 (d, J = 2.8 Hz, 1H), 
7.30 (m, 5H), 11.63 (s, 1H); ¹³C  NMR (100 MHz, CDCl₃) δ 36.7, 51.9, 70.7, 72.9, 
101.9, 104.7, 111.9, 127.8, 127.8, 128.3, 137.4, 143.4, 161.0, 165.0, 171.5;  MS (ESI
+) for C17H18O5 [M+Na] calc 325.1052 found 325.1054.
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Bis-MOM ether To a 0 °C solution of bis-phenol 218 (2.079 g, 6.877 mmol) and 
diisopropylethylamine (12 mL, 68.77 mmol) in CH2Cl2 (22 mL) was added a 55% 
solution of chloromethyl methyl ether (4.75 mL, 34.38 mmol) over 5 min. The 
reaction stirred for 10 min at 0 °C then warmed to room temperature and stirred for 
15 h. The red solution was quenched with saturated aqueous NH4Cl (20 mL) and 
stirred for 10 min. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (3 × 20 mL). The combined organic layers were washed with 1N HCl (10 
mL), saturated aqueous NaHCO3 (20 mL), dried over MgSO4, filtered and 
concentrated to red/orange oil (2.90 g). Purification by  column (20% EtOAc/
Hexanes) gave bis-MOM ether (2.56 g, 6.57 mmol) as yellow oil in 95% yield. IR 
(film) 2952, 1729, 1605, 1271, 1147, 1018 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 2.84 (t, 
J = 7.2 Hz, 2H), 3.40 (s, 3H), 3.41 (s, 3H), 3.61 (t, J = 7.2 Hz, 2H), 3.78 (s, 3H), 4.45 
(s, 2H), 5.08 (s, 2H), 5.09 (s, 2H), 6.58 (d, J = 1.6 Hz, 1H), 6.66 (d, J = 1.6 Hz, 1H), 
7.22 (m, 5H); ¹³C NMR (100 MHz, CDCl₃) δ 34.2, 52.0, 56.1, 56.1, 70.5, 72.8, 94.3, 
94.9, 102.0, 110.8, 118.8, 127.4, 127.5, 128.2, 138.4, 138.9, 155.4, 158.8, 168.2; 
MS (ESI+) for C21H26O7 [M+Na] calc 413.1576 found 413.1579.
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Aryl Bromide 219 To a 0 °C solution of bis-MOM ether (2.45 g, 6.27 mmol) in 
CH2Cl2 (30 mL) was added N-bromosuccinimide (1.12 g, 6.27 mmol) in one portion. 
The reaction mixture was stirred at 0 °C for 30 min then warmed to room 
temperature and stirred 6.5 h. The reaction was quenched with saturated aqueous 
Na₂S₂O₃  (15 mL), stirred 5 min, and the layers were separated. The aqueous layer 
was extracted with CH2Cl2 (2 × 20 mL) and the combined organic layers were 
washed with brine (5 mL), dried over MgSO4, filtered and concentrated to yellow oil. 
Purification by column (20% EtOAc/Hexanes to 40% EtOAc/Hexanes) gave aryl 
bromide 219 (2.67 g, 5.71 mmol) as white solids in 91% yield. IR (film) 2952, 1731, 
1589, 1321, 1261, 1222, 1154, 1095, 1066, 1043, 931 cm-1; ¹H NMR (400 MHz, 
CDCl₃) δ 3.12 (t, J = 8.0 Hz, 2H), 3.46 (s, 3H), 3.50 (s, 3H), 3.67 (t, J = 8.0 Hz, 2H), 
3.83 (s, 3H), 4.54 (s, 2H), 5.15 (s, 2H), 5.23 (s, 2H), 6.90 (s, 1H), 7.30 (m, 5H); ¹³C 
NMR (100 MHz, CDCl₃) δ 34.6, 52.3, 56.3, 56.5, 68.7, 72.7, 94.9, 95.1, 101.7, 108.3, 
120.7, 127.5, 127.6, 128.3, 136.8, 138.4, 1534.0, 155.2, 167.6; MS (ESI+) for 
C21H25BrO7 [M+Na] calc 491.0681 found 491.0684.
Arene 220. Method A: To a degassed mixture of aryl bromide 219 (1.73 g, 3.686 
mmol) and Cs2CO3 (3.60 g, 11.059 mmol) in DMF (12 mL) was added Pd(PPh3)4 
(426 mg, 0.369 mmol) and trimethylboroxine (0.510 mL, 3.686 mmol). The mixture 
was heated to 120 °C and stirred for 13 h. The reaction mixture was cooled to room 
temperature, filtered through Celite®, rinsed with EtOAc (50 mL) and concentrated 
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to black oil. The concentrate was dissolved in ether (50 mL), washed with water (1 × 
20 mL) and the aqueous washes were back-extracted with ether (5 × 20 mL). The 
combined organic layers were washed with brine (10 mL), dried over Na2SO4, 
filtered and concentrated to black oil.  Purification by column chromatography (30% 
EtOAc/Hexanes) gave arene 220 (1.36 g, 3.36 mmol) as white solids in 91% yield. 
Method B: To a -100 °C  solution of aryl bromide 219 (920 mg, 1.96 mmol) in THF 
(4.0 mL) was added 2.5 M n-BuLi in hexanes (0.87 mL, 2.16 mmol) dropwise and 
the resultant solution stirred for 10 min acquiring an orange/red color. The reaction 
was then treated with iodomethane (0.37 mL, 5.88 mmol) over 2 min and the red 
solution immediately turned clear. The reaction mixture stirred at -100 °C  for 20 min 
and then was allowed to warm 0 °C  and stirred for 20 min. The reaction mixture was 
quenched with a saturated solution of aqueous NH₄Cl (8 mL), the layers separated, 
and the aqueous layer was extracted with CH₂Cl₂ (3 × 10 mL). The combined organic 
layers were washed with brine (10 mL), dried over MgSO4, filtered and concentrated 
to a crude orange oil (940 mg). The material was purified by column chromatography 
(2% to 10% ethyl acetate/hexanes) to afford the arene 220 (800 mg, 1.960 mmol) in 
quantitative yield. IR (film) 2951, 1729, 1594, 1476, 1315, 1267, 1152, 1094, 1058, 
998, 923 cm-1; ¹H NMR (300 MHz, CDCl₃) δ 2.15 (s, 3H), 2.92 (t, J = 7.5 Hz, 2H), 
3.45 (s, 3H), 3.46 (s, 3H), 3.59 (t, J = 7.5 Hz, 2H), 3.83 (s, 3H), 4.51 (s, 2H), 5.13 (s, 
2H), 5.17 (s, 2H), 6.82 (s, 1H), 7.31 (m, 5H); ¹³C NMR (100 MHz, CDCl₃) δ 11.4, 
31.6, 51.9, 56.0, 56.1, 69.6, 70.5, 94.7, 95.2, 100.7, 119.7, 120.2, 127.4, 127.5, 
128.3, 135.5, 138.4, 152.6, 156.7, 168.8; MS (ESI+) for C22H28O7 [M+Na] calc 
427.1733 found 427.1736.
110
Bis-phenol 221 To a biphasic solution of arene 220 (1.86 g, 4.6 mmol) in methanol 
(9.3 mL) was added concentrated HCl (0.38 mL, 4.606 mmol) and the reaction 
mixture was heated to 40 °C for 17 h. The reaction mixture was cooled to room 
temperature and quenched with saturated aqueous NaHCO3 (15 mL) and diluted 
with CH2Cl2 (50 mL). The layers were separated and the aqueous phase was 
extracted with CH2Cl2 (4 × 20 mL) and the combined organic layers were dried over 
Na2SO4, filtered and concentrated to orange solids. Purification by column (20 % 
EtOAc/Hexanes) gave the bis-phenol 221 (1.411 g, 4.46 mmol) as white solids in 
97% yield. IR (film) 3282, 2953, 1651, 1601, 1485, 1253, 1159 cm-1; ¹H NMR (400 
MHz, CDCl₃) δ 2.14 (s, 3H), 3.28 (t, J = 8.0 Hz, 2H), 3.58 (t, J = 8.0 Hz, 2H), 3.38 (s, 
3H), 4.53 (s, 2H), 5.51 (s, 1H), 6.27 (s, 1H), 7.28 (m, 5H); ¹³C NMR (100 MHz, 
MeOD) δ 11.3 32.7, 71.0, 73.8, 101.8, 108.1, 118.0, 128.7, 128.9, 129.4, 139.8, 
140.4, 161.5, 161.6, 172.8; MS (ESI+) for C18H20O5 [M+Na] calc 339.1208 found 
339.1211.
Bis-TIPS ether To a 0 °C slurry  of bis-phenol 221 (1.38 g, 4.35 mmol) in CH2Cl2 (10 
mL) was added 2,6-lutidine (2.41 mL, 20.68 mmol) that gave a transparent solution, 
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which was treated with TIPSOTf (2.75 mL, 10.23 mmol) dropwise over 10 min. The 
reaction mixture stirred for 60 min at 0 °C and was then warmed to room 
temperature for 14 h. The reaction was quenched with a saturated aqueous NaHCO3 
(15 mL) and diluted with additional CH2Cl2 (15 mL). The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (3 × 15 mL). The combined organic 
layers were washed with brine (10 mL), dried with Na2SO4, filtered, concentrated. 
Purification by column chromatography (Hexanes to 10% EtOAc/Hexanes) gave bis-
TIPS ether (2.74 g; 4.35 mmol) in quantitative yield. IR (film) 2945, 2866, 1730, 
1590, 1470, 1345, 1261, 1166, 1068, 882, 686 cm-1; ¹H NMR (500 MHz, CDCl₃) δ 
1.08 (m, 36H), 1.23 (m, 6H), 2.13 (s, 3H), 2.89 (t, J = 8.0 Hz, 2H), 3.58 (t, J = 8.0 Hz, 
2H), 3.78 (s, 3H), 4.51 (s, 2H), 6.23 (s, 1H), 7.27 (m, 2H), 7.30 (m, 3H); ¹³C NMR 
(125 MHz, CDCl₃) δ 11.9, 13.0, 13.2, 17.9, 18.0, 32.0, 51.9, 69.9, 72.9, 107.1, 120.2, 
120.3, 127.5, 127.7, 128.4, 135.4, 138.5, 151.0, 155.4, 169.6; MS (ESI+) for 
C36H60O5Si2 [M+Cs] calc 761.3034 found 761.3053.
Alcohol 158. To a solution of benzyl ether (2.87 g, 4.56 mmol) in THF (37 mL) was 
added 20% Pd(OH)2/C (718 mg). The reaction mixture was degassed under vacuum 
then purged with H2. The reaction stirred for 1 h under H2 atmosphere (balloon) and 
was filtered through Celite®, rinsing the cake once with THF (100 mL). The filtrate 
was concentrated and taken on crude. To a flask containing CH2Cl2 (12 mL) and 2.0 
M oxalyl chloride in CH2Cl2 (4.0 mL, 8.0 mmol) at -78 °C was added DMSO (1.13 
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mL, 16.02 mmol) dropwise over 10 min. The solution stirred for 25 min at -78 °C  and 
was treated with a solution of alcohol 158 (2.15 g, 4.00 mmol) in CH2Cl2 (10 mL) 
over 5  min, followed CH2Cl2 rinses (2 × 5 mL). The turbid white mixture stirred for 1 
h at -78 °C and was then treated with Et3N (0.55 mL, 3.91 mmol) over 5 min. The 
reaction stirred for 10 min at -78 °C, warmed to 0 °C  and stirred for 1 h, then warmed 
to room temperature and stirred for 20 min. The reaction mixture was quenched with 
saturated aqueous NaHCO3 (8 mL), the layers separated and the aqueous layer was 
extracted with CH2Cl2 (5 × 5 mL). The combined organic layers were dried over 
Na2SO4, filtered and concentrated to orange oil. Purification by column 
chromatography (5% EtOAc/Hexanes to 10% EtOAc/Hexanes) gave aldehyde # 
(2.00 g, 3.73 mmol) in 93% yield. IR (film) 2946, 2867, 2763, 2721, 1726, 1590, 
1471, 1345, 1258, 1166, 882, 684 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.09 (m, 36H), 
1.26 (m, 6H), 2.07 (s, 3H), 3.60 (s, 2H), 3.82 (s, 3H), 6.33 (s, 1H), 9.59 (s, 1H); ¹³C 
NMR (100 MHz, CDCl₃) δ 12.3, 13.0, 13.2, 17.8, 18.0, 46.1, 51.9, 108.4, 120.0, 
121.2, 130.5, 151.9, 156.0, 169.1, 198.76;  MS (ESI+) for C29H52O5Si2 [M+Cs] calc 
669.2408 found 669.2411.
TiPS Protected Catechol. To a 0 °C  solution of bis-phenol 89 (530 mg, 2.09 mmol) 
and 2,6-lutidine (1.21 mL, 10.42 mmol) in CH₂Cl₂ (20 mL) was added TIPSOTf (1.40 
mL, 5.21 mmol), dropwise, over 2 min.  The reaction was stirred for 15 min at 0 °C 
then warmed to room temperature and was stirred for 16 h. The reaction was 
113
quenched with saturated aqueous NaHCO₃, the layers separated, and the aqueous 
layer was extracted with CH₂Cl₂ (3 x 10 mL). The combined organic layers were 
dried over Na₂SO₄, filtered, and concentrated. Purification by column 
chromatography (Hexanes to 5% Ether/Hexanes) afforded bis-TIPS protected aryl 
ether (1.16 g, 2.04 mmol) in 98% yield as pale yellow oil. IR (film) 2946, 2867, 1738, 
1592, 1471, 1324, 1262, 1165, 1068, 997, 882, 832, 793, 685 cm -1; ¹H NMR (400 
MHz, CDCl₃) δ 1.12 (m, 36H), 1.24 (m, 6H), 2.11 (s, 3H), 3.64 (m, 5H), 3.80 (s, 3H), 
6.29 (s, 1H); ¹³C NMR (100 MHz, CDCl₃) δ 12.3, 13.0, 13.1, 17.9, 18.0, 36.3, 51.9, 
51.9, 108.2, 119.8, 121.1, 132.4, 151.6, 155.7, 169.0, 171.1; MS (ESI+) for 
C30H54O6Si2 [M+Cs] calc 699.2513 found 699.2551.
Aldehyde 158 To a -78 °C solution of methyl ester (1.15 g, 2.03 mmol) in CH₂Cl₂ (26 
mL) was added 1.0 M DIBAL in hexanes (2.1 mL, 2.05 mmol) over 5 min. After 2 h at 
-78 °C the reaction was treated with additional 1.0 M DIBAL in hexanes (1.0 mL, 
1.00 mmol) and stirred at -78 °C  for 1 h. The reaction was quenched at -78 °C with 
saturated aqueous Rochelleʼs salt (10 mL) and warmed to room temperature and 
stirred for 3 hours. The layers were separated and the aqueous layer was extracted 
with CH₂Cl₂ (3 x 10 mL). The combined organic layers were washed with Na₂SO₄, 
filtered, and concentrated to yellow oil. Purification by column chromatography (7% 
EtOAc/Hexanes) afforded aldehyde 158 (847 mg, 1.58 mmol) in 78% yield as yellow 
oil. IR (film) 2946, 2867, 2763, 2721, 1726, 1590, 1471, 1345, 1258, 1166, 882, 684 
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cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.09 (m, 36H), 1.26 (m, 6H), 2.07 (s, 3H), 3.60 (d, 
J = 2.0 Hz, 2H), 3.82 (s, 3H), 6.33 (s, 1H), 9.59 (t, J = 2.0 Hz, 1H); ¹³C NMR (100 
MHz, CDCl₃) δ 12.3, 13.0, 13.2, 17.8, 18.0, 46.1, 51.9, 108.4, 120.0, 121.2, 130.5, 
151.9, 156.0, 169.1, 198.76;  MS (ESI+) for C29H52O5Si2 [M+Cs] calc 669.2408 
found 669.2411.
(+)-Alcohol 223 To a yellow 0 °C  solution of N-acylpropionate thiazolidinethione 197 
(703 mg, 2.65 mmol) in CH2Cl2 (20 mL) was added TiCl4 (0.30 mL, 0.2.78 mmol), 
dropwise, over 2 min.  The resulting orange slurry was stirred for 15 min at 0 °C  and 
was treated with (-)-sparteine (0.67 mL, 2.65 mmol) over 3 min at 0 °C, giving a 
deep red solution.  The reaction mixture stirred at 0 °C for 20 min then cooled to -78 
°C  and treated with 1-methyl-2-pyrrolidinone (0.085 mL, 0.85 mmol) over 2 min.  The 
reaction mixture stirred at -78 °C for 10 min and was treated with a solution of 
aldehyde 158 (1.56 g, 2.91 mmol) in CH2Cl2 (5 mL) over 10 min followed by a 
CH2Cl2 rinse (5 mL). The reaction mixture stirred at -78 °C for 1 h then warmed to 0 
°C  and stirred for 1 h. The reaction mixture was quenched with half-saturated 
aqueous NH4Cl (5 mL) and diluted with water (3 mL). The layers were separated and 
the aqueous layer was extracted with CH2Cl2 (3 × 15 mL), the organics combined, 
washed with brine (15 mL), dried over Na2SO4, filtered, and concentrated to yellow 
oil.  Purification by  column chromatography (5% EtOAc/Hexanes to 10% EtOAc/
Hexanes gradient) afforded (+)-alcohol 223 (2.00 g, 2.50 mmol) in 94% yield as 
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bright yellow solids in > 20:1 dr as determined by 1H NMR. [α]19D = +79.2 (c = 1.0, 
CH2Cl2); IR (film) 3429, 2946, 2868, 1696, 1589, 1469, 1342, 1266, 1166, 1065, 883, 
687 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.08 (m, 36H), 1.28 (m, 6H), 1.32 (d, J = 6.8 
Hz, 3H), 2.16 (s, 3H), 2.63 (dd, J = 10.8, 14.0 Hz, 1H), 2.85 (d, J = 11.4 Hz, 1H), 
2.87 (dd, J = 3.2, 14.0 Hz, 1H),  3.06 (dd, J = 10.8, 13.0 Hz, 1H), 3.31 (dd, J = 3.2, 
13.0 Hz, 1H), 3.40 (dd, J = 7.2, 11.2 Hz, 1H),  3.87 (s, 3H), 3.90 (d, J = 6.8 Hz, 1H), 
4.15 (m, 1H), 4.75 (m, 1H), 5.27 (m, 1H), 6.26 (s, 1H), 7.30 (m, 5H); ¹³C NMR (100 
MHz, CDCl₃) δ 10.9, 12.5, 13.1, 13.2, 17.9, 18.0, 32.2, 36.0, 36.7, 45.3, 69.7, 72.0, 
107.6, 120.0, 120.7, 127.2, 128.9, 129.5, 136.3, 136.7, 151.6, 156.2, 171.4, 176.9, 
201.6; MS (ESI+) for C42H67NO6S2Si2 [M+K] calc 840.3585 found 840.3582.
(+)-Weinreb Amide To a bright yellow solution of (+)-alcohol 223 (1.07 g, 1.33 
mmol) in CH2Cl2 (12 mL) was added imidazole (364 mg, 5.34 mmol) and N,O-
dimethylhydroxylamine•HCl (261 mg, 2.67 mmol) at room temperature. The reaction 
mixture was stirred for 16 h at room temperature and was quenched with saturated 
aqueous NH4Cl (10 mL), stirred 5 min, and the layers were separated.  The aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL), and the combined organic layers were 
dried over Na2SO4 and concentrated to yellow oil. Purification by column 
chromatography (CH2Cl2 to 5% EtOAc/CH2Cl2 to 20% EtOAc/CH2Cl2) gave(+)- 
Weinreb  amide (835 mg, 1.27 mmol) in 96% yield as clear oil.  [α]22D = +21.1 (c = 
0.25, CH2Cl2); IR (film) 3457, 2945, 2867, 172, 1589, 1467, 1342, 1266, 1191, 1166, 
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1066, 996, 882, 686 cm-1; ¹H NMR (500 MHz, CDCl₃) δ 1.07 (m, 36H), 1.22 (m, 6H), 
1.24 (d, J = 6.9 Hz, 3H), 2.17 (s, 3H), 2.64 (dd, J = 10.0, 14.0 Hz, 1H), 2.84 (dd, J = 
5.0, 14.0 Hz, 1H), 2.96 (s, 1H), 3.17 (s, 3H), 3.62 (s, 3H), 3.66 (s, 1H), 3.89 (s, 3H), 
3.92 (dq, 5.0, 5.0, 5.0, 10.0 Hz, 1H), 6.24 (s, 1H); ¹³C  NMR (100 MHz, CDCl₃) δ 
12.1, 12.2, 13.0, 13.1, 13.2, 17.7, 17.9, 31.9, 35.8, 40.4, 51.9, 61.2, 72.3, 107.2, 
120.0, 120.7, 128.2, 136.6, 151.2, 155.8, 170.4; MS (ESI+) for C34H63NO7Si2 [M+Na] 
calc 676.4041 found 676.4046.
(+)-Lactone 224 To a solution of alcohol (515 mg, 0.787 mmol) in CH₂Cl₂ (25 mL) 
was treated with trifluoroacetic acid (72 μL, 0.95 mmol) over 2 min. and the solution 
stirred for at room temperature for 1.5 h. The reaction mixture was quenched with 
saturated aqueous NaHCO₃  (10 mL) and stirred for 5 min. The layers were 
separated and the aqueous phase was extracted with CH₂Cl₂ (3 x 10 mL). The 
combined organic layers were dried over Na₂SO₄, filtered, and concentrated to 
yellow oil. Purification by column chromatography (5% to 15% EtOAc/CH₂Cl₂) gave 
pure (+)-lactone 224 (478 mg, 0.768 mmol) in 98% yield. [α]20D = +18.1 (c = 
0.5,CH2Cl2); IR (film) 2944, 2867, 1727, 1661, 1591, 1566, 1472, 1243, 1172, 1076, 
883, 733, 685 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.11 (m, 36H), 1.28 (m, 6H), 1.33 
(d, J = 6.8 Hz, 3H), 2.03 (s, 3H), 2.67 (dd, J = 10.4, 16.4 Hz, 1H), 2.94 (dd J = 2.6, 
16.4 Hz, 1H) 3.20 (s, 3H), 3.29 (m, 1H), 3.66 (s, 3H), 4.40 (ddd, J = 2.6, 10.4, 10.4 
Hz, 1H), 6.28 (s, 1H); ¹³C NMR (100 MHz) δ 11.7, 13.1, 14.6, 17.9, 29.7, 39.8, 61.6, 
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77.9, 109.9, 109.8, 118.3, 140.5, 157.6, 158.9, 162.3, 174.8; MS (ESI+) for 
C33H59NO6Si2
(+)-Ketone 225 To a -78 °C solution of (+)-amide 224 (474 mg, 0.762 mmol) in THF 
(6 mL) was added a 3.0 M solution of methylmagnesium bromide in THF (0.76 mL, 
2.286 mmol) over 5 min. The reaction mixture was stirred at -78 °C for 20 min and 
was then warmed to 0 °C  for 1 h. The reaction mixture was quenched with saturated 
aqueous NH₄Cl (5 mL), diluted with water (2 mL), and the layers were separated. 
The aqueous layer was extracted with EtOAc (4 x 10 mL) and the combined organic 
layers were washed with brine (10 mL), dried over Na₂SO₄, filtered, and 
concentrated to yellow oil. Purification by  column chromatography (10% EtOAc/
Hexanes) gave (+)-ketone 225 (401 mg, 0.695 mmol) in 91% yield. [α]20D +77.4 (c = 
0.25, CH2Cl2); IR (film) 3854, 2945, 2892, 2867, 1726, 1591, 1566, 1473, 1354, 
1243, 1202, 1172, 1069, 882, 852, 828, 685 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.10 
(m, 36 H), 1.29 (m, 9H), 2.05 (s, 3H), 2.26 (s, 3H), 2.60 (dd, J = 11.8, 16.1 Hz, 1H), 
2.88 (dd, J = 2.6, 16.1 Hz, 1H), 2.94 (m, 1H), 4.44 (m, 1H), 6.29 (s, 1H); ¹³C  NMR 
(100 MHz, CDCl₃) δ 11.7, 12.8, 13.2, 13.3, 17.9, 18.0, 29.5, 30.2, 50.5, 109.5, 109.6, 
118.1, 140.4, 157.7, 159.0, 162.2, 209.8; MS (ESI+) for C32H56O5Si2 [M+Na] calc 
599.36 found 599.36.
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(+)-TBS ether 230 To a -78 °C solution of (+)-Weinreb amide (555 mg, 0.849 mmol) 
in CH2Cl2 (6 mL) was added 2,6-lutidine (0.26 mL, 3.39 mmol) followed by TBSOTf 
(0.39 mL, 1.70). The reaction was stirred for 60 min at -78 °C and then was 
quenched with a saturated aqueous solution of NaHCO3 (2 mL), warmed to room 
temperature and diluted with CH2Cl2 (5 mL) and water (1 mL). The layers were 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. 
Purification by column chromatography (10% EtOAc/Hexanes) afforded (+)-TBS 
ether 230 (620 mg, 0.807 mmol) as a clear oil in 95% yield. [α]22D = +19.5 (c = 0.24, 
CH2Cl2); IR (film) 2947, 2868, 1731, 1667, 1589, 1470, 1341, 1257, 1166, 1066, 997, 
882, 838, 777, 686 cm-1; ¹H NMR (400 MHz, CDCl₃) δ -0.43 (s, 3H), -0.05 (s, 3H), 
0.82 (s, 9H), 1.07 (m, 39H), 1.25 (m, 6H), 2.17 (s, 3H), 2.74 (dd, J = 5.2 Hz, 14.0 Hz, 
1H), 2.89 (brs, 1H), 2.92 (dd, J = 8.4, 14.0 Hz, 1H), 3.14 (s, 3H), 3.48 (s, 3H), 3.84 
(s, 3H), 4.20 (m, 1H), 6.19 (s, 1H); ¹³C NMR (100 MHz, CDCl₃) δ -4.9, 12.2, 12.9, 
13.1, 13.2, 26.1, 36.7, 51.8, 60.9, 73.2, 106.3, 120.5, 121.4, 136.4, 151.0, 155.2, 
169.6; MS (ESI+) for C40H77NO7Si3 [M+Cs] calc 900.4062 found 900.4027.
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(+)-Ketone 231 To a -78 °C solution of (+)-Weinreb amide 230 (600 mg, 0.781 
mmol) in THF (6 mL) was added 3.0 M MeMgBr in Et₂O (0.78 mL, 2.34 mmol). The 
reaction mixture was stirred for 30 min at -78 °C  and then warmed to 0 °C and was 
stirred for 45 min. The reaction mixture was quenched with saturated aqueous 
NH4Cl (2 mL), warmed to room temperature, and the layers separated. The aqueous 
layer was extracted with CH2Cl2 (3 × 4 mL) and the combined organic layers were 
dried over Na2SO4, filtered and concentrated. Purification by column 
chromatography (5% EtOAc/Hexanes ) provided (+)-ketone 231 (539 mg, 0.745 
mmol) in 95% yield as clear oil. [α]20D = +53.6 (c = 0.26, CH2Cl2); IR (film) 2947, 
2868, 1729, 1589, 1345, 1259, 1192, 1167, 1068, 839, 776, 685 cm-1; ¹H NMR (400 
MHz, CDCl₃) δ -0.35 (s, 3H), -0.08 (s, 3H), 0.82 (s, 9H), 1.07 (m, 39H), 1.23 (m, 6H), 
2.14 (s, 3H), 2.20 (s, 3H), 2.62 (dd, J = 4.8, 14.4 Hz, 1H), 2.71 (m, 2H), 3.82 (s, 3H), 
4.18 (m, 1H), 6.21 (s, 1H); ¹³C NMR (100 MHz, CDCl₃) δ -5.1, 11.8, 12.7, 13.1, 13.3, 
17.9, 18.0, 26.0, 30.6, 34.7, 51.7, 52.7, 74.2, 106.7, 120.1, 121.3, 136.1, 151.1, 
155.3, 169.5, 210.6; MS (ESI+) for C39H74O6Si3 [M+Cs] calc 855.3848 found 
855.3774.
TMS Enolsilane 227. To a 0 °C  solution of (+)-ketone 225 (45 mg, 0.078 mmol) in 
CH2Cl2 (0.62 mL) was added i-Pr2NEt (82 μL, 0.47 mmol) followed by  TBSOTf (53 
μL, 0.234 mmol). The reaction stirred for 30 min a 0 °C and was quenched with 
saturated aqueous NaHCO3 (0.6 mL) and warmed to room temperature. The 
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reaction was diluted with water (1 mL) and CH2Cl2 (3 mL), the layers separated, and 
the aqueous layer was extracted with CH2Cl2 (3 × 2 mL). The combined organic 
layers were dried over Na2SO4, filtered and concentrated to minimal volume and 
filtered through a silica gel plug (3% EtOAc/Hexanes with 1% Et3N). The filtrate was 
concentrated to oil, azeotropically dried with toluene, and concentrated for 30 min 
under high vacuum. The formation of enolsilane 227 was confirmed by 1H NMR 
analysis and was then used immediately  in the next reaction without further analysis 
as it showed significant moisture sensitivity. 1H NMR (400 MHz, C₆D₆) δ 0.20 (s, 9H), 
1.08 (m, 36H), 1.28 (m, 9H), 2.07 (s, 3H), 2.40 (m, 1H), 2.66 (dd, J = 10.8, 16.4 Hz, 
1H), 2.95 (dd, J = 2.8, 16.4 Hz, 1H), 4.07 (s, J = 14.4 Hz, 2H), 4.17 (m, 1H), 6.30 (s, 
1H).
TBS Enolsilane 229 To a 0 °C  solution of (+)-ketone 225 (45 mg, 0.078 mmol) in 
CH2Cl2 (0.62 mL) was added i-Pr2NEt (82 μL, 0.47 mmol) followed by  TBSOTf (53 
μL, 0.234 mmol). The reaction stirred for 30 min a 0 °C and was quenched with 
saturated aqueous NaHCO3 (0.6 mL) and warmed to room temperature. The 
reaction was diluted with water (1 mL) and CH2Cl2 (3 mL), the layers separated, and 
the aqueous layer was extracted with CH2Cl2 (3 × 2 mL). The combined organic 
layers were dried over Na2SO4, filtered and concentrated to minimal volume and 
filtered through a silica gel plug (3% EtOAc/Hexanes with 1% Et3N). The filtrate was 
concentrated to oil, azeotropically dried with toluene, and concentrated for 30 min 
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under high vacuum. The formation of enolsilane 229 was confirmed by 1H NMR 
analysis and was then used immediately  in the next reaction without further analysis 
as it showed significant moisture sensitivity. 1H NMR (400 MHz, C₆D₆) δ 0.05 (s, 3H), 
0.06 (s, 3H), 0.80 (s, 9H), 1.11 (m, 18H), 1.24 (m, 24H), 1.54 (m, 3H), 2.08 (s, 3H), 
2.34 (m, 2H), 2.84 (dd, J = 2.4, 16.0 Hz, 1H), 3.96 (s, 2H), 4.16 (m, 1H), 6.60 (s, 1H).
(+)-Tetrahydropyran 233: TBS Enolsilane Method: A -40 °C  solution of lactol-
acetate (30 mg, 0.049 mmol) in CH₂Cl₂ (0.22 mL) was treated with BF₃·OEt₂ (12.5 
μL, 0.099 mmol) and stirred at -40 °C for 3 min. The reaction was then treated with a 
solution of enolsilane (45 mg, 0.074 mmol) in CH₂Cl₂ (0.15 mL) dropwise over 3 min. 
The reaction stirred at -40 °C for 30 min and was then treated with additional 
BF₃·OEt₂ (6.2 μL, 0.049 mmol) and stirred for 30 min at -40 °C. The reaction mixture 
was quenched with saturated aqueous NaHCO₃  (0.3 mL) and warmed to room 
temperature. The layers were separated and the aqueous was extracted with CH₂Cl₂ 
(3 x 1 mL). The combined organic layers were dried over Na₂SO₄, filtered, and 
concentrated. Purification by column chromatography (10 to 25% Et₂O/Hexanes 
gradient) afforded the desired (+)-tetrahydropyran 233 (8.5 mg, 0.0095 mmol) in 
19% yield as well as ketone 225 (22 mg, 0.038 mmol) for a 64% yield based on 
recovered ketone. [α]20D + 44.1 (c = 0.26, CH2Cl2); IR (film) 2946, 2866, 1729, 1591, 
1566, 1471, 1412, 1358, 1245, 1172, 1070, 882, 835, 686 cm-1; ¹H NMR (400 MHz, 
CDCl₃) δ0.04 (s, 3H), 0.05 (s, 3H), 0.86 (s, 3H), 0.89 (s, 9H), 0.91 (s, 3H), 1.11 (m, 
122
36 H), 1.25 (m, 9H), 1.65 (m, 1H), 1.94 (m, 1H), 2.03 (s, 3H), 2.54 (m, 2H), 2.91 (m, 
3H)3.45 (m, 1H), 3.48 (s, 3H), 3.59 (m, 2H), 3.66 (m, 1H), 3.89 (m, 2H), 4.44 (m, 
1H), 4.54 (s, 2H), 6.30 (s, 1H)7.32 (m, 5H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.2, 
11.8, 12.7, 13.1, 13.3, 18.0, 18.0, 18.0, 24.2, 25.8, 29.6, 29.8, 38.2, 42.6, 51.1, 58.6, 
69.4, 72.8, 73.4, 75.2, 79.1, 109.5, 109.5, 118.1, 127.4, 127.6, 128.3, 138.6, 140.5, 
157.7, 159.0, 162.4, 210.4; MS (ESI+) for C55H94O9Si3 [M+Cs] calc 1115.5260 found 
1115.5308.
TMS Enolsilane 232. A 0 °C solution of ketone (54 mg, 0.075 mmol) in CH2Cl2 (0.6 
mL) was treated with i-Pr2NEt (0.8 mL, 0.45 mmol) followed by  TMSOTf (41 μL, 
0.224 mmol).  After 60 min the reaction was then quenched with a saturated solution 
of aqueous NaHCO3 (0.5 mL) and warmed to room temperature. The reaction was 
then diluted with saturated aqueous NaHCO3 (1 mL) and CH2Cl2 (1 mL) and the 
layers were separated. The aqueous layer was extracted with CH2Cl2 (3 × 2 mL) and 
the combined organics were dried over Na2SO4, filtered and concentrated. 
Purification by column chromatography (1% Et3N/Hexanes to 5% EtOAc/Hexanes 
with 1% Et3N ) gave (59 mg, 0.075 mmol) for a yield of 100%. The formation of 
enolsilane 232 was confirmed by 1H NMR analysis and was then used immediately 
in the next reaction without further analysis as it showed significant moisture 
sensitivity. 1H NMR (400 MHz C₆D₆) δ -0.17 (s, 3H), 0.13 (s, 3H), 0.18 (s, 9H), 1.01 
123
(m, 9H), 1.16 (m, 36H), 1.27 (m, 9H), 2.32 (m, 1H), 2.44 (s, 3H), 3.12 (m, 2H), 3.70 
(s, 3H), 4.21 (d, J = 18.0 Hz, 3H), 4.40 (m, 1H), 6.47 (s, 1H).
TBS Enolsilane 192 To a 0 °C  solution of ketone 231 (231 mg, 0.319 mmol) in 
CH2Cl2 (2.5 mL) was added i-Pr2NEt (0.33 mL, 1.92 mmol) followed by TBSOTf 
(0.22 mL, 0.958 mmol). The reaction stirred for 90 min a 0 °C and was quenched 
with saturated aqueous NaHCO3 (2.5 mL) and warmed to room temperature. The 
reaction was diluted with water (1 mL) and CH2Cl2 (3 mL), the layers separated, and 
the aqueous layer was extracted with CH2Cl2 (3 × 2 mL). The combined organic 
layers were dried over Na2SO4, filtered and concentrated to minimal volume and 
filtered through a silica gel plug (3% EtOAc/Hexanes with 1% Et3N). The filtrate was 
concentrated to oil, azeotropically dried with toluene, and concentrated for 30 min 
under high vacuum. The formation of enolsilane 192 was confirmed by 1H NMR 
analysis and was then used immediately  in the next reaction without further analysis 
as it showed significant moisture sensitivity. 1H NMR (400 MHz C₆D₆) δ -0.32 (s, 3H), 
-0.05 (s, 3H), -0.08 (s, 3H), 0.14 (s, 3H), 0.84 (s, 9H), 0.88 (s, 9H), 1.01 (d, J = 7.2 
Hz, 3H), 1.11 (m, 36H), 1.27 (m, 6H), 2.14 (m, 1H), 2.18 (s, 3H), 2.86 (m, 2H), 3.82 
(s, 3H), 4.08 (m, 3H), 6.19 (s, 1H).
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(+)-Tetrahydropyran 234 
TMS Enolsilane Method: A -40 °C solution of (-)-acetate 193 (16.0 mg, 0.034 
mmol) in CH₂Cl₂ (0.2 mL) was treated with BF₃·OEt₂ (8.7 μL, 0.069 mmol), stirred for 
4 min, then treated with a 5.0 M solution of enolsilane 192 in CH2Cl2 (137 μL, 0.069 
mmol) and stirred 30 min at-40 °C. The reaction was quenched with satʼd aqueous 
NH4Cl (0.1 mL) and warmed to room temperature. The reaction mixture was then 
diluted with CH2Cl2 (3 mL) and water (1 mL) and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (3 × 3 mL) and the combined organic 
layers were dried over Na2SO4, filtered and concentrated. The crude material was 
purified by column chromatography (5% to 10% EtOAc/Hex gradient) to afford (+)-
tetrahydropyran 234 (15.5 mg, 0.014 mmol) and recovered (-)-acetate 193 (6.9 mg, 
0.015 mmol).
TBS Enolsilane Method A: A mixture of acetate 193 (20.0 mg, 0.043 mmol) and 
enolsilane 192 (54 mg, 0.064 mmol) were azeotropically dried with toluene at 55 °C 
then dried further for 45 min under high vacuum. The mixture was then flushed with 
argon over 5 min, dissolved in CH2Cl2 (0.2 mL) and cooled to -40 °C. The clear 
solution was treated with BF₃·OEt₂ (11 μL, 0.086 mmol) and stirred at -40 °C for 30 
min. The reaction mixture was quenched with saturated aqueous NaHCO3 (0.2 mL), 
warmed to room temperature and diluted with CH2Cl2 (3 mL) and water (1 mL). The 
layers were separated. and the aqueous layer was extracted with CH2Cl2 (3 × 3 mL). 
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The combined organic layers were washed with brine (1 × 2 mL), dried over Na2SO4, 
filtered and concentrated. Purification by  column chromatography (5% EtOAc/Hex to 
10% EtOAc/Hex) gave the product 234 (18 mg, 0.016 mmol) in 37% yield. 
TBS Enolsilane Method B: A -40 °C  solution of (-)-lactol-acetate 193 (103.0 mg, 
0.221 mmol; azeotropically dried with toluene and dried further under high vacuum 
over 1 h immediately prior to use) in CH2Cl2 (1 mL) was treated with BF₃·OEt₂  (56 
μL, 0.44 mmol) and stirred at -40 °C for 2 min. The reaction was then treated with a 
0.5 M solution of enolsilane 192 (0.54 mL, 0.27 mmol) in CH2Cl2 over 5 min followed 
by CH2Cl2 rinse (0.2 mL). The reaction stirred for 30 min at -40 °C  and was then 
treated with a second portion of BF₃·OEt₂ (28 μL, 0.22 mmol) and stirred for 30 min. 
The reaction was quenched with saturated aqueous NH4Cl (1 mL), warmed to room 
temperature, then diluted with CH2Cl2 (3 mL) and water (1 mL). The aqueous layer 
was extracted with CH2Cl2 (3 × 5 mL), the combined organic layers were dried over 
Na2SO4, filtered and concentrated. Purification by column chromatography (5% 
EtOAc/Hexanes to 8% EtOAc/Hexanes) afforded (+)-tetrahydropyran 234 (144 mg, 
0.13 mmol) in 59% yield as clear oil as well as recovered (+)-ketone 231 (103 mg, 
0.14 mmol) for 85% yield based on recovered ketone. [α]20D = +49.1 (c = 0.25, 
CH2Cl2); IR (film) 2947, 2864, 1733, 1586, 1471, 1259, 1166, 882, 837 cm-1; ¹H NMR 
(500 MHz, C₆D₆) δ -0.19 (s, 3H), 0.04 (s, 3H), 0.08 (s, 3H), 0.10 (s, 3H), 0.97 (m, 
21H), 1.14 (m, 39H), 1.26 (d, J = 6.9 Hz, 3H), 1.29 (m, 9H), 1.82 (ddd, J = 6.7, 11.7, 
13.2 Hz, 1H), 2.14 (dd, J = 3.6, 13.2 Hz, 1H), 2.36 (s, 3H), 2.68 (d, J = 15.0 Hz, 1H) 
2.87 (dd, J = 3.7, 6.9 Hz, 1H), 2.96 (m, 3H), 3.65 (m, 1H), 3.67 (s, 3H), 3.74 (dd, J = 
5.8, 10.3 Hz, 1H), 3.79, (m, 1H), 3.96 (dd, J = 1.9, 10.3 Hz, 1H), 4.04 (t, J = 6.7 Hz, 
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1H), 4.09 (d, 9.5 Hz, 1H), 4.46 (m, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.70 (d, J = 12.0 
Hz, 1H), 6.47 (s, 1H), 7.10 (t, 7.5, 7.5 Hz, 2H), 7.21 (t, J = 7.5, 7.5 Hz, 1H), 7.46 (d, J 
= 7.5 Hz, 2H); ¹³C  NMR (100 MHz, C₆D₆) δ -4.7, -4.0, 12.5, 13.2, 13.5, 13.6, 13.8, 
18.2, 18.2, 18.3, 23.7, 26.1, 26.4, 30.3, 35.4, 39.0, 44.5, 51.5, 54.2, 58.6, 71.2, 72.0, 
73.3, 73.8, 75.1, 75.3, 79.0, 107.1, 121.4, 121.8, 127.5, 127.9, 128.2, 137.2, 139.7, 
151.6, 155.5, 169.3, 210.4; MS (ESI+) for C62H112O10Si4 [M+Cs] calc 1261.6387 
found 1261.638.
(+)-Alcohol 235 A vacuum dried, argon flushed vial containing ketone 234 (128 mg, 
0.113 mmol) was charged with CH2Cl2 (0.55 mL) and cooled to -25 °C  external 
temperature. The solution was then treated dropwise with a 1.0 M solution of 
Me2AlCl (0.55 mL, 0.566 mmol) over 10 min and stirred for an additional 2 min. The 
reaction was then treated with n-Bu3SnH (84 μL, 0.312 mmol; 2.75 eq) over 5 min 
at -25 °C. followed by treatment with additional n-Bu3SnH (99 μL; 3.25 eq) dropwise 
over 2 h (3 μL, 0.1 equiv, every 4 min).The reaction gradually warmed to -10 °C for 
over 45 min and was then quenched with saturated aqueous NaHCO3 (2 mL).  he 
reaction was diluted with CH2Cl2 (10 mL) and water (5 mL) and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (3 × 10 mL), the combined 
organic layers were then washed with brine (5 mL), dried with Na2SO4, filtered 
through a cotton plug, and concentrated. Purification by plug column 
chromatography (Hexanes to 5% EtOAc/Hex) afforded a mixture of isomers (117 
127
mg, 0.103 mmol) in 91% yield as a 3:1 ratio of diastereomers by NMR. Purification 
by column chromatography (Hexanes to 5% EtOAc/Hex) afforded the desired isomer 
(89 mg, 0.079 mmol) for a 70% isolated yield of(+)-alcohol 235. [α]21D = +30.6  (c = 
0.26, CH2Cl2); IR (film) 3508, 2948, 2866, 1729, 1589, 1470, 1344, 1256, 1165, 
1070, 881, 836, 775 cm-1; ¹H NMR (500 MHz, CDCl₃) δ -0.43 (s, 3H), -0.11 (s, 3H), 
-0.08 (s, 6H), 0.81 (s, 9H), 0.88 (s, 3H), 0.91 (s, 3H), 0.92 (s, 9H), 0.99 (d, J = 6.5 
Hz, 3H), 1.12 (m, 36H), 1.28 (m, 6H), 1.58 (m, 1H), 1.74 (m, 3H), 1.97 (m, 1H), 2.19 
(s, 3H), 2.72 (m, 1H), 2.97 (dd, J = 10.5, 13.5 Hz, 1H), 3.50 (s, 3H), 3.53 (m, 1H), 
3.61 (m, 3H), 3.81 (m, 4H), 3.92 (m, 1H), 3.98 (m, 1H), 4.05 (m, 1H), 4.56 (d, J = 
12.0 Hz, 1H), 4.65 (d, J = 12.0 Hz, 2H), 6.21 (s, 1H), 7.33 (m, 5H); ¹³C NMR (125 
MHz, CDCl₃) δ -5.33, -5.09, -4.99, -4.22, 11.19, 12.95, 12.99, 13.17, 17.87, 17.88, 
17.98, 18.01, 23.84, 25.75, 25.93, 29.71, 33.00, 34.88, 39.03, 45.73, 51.63, 58.42, 
69.13, 70.69, 71.77, 72.32, 73.36, 77.25, 78.90, 81.92, 106.04, 119.85, 121.43, 
127.43, 127.53, 127.58, 128.20, 128.23, 137.80, 138.21, 150.79, 154.95, 169.66; 
MS (ESI+) for C62H114O10Si4 [M+Cs] calc 1263.654 found 1263.652.
(+)-TBS ether To a 0 °C solution of (+)-alcohol 235 (154 mg, 0.136 mmol) in CH₂Cl₂ 
(0.7 mL) was added 2,6-lutidine (40 μL, 0.544 mmol) followed by TBSOTf (63 μL, 
0.272 mmol). The reaction stirred for 15 min and was warmed to room temperature 
over 1 h, stirred 15 h at room temperature, and was quenched with NaHCO₃  (0.5 
mL) and CH₂Cl₂ (0.5 mL). The layers were separated and the aqueous phase was 
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extracted with CH₂Cl₂ (4 x 3 mL), the organics combined, dried over Na₂SO₄, filtered, 
and concentrated. Purification by column chromatography (Hexanes to 3% EtOAc/
Hexanes) gave (+)-TBS ether (144 mg, 0.116 mmol) in 85% yield as clear oil. [α]25D 
= +25.3 (c = 0.25, CH2Cl2); IR (film) 2949, 2866, 1729, 1588, 1256, 1165, 836 cm-1; 
¹H NMR (400 MHz, CDCl₃) δ -0.42 (s, 3H), -0.15 (s, 3H), 0.06 (m, 12H), 0.87 (m, 
33H), 1.09 (m, 39H), 1.28 (m, 6H), 1.59 (m, 2H), 1.75 (m, 2H), 1.89 (m, 1H), 2.20, (s, 
3H), 2.73 (m, 1H), 2.80 (m 1H), 3.35 (d, J = 8.4 Hz, 1H), 3.46 (s, 3H), 3.52 (m, 3H), 
3.72 (d, J = 8.8 Hz, 2H) 3.81 (s, 3H), 3.98 (brs, 2H), 4.54 (m, 2H), 6.18 (s, 1H), 7.28 
(m, 5H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.7, -4.7, -4.2, -3.2, -1.0, 10.6, 13.1, 
13.2, 17,9, 18.0, 18.0, 18.1, 18.1, 18.1, 24.6, 25.9, 26.1, 26.3, 29.7, 29.9, 33.9, 35.2, 
38.6, 43.2, 51.5, 58.7, 69.5, 71.0, 73.2, 73.4, 79.3, 106.1, 120.5, 121.3, 127.8, 
127.4, 128.1, 137.5, 138.8, 150.9, 155.0, 169.5; MS (ESI+) for C68H128O10Si5 [M+Cs] 
calc 1377.741 found 1377.744
(+)-Alcohol 236. A degassed solution of (+)-benzyl ether (106 mg, 0.085 mmol) in 
THF (0.57 mL) was purged with H₂ and treated with Pd(OH)₂/C  (24 mg).  The 
reaction mixture was stirred under H₂ atmosphere for 5 h and was filtered through 
Celite®, washed with EtOAc (15 mL), and concentrated to clear oil. Purification by 
plug column chromatography (5% EtOAc/Hexanes) gave (+)-alcohol 236 (99 mg, 
0.085 mmol) in quantitative yield as waxy white solids. [α]22D = +22.0 (c = 0.25 
CH2Cl2); IR (film) 3507, 2949, 2866, 1729, 1589, 1471, 1255, 1165, 835, 773 cm-1; 
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¹H NMR (500 MHz, CDCl₃) δ -0.31 (s, 3H), -0.12 (s, 3H), 0.32 (s, 6H), 0.07 (m, 6H), 
0.80 (s, 3H), 0.82 (s, 9H), 0.88 (s, 3H), 0.88 (m, 21H), 1.09 (m, 36H), 1.21 (m, 6H), 
1.56 (m, 2H), 1.72 (m, 1H), 1.80 (m, 2H), 2.19 (s, 3H), 2.45 (brs 1H), 2.77 (m, 2H), 
3.31 (m, 2H), 3.41 (s, 3H), 3.46 (m, 1H), 3.67 (m, 2H), 3.72 (s, 1H), 3.81 (s, 3H), 
3.97 (m, 2H), 6.17 (s, 1H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.8, -4.4, -4.2, -3.3, 
1.0, 10.6, 12.9, 13.3, 13.5, 17.9, 18.0, 18.1, 18.1, 18.2, 24.5, 25.8, 26.0, 26.2, 29.7 
30.4, 33.5, 35.7, 38.6, 51.7 58.1 61.5 69.9 73.0, 75.6, 80.54, 106.2, 120.4, 121.2 
137.2 150.9 155.1 169.8; MS (ESI+) for C61H122O10Si5 [M+Cs] calc 1287.694 found 
1287.694
(+)-Aldehyde To a solution of 2.0 M oxalyl chloride in CH₂Cl₂ (85 μL, 0.170 mmol) in 
CH₂Cl₂ (0.27 mL) at -78 °C was added a solution of DMSO (24 μL, 0.339 mmol) 
diluted with CH₂Cl₂ (24 μL). The resultant solution stirred at -78 °C  for 25 min and 
was then treated dropwise with a solution of (+)-alcohol 236 (98 mg, 0.085 mmol) in 
CH₂Cl₂ (0.3 mL) at -78 °C, followed by  CH₂Cl₂ rinse (2 x 0.1 mL). The resulting 
cloudy white mixture was stirred at -78 °C for 1 h and was treated with triethylamine 
(50.0 μL, 0.339 mmol) and stirred for 30 min at -78 °C. The reaction mixture was 
warmed to 0 °C for 1 h and quenched with saturated NaHCO₃. The layers were 
separated and the aqueous layer was extracted with CH₂Cl₂  (3 x 4 mL), the 
combined organic layers were dried over Na₂SO₄, filtered and concentrated. 
Purification by plug column (Hexanes to 4% Ethyl Acetate/Hexanes) afforded (+)-
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aldehyde (75.5 mg, 0.065 mmol) in 79% yield. [α]25D = +26.0 (c = 0.25, CH2Cl2); IR 
(film) 2949, 2866, 2732, 2713, 1731, 1589, 1471, 1256, 1165, 836, 773 cm-1; ¹H 
NMR (500 MHz, CDCl₃) δ -0.39 (s, 3H), -0.12 (s, 3H), 0.03 (s, 6H), 0.08 (m, 6H), 
0.80 (s, 3H), 0.82 (m, 6H), 0.88 (m, 27H), 1.09 (m, 36H), 1.22 (m, 6H), 1.52 (m, 1H), 
1.63 (m, 1H), 1.75 (m, 3H), 2.19 (s, 3H), 2.77 (m, 2H), 3.42 (s, 3H), 3.50 (m, 3H), 
3.72 (m, 1H), 3.81 (s, 3H), 3.94 (m, 2H), 6.17 (s, 1H), 9.66 (s, 1H); ¹³C NMR (125 
MHz, CDCl₃) δ -5.2, -5.0, -4.7, -4.6, -4.4, -3.2, -3.1, 1.0, 10.2, 10.4, 12.9, 13.1, 13.2, 
17.9, 18.0, 18.1, 18.1, 22.2, 24.7, 25.9, 26.1, 26.2, 26.3, 29.6, 29.7, 30.2, 33.8, 34.4, 
38.4, 43.8, 51.6, 58.8, 59.2, 69.1, 72.9, 84.3, 85.7, 106.0, 120.4, 121.4, 137.5, 
150.8, 155.0, 169.7, 202.1; MS (ESI+) for C61H120O10Si5 [M+Cs] calc 1285.768 found 
1285.675.
(+)-Acid 237 To a solution of (+)-aldehyde (75 mg, 0.065 mmol) in t-BuOH (3 mL) 
was added 2-methyl-2-butene (0.17 mL, 1.156 mmol) followed by dropwise addition 
of a pre-made solution of NaClO₂ (71 mg, 0.780 mmol) in 0.05 M potassium 
biphthalate pH 4 buffer (3 mL). The yellow solution stirred for 1 h, gradually 
becoming clear and colorless. The reaction was then diluted with brine (10 mL) and 
EtOAc (10 mL) and stirred for 5 min. The layers were separated and the aqueous 
was extracted with EtOAc (4 x 5 mL). The combined organic layers were dried over 
Na₂SO₄, filtered, concentrated, and absorbed on silica gel. Purification by column 
chromatography (5% EtOAc/Hexanes) afforded (+)-acid 237 (67 mg, 0.057 mmol) in 
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88% yield over two steps. [α]22D = +25.7 (c = 0.25, CH2Cl2); IR (film) 3168, 2949, 
2866, 1721, 1589, 1471, 1255, 1166, 1069, 882, 836, 774 cm-1; ¹H NMR (500 MHz, 
CDCl₃) δ -0.48 (s, 3H), -0.15, (s, 3H), 0.03 (s, 3H), 0.04 (s, 3H), 0.10 (s, 3H), 0.11 (s, 
3H), 0.80 (m, 15H), 0.90 (m, 21H), 1.10 (m, 36H), 1.21 (m, 6H), 1.50 (m, 1H), 1.66 
(m, 1H), 1.74 (m, 1H), 1.87 (m, 1H), 1.94 (m, 1H), 2.18 (s, 3H), 2.77 (m, 2H), 3.47 
(m, 4H), 3.53 (m, 1H), 3.83 (s, 3H), 3.88 (m, 2H), 4.06 (m, 1H), 4.17 (m, 1H), 6.17 
(m, 1H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.9, -4.7, -4.6, -4.5, -4.4, -4.3, -3.0, 1.0, 
10.2, 13.1, 13.2, 17.9, 18.0, 18.1, 18.1, 18.2, 20.2, 22.3, 22.7, 24.5, 25.2, 25.8, 26.0, 
26.2, 26.3, 26.5, 29.7, 29.9, 34.0, 34.7, 38.0, 43.5, 51.9, 59.1, 69.3, 72.8, 75.5, 81.4, 
105.9, 120.2, 121.3, 137.7, 151.0, 170.1, 172.4; MS (ESI+) for C61H120O11Si5 [M+Cs] 
calc 1301.673 found 1301.679. 
(+)-Teoc-Protected Hemiaminal 238 A 0 °C  solution of (+)-carboxylic acid 237 (11.0 
mg, 0.009 mmol) in anhydrous acetone (0.75 mL) was treated with triethylamine (3.1 
μL, 0.023 mmol) followed by ethylchloroformate (2.0 μL, 0.021 mmol) and stirred at 
0 °C for 30 min. The reaction mixture was then treated with a 0.62 M aqueous 
solution of NaN₃  (30 μL, 0.019 mmol), stirred at 0 °C for 2 h, poured into ice water (3 
mL) and extracted with cold ether (5 x 3 mL). The combined organic layers were 
dried over Na₂SO₄, filtered and concentrated at 30 °C. The residue was dissolved in 
toluene, dried again over Na₂SO₄, filtered, flushed with argon and set into a pre-
heated 120 °C sand bath and stirred for 40 min. The reaction mixture was cooled to 
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50 °C and the solvent removed in vacuo. The residue was cooled to room 
temperature and charged with anhydrous DMF (50 μL). The solution was treated 
with β-trimethylsilylethanol (47 μL , 0.33 mmol) followed by copper(I) chloride (1.0 
mg, 0.009 mmol), giving a pale green mixture. The reaction mixture stirred for 2 h 
giving a more intense green mixture that was diluted with water (2 mL) and ether (2 
mL).  The layers were separated and the aqueous layer was extracted with ether (4 
x 2 mL). The combined organic layers were dried over Na₂SO₄, filtered, and 
concentrated to clear oil. Purification by  column chromatography (3.5% ether/
hexanes) afforded (+)-hemiaminal 238 (9.1 mg, 0.007 mmol) in 76% yield as clear 
oil. [α]25D = +30.3 (c = 0.25, CH2Cl2); IR (film) 3436, 2950, 2866, 1730, 1588, 1471, 
1252, 1166, 1067, 836, 773; ¹H NMR (500 MHz, CDCl₃) δ -0.51 (s, 3H), -0.10 (s, 
3H), 0.03 (m, 15H), 0.07 (s, 6H), 0.81 (m, 12H), 0.88 (s, 9H), 0.89 (m, 12H), 1.01 (m, 
2H), 1.09 (m, 36H), 1.25 (m, 9H), 1.49 (m, 1H), 1.57 (m, 1H), 1.79 (m, 3H), 2.19 (s, 
3H), 2.70 (m, 1H), 2.85 (dd, J = 10.5, 14.5 Hz, 1H), 3.32 (s, 3H), 3.41 (m, 1H), 3.52 
(m, 1H), 3.84 (s, 3H), 3.86 (m, 1H), 3.95 (m, 2H), 4.12 (m, 1H), 4.22 (m, 1H), 4.90 
(m, 1H), 5.30 (brs, 1H), 6.16 (s, 1H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.8, -4.6, 
-4.4, -4.4, -1.5, 0.7, 1.0, 1.3, 10.4, 13.0, 13.1, 13.2, 13.3, 17.6, 17.8, 17.9, 18.0, 18.1, 
22.7, 23.7, 25.8, 25.9, 26.0, 26.1, 26.2, 29.7, 31.0, 33.7, 38.2, 42.6, 51.7, 55.4, 63.1, 
69.3, 72.9, 82.3, 105.9, 120.2, 121.5, 137.7, 150.9, 154.9, 157.0, 169.8; MS (ESI+) 
for C66H133NO11Si6 [M+Cs] calc 1416.7549 found 1416.753.
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(+)-Alcohol 235 A room temperature solution of (+)-ketone 234 (103 mg, 0.091 
mmol) in THF (2.2 mL) was treated with (R)-2-methyl-CBS-oxazaborolidine 1 M in 
toluene (0.18  mL, 0.18 mmol) followed by 1 M BH₃·THF in THF (0.18 mL, 0.18 
mmol) and stirred for 2 h. The reaction was quenched with saturated aqueous 
NaHCO₃, diluted with CH₂Cl₂ and stirred for 15 min. The layers were separated and 
the aqueous layer was extracted with CH₂Cl₂, dried over Na₂SO₄, filtered, 
concentrated, and purified by column chromatography (8% EtOAc/Hexanes) to give 
(+)-alcohol 235 (84 mg, 0.074 mmol) in 82% yield as clear oil. [α]21D = +30.6  (c = 
0.26, CH2Cl2); IR (film) 3508, 2948, 2866, 1729, 1589, 1470, 1344, 1256, 1165, 
1070, 881, 836, 775 cm-1; ¹H NMR (500 MHz, CDCl₃) δ -0.43 (s, 3H), -0.11 (s, 3H), 
-0.08 (s, 6H), 0.81 (s, 9H), 0.88 (s, 3H), 0.91 (s, 3H), 0.92 (s, 9H), 0.99 (d, J = 6.5 
Hz, 3H), 1.12 (m, 36H), 1.28 (m, 6H), 1.58 (m, 1H), 1.74 (m, 3H), 1.97 (m, 1H), 2.19 
(s, 3H), 2.72 (m, 1H), 2.97 (dd, J = 10.5, 13.5 Hz, 1H), 3.50 (s, 3H), 3.53 (m, 1H), 
3.61 (m, 3H), 3.81 (m, 4H), 3.92 (m, 1H), 3.98 (m, 1H), 4.05 (m, 1H), 4.56 (d, J = 
12.0 Hz, 1H), 4.65 (d, J = 12.0 Hz, 2H), 6.21 (s, 1H), 7.33 (m, 5H); ¹³C NMR (125 
MHz, CDCl₃) δ -5.33, -5.09, -4.99, -4.22, 11.19, 12.95, 12.99, 13.17, 17.87, 17.88, 
17.98, 18.01, 23.84, 25.75, 25.93, 29.71, 33.00, 34.88, 39.03, 45.73, 51.63, 58.42, 
69.13, 70.69, 71.77, 72.32, 73.36, 77.25, 78.90, 81.92, 106.04, 119.85, 121.43, 
127.43, 127.53, 127.58, 128.20, 128.23, 137.80, 138.21, 150.79, 154.95, 169.66; 
MS (ESI+) for C62H114O10Si4 [M+Cs] calc 1263.654 found 1263.652.
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(+)-Lactone 243 To a 0 °C solution of (+)-silyl ether 235 (70 mg, 0.062 mmol) in 
DMF (1.0 mL) was added 1.0 M TBAF in THF (0.37 mL, 0.37 mmol) and the reaction 
stirred for 2 h at 0 °C. The reaction was quenched with saturated aqueous NH₄Cl, 
the layers were separated, and the aqueous layer was extracted with EtOAc (5 x 2 
mL). The combined organic layers were dried over Na₂SO₄, filtered, and 
concentrated to orange oil. Purification by column chromatography (25% EtOAc/
Hexanes to 40% EtOAc/Hexanes) provided the (+)-lactone 243 (32 mg, 0.048 mmol) 
in 77% yield as white waxy solid. [α]23D = +29.1 (c = 0.26, CH2Cl2); IR (film) 3378, 
2929, 2857, 1661, 1619, 1496, 1470, 1374, 1253, 1172, 1102, 836, 775, 737, 699 
cm-1; ¹H NMR (500 MHz, CDCl₃) δ 0.05 (s, 6H), 0.89 (s, 3H), 0.90 (s, 9H), 0.94 (s, 
3H), 1.11 (d, J = 7.0 Hz, 3H), 1.50 (d, J = 15.3 Hz, 1H), 1.57 (m, 1H), 1.93 (m, 5H), 
2.15 (m, 1H), 2.81 (dd, 12.3, 16.5 Hz, 1H), 2.98 (dd, J = 3.0, 16.5 Hz, 1H), 3.45 (s, 
3H), 3.49 (q, J = 5.0, 8.6 Hz, 1H), 3.59 (m, 3H), 3.76 (dd, J = 3.5, 10.7 Hz, 1H), 4.04 
(d, J = 10.0 Hz, 1H), 4.17 (q, J = 5.9, 10.7 Hz, 1H), 4.25 (brs, 1H), 4.48 (ddd, J = 3.0, 
6.3, 12.3 Hz, 1H), 4.52 (d, J = 11.9 Hz, 1H), 4.58 (d, J = 11.9 Hz, 1H), 6.29 (s, 1H), 
7.28 (m, 6H), 11.17 (s, 1H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.3, 9.6, 10.5, 18.0, 
25.0, 25.8, 28.1, 30.2, 32.3, 38.5, 42.8, 58.4, 69.0, 72.7, 72.7, 73.5, 80.5, 80.6, 82.6, 
101.2, 101.4, 113.6, 127.7, 127.7, 128.4, 138.0, 139.8, 161.4, 162.2, 170.8; MS (ESI
+) for C37H56O9Si [M+Cs] calc 805.2748 found 805.2814.
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(+)-TBS ether To a 0 °C  solution of (+)-triol 243 (31 mg, 0.046 mmol) in THF (0.4 
mL) was added 2,6-lutidine (27 μL, 0.37 mmol) followed by TBSOTf (42 μL, 0.18 
mmol).  The reaction stirred for 2 h at 0 °C  and was quenched with NaHCO₃  (0.4 mL) 
and diluted with CH₂Cl₂ (0.4 mL). The layers were separated and the aqueous phase 
was extracted with CH₂Cl₂ (3 x 2 mL), the organics combined, dried over Na₂SO₄, 
filtered, and concentrated. Purification by column chromatography (Hexanes to 5% 
EtOAc/Hexanes) gave (+)-TBS ether (39 mg, 0.038 mmol) in 83% yield as clear oil. 
[α]25D = +46.5 (c = 0.49, CH2Cl2); IR (film) 2955, 2930, 2857, 1725, 1592, 1568, 
1472, 1360, 1252, 1166, 1069, 1005, 837, 776 cm-1; ¹H NMR (500 MHz, CDCl₃) δ 
0.02 (s, 3H), 0.08 (s, 3H), 0.08 (s, 3H), 0.10 (s, 3H), 0.25 (s, 3H), 0.27 (m, 9H), 0.84 
(s, 9H), 0.09 (s, 3H), 0.93 (s, 9H), 0.96 (s, 3H), 1.05 (s, 9H), 1.05 (s, 9H), 1.10 (d, J = 
6.7 Hz, 3H),  1.65 (m, 2H), 2.00 (m, 3H), 2.05 (s, 3H), 2.60 (dd, J = 12.2, 16.1 Hz, 
1H), 2.99 (m, 1H), 3.37 (m, 1H), 3.50 (s, 3H), 3.51 (m, 1H), 3.61 (m, 2H), 3.71 (dd, J 
= 3.6, 10.3 Hz, 1H), 4.01 (q, J = 5.5, 10.9 Hz, 1H), 4.13 (m, 1H), 4.26, (m, 1H), 4.56 
(s, 2H), 6.34 (s, 1H), 7.28 (m, 5H); ¹³C  NMR (125 MHz, CDCl₃) δ -4.9, -4.8, -4.4, 
-4.4, -4.3, -4.2, -4.2, -3.4, 9.0, 11.8, 18.0, 18.1, 18.3, 18.6, 25.2, 25.7, 25.8, 25.9, 
29.9, 30.0, 33.1, 38.2, 40.1, 58.6, 68.7, 69.3, 69.6, 73.3, 73.5, 76.3, 77.2, 79.0, 80.7, 
110.6, 110.7, 118.6, 127.4, 127.5, 128.3, 138.3, 141,2, 156.9, 158.3, 163.4; MS (ESI
+) for C55H98O9Si4 [M+Cs] calc 1147.5342 found 1147.5349.
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(+)-Alcohol 244 A degassed solution of (+)-benzyl ether (41 mg, 0.040 mmol) in 
THF was purged with H₂  and treated with Pd(OH)₂/C (11 mg). The reaction mixture 
stirred under H₂ pressure for 14 h and was filtered through Celite®, washed with 
EtOAc (15 mL), and concentrated to yellow oil. Purification by plug column (10% 
EtOAc/Hexanes) gave (+)-alcohol 244 (37 mg, 0.040 mmol) in quantitative yield as 
glassy white solids. [α]25D = +39.2 (c = 0.24, CH2Cl2); IR (film) 3460, 2955, 2930, 
2885, 2857, 1708, 1592, 1567, 1472, 1360, 1253, 1166, 1069, 837, 776 cm-1; ¹H 
NMR (400 MHz, CDCl₃) δ 0.00 (s, 3H) 0.06 (s, 3H), 0.07 (s, 3H), 0.10 (s, 3H), 0.22 
(s, 3H), 0.23 (s, 3H), 0.24 (s, 6H), 0.84 (s, 9H), 0.85 (s, 3H), 0.90 (s, 9H), 0.91 (s, 
3H), 1.01 (s, 18H), 1.04 (d, J = 6.8 Hz, 3H), 1.70 (m, 2H), 1.91 (m, 2H), 1.99 (m, 1H), 
2.07 (s, 3H), 2.74 (dd, J = 12.8, 16.4 Hz, 1H), 2.99 (m, 1H), 3.22 (m, 1H), 3.32 (m, 
1H), 3.43 (m, 1H), 3.55 (s, 3H), 3.59 (m, 1H), 3.64 (m, 1H), 3.80 (m, 1H), 4.03 (m, 
1H), 4.24 (m, 2H), 6.29 (s, 1H); ¹³C  NMR (125 MHz, CDCl₃) δ -4.9, -4.6, -4.3, -4.2, 
-4.2, -4.1, -3.2, 8.6, 11.7, 18.0, 18.1, 18.3, 18.5, 24.8, 25.7, 25.9, 25.9, 25.9, 29.1, 
30.8, 34.4, 38.4, 39.9, 59.2, 62.4, 67.9, 73.1, 76.3, 76.8, 77.2, 79.6, 81.0, 110.1, 
110.5, 118.8, 141.7, 157.1, 158.6, 164.3;  MS (ESI+) for C48H92O9Si [M+Cs] calc 
1057.4873 found 1057.4695.
(+)-Acid 245 To a solution of oxalyl chloride (7.5 μL, 0.086 mmol) in CH₂Cl₂ (0.20 
mL) at -78 °C was added DMSO (12.5 μL, 0.173 mmol). The resultant solution 
stirred at -78 °C  for 30 min and was then treated dropwise with a solution of (+)-
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alcohol 244 (40 mg, 0.043 mmol) in CH₂Cl₂ (0.2 mL) at -78 °C, followed by CH₂Cl₂ 
rinse (2 x 0.1 mL). The resulting cloudy white mixture stirred at -78 °C  for 1 h and 
was treated with triethylamine (24.0 μL, 0.173 mmol) and stirred for 30 min at -78 
°C. The reaction mixture was warmed to 0 °C for 40 min then warmed to room 
temperature for 20 min and quenched with saturated NaHCO₃. The layers were 
separated and the aqueous layer extracted with CH₂Cl₂ (3 x 3 mL), the combined 
organic layers were dried over Na₂SO₄, filtered and concentrated. Filtration through a 
silica gel plug (Hexanes to 25% Ether/Hexanes) afforded the intermediate aldehyde 
(40 mg, 0.043 mmol), which was immediately taken on to the next step. 
! To a solution of the intermediate aldehyde (41 mg, 0.044 mmol) in t-BuOH 
(2.13 mL) was added 2-methyl-2-butene (0.11 mL, 1.065 mmol) followed by 
dropwise addition of a pre-made solution of NaClO₂ (60.2 mg, 0.533 mmol) in 0.05 M 
potassium biphthalate pH 4 buffer (2.13 mL). The yellow solution stirred for 1 h, 
gradually  becoming clear and colorless. The reaction mixture was then diluted with 
brine and EtOAc and stirred for 5 min. The layers were separated and the aqueous 
layer was extracted with EtOAc (4 x 4 mL). The combined organic layers were dried 
over Na₂SO₄, filtered, and concentrated. Purification by column chromatography 
(25% EtOAc/Hexanes) afforded (+)-acid 245 (38.5 mg, 0.041 mmol) in 93% yield 
over two steps. [α]25D = +53.3 (c = 0.26, CH2Cl2); IR (film) 3159, 2956, 2930, 2857, 
1725, 1592, 1567, 1360, 1255, 1168, 1071, 1005, 837, 777 cm-1; ¹H NMR (400 MHz, 
CDCl₃) δ -0.00 (s, 3H), -0.07 (s, 6H), 0.16 (s, 3H), 0.21 (s, 3H), 0.22 (s, 3H), 0.25 (s, 
3H), 0.26 (s, 3H), 0.86 (s, 9H), 0.88 (s, 3H), 0.91 (s, 9H), 0.96 (d, J = 7.2 Hz, 3H), 
0.99 (s, 3H), 1.00 (s, 9H), 1.01 (s, 9H), 1.55 (m, 1H), 1.83 (m, 2H), 2.04 (s, 3H), 2.18 
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(m, 2H), 2.82 (dd, J = 2.4, 16.8 Hz, 1H), 3.01 (dd, J = 13.2, 16.8 Hz, 1H), 3.40 (m, 
1H), 3.43 (s, 3H), 3.61 (m, 1H), 3.75 (d, J = 3.7 Hz, 1H), 4.13 (m, 1H), 4.29 (m, 1H), 
4.44 (dd, J = 3.6, 10.4 Hz, 1H), 6.28 (s, 1H); ¹³C NMR (125 MHz, CDCl₃) δ -4.9, -4.4, 
-4.2, -4.2, -2.8, 8.1, 11.7, 18.0, 18.3, 18.3, 18.5, 25.7, 25.9, 26.0, 26.0, 26.0, 26.2, 
28.1, 31.6, 33.1, 37.0, 37.8, 58.4, 66.5, 73.3, 77.2, 77.5, 79.7, 83.2, 109.6, 110.3, 
118.9, 142.1, 157.3, 158.9, 166.0, 172.6; MS (ESI+) for C48H90O10Si4 [M+Cs] calc 
1071.4665 found 1071.4554.
(+)-Teoc-Protected Hemiaminal 190 A 0 °C  solution of (+)-carboxylic acid 245 
(16.0 mg, 0.017 mmol) in anhydrous acetone (1.38 mL) was treated with 
triethylamine (5.7 μL, 0.041 mmol) followed by ethylchloroformate (3.6 μL, 0.037 
mmol) and stirred at 0 °C for 30 min. The reaction mixture was then treated with a 
0.62 M aqueous solution of NaN₃  (55 μL, 0.034 mmol), stirred at 0 °C for 2 h, poured 
into ice water and extracted with cold ether (5 x 3 mL). The combined extracts were 
dried over Na₂SO₄, filtered and concentrated at 30 °C. The residue was dissolved in 
toluene, dried again over Na₂SO₄, filtered, flushed with argon and set into a pre-
heated 120 °C sand bath and stirred for 30 min. The reaction mixture was cooled to 
50 °C and the solvent removed in vacuo. The residue was cooled to room 
temperature and charged with anhydrous DMF (0.1 mL). The solution was treated 
with β-trimethylsilylethanol (0.05 mL. 0.34 mmol) followed by copper(I) chloride (1.7 
mg, 0.017 mmol), giving a pale green mixture. The reaction mixture stirred for 2 h 
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giving a more intense green mixture that was diluted with water (2 mL) and ether (2 
mL).  The layers were separated and the aqueous layer was extracted with ether (4 
x 2 mL). The combined organic layers were dried over Na₂SO₄, filtered, and 
concentrated to clear oil. Purification by column chromatography (10% ether/
hexanes) afforded (+)-hemiaminal 190 (13.5 mg, 0.013 mmol) in 76% yield as clear 
oil. [α]18D = +27.4 (c = 0.25, CH2Cl2); IR (film) 2955, 2857, 1726, 1592, 1568, 1472, 
1351, 1250, 1167, 1069, 836, 776; ¹H NMR (400 MHz, CDCl₃) δ -0.02 (s, 3H), 0.01 
(s, 9H), 0.05 (s, 3H), 0.06 (s, 3H), 0.08 (s, 3H), 0.22 (s, 3H), 0.23 (s, 9H), 0.80 (s, 
9H), 0.86 (s, 3H), 0.91 (s, 9H), 0.94 (m, 2H), 0.98 (s, 3H), 1.00 (s, 9H), 1.02 (s, 9H), 
1.06 (d, J = 6.8 Hz, 3H), 1.47 (m, 1H), 1.62 (m, 1H), 1.82 (m, 1H), 1.95 (m, 1H), 2.07 
(s, 3H), 2.26 (m, 1H), 2.60 (dd, J = 12.4, 16.4 Hz, 1H), 3.03 (m, 1H), 3.36 (s, 3H), 
3.38 (m, 1H), 3.59 (m, 1H), 4.00 (m, 1H), 4.12 (m, 4H), 4.81 (m, 1H), 5.45 (m, 1H), 
6.30 (s, 1H); ¹³C NMR (125 MHz, CDCl₃) δ -5.0, -4.9, -4.5, -4.4, -4.4, -4.3, -4.2, -3.5, 
-1.5, 8.8, 11.7, 17.5, 18.0, 18.1, 18.3, 18.5, 25.7, 25.8, 25.9, 26.0, 26.5, 29.4, 29.7, 
31.4, 32.4, 37.3, 39.5, 55.8, 63.3, 67.4, 68.5, 73.3, 77.4, 79.3, 84.1, 110.6, 110.7, 
118.5, 141.3, 156.8, 156.9, 158.2, 163.6; MS (ESI+) for C53H103NO10Si5 [M+Cs] calc 
1186.5483 found 1186.5471.
Acid Chloride 189 To a solution of (-)-carboxylic acid 137 (9.6 mg, 0.032 mmol) in 
CH₂Cl₂ (0.96 mL) was added 0.62 M pyridine in CH₂Cl₂ (0.20 mL), followed by 0.48 M 
SOCl₂ (0.20 mL). The reaction mixture stirred for 2 hours and the solvent was 
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removed under increased argon pressure, then concentrated further in vacuo at 30 
°C. The material was suspended in d₆-benzene and analyzed by 1H NMR to confirm 
the formation of acid chloride 189 then taken on immediately without further analysis 
as it showed significant moisture sensitivity. The NMR sample was transferred to an 
oven dried vial, the tube rinsed with anhydrous toluene, concentrated in vacuo, and 
dissolved in THF (0.32 mL) to make a 0.1 M solution that was used immediately in 
the next step. 1H NMR δ -0.04 (s, 9H), 0.91 (ddd, m, 2H), 1.64 (s, 3H), 2.30 (dd, J = 
4.4, 14.4 Hz, 1H), 2.37 (dd, J = 7.6, 14.4 Hz, 1H), 3.09 (s, 3H), 3.51 (ddd, J = 6.8, 
9.6, 9.6 Hz, 1H), 3.76 (m, 2H), 4.36 (d, J = 5.6 Hz, 1H), 4.50 (q, J = 7.2, 14.8 Hz, 
2H), 4.81 (m, 2H).
(+)-N-Acyl Hemiaminal 246 To a -78 °C solution of (+)-hemiaminal 190 (7.5 mg, 
0.0071 mmol) in THF (0.28 mL) was added a solution of 2.0 M i-PrMgCl in THF (12.5 
μL, 0.025 mmol) and stirred for 30 min. The reaction was then treated with a 0.1 M 
solution of acid chloride (142 μL, 0.0142 mmol), stirred at -78 °C for 30 min, then 
warmed to -40 °C and stirred for 45 min. The reaction was quenched with saturated 
aqueous NH₄Cl (0.2 mL), warmed to room temperature and diluted with CH₂Cl₂ (4 
mL) and saturated aqueous NH₄Cl (4 mL). The layers were separated and the 
aqueous layer was extracted with CH₂Cl₂ (4 x 3 mL). The combined organic 
extracts were dried over Na₂SO₄, filtered, and concentrated. Purification by column 
141
chromatography (5% EtOAc/Hexanes) gave fully protected (+)-irciniastatin A 8 (8.3 
mg, 0.0062 mmol)  in 87% yield as well as recovered (+)-hemiaminal 190 (1.0 mg, 
0.0009 mmol) in 13% yield. [α]23D = +42.8 (c = 0.21, CH2Cl2); IR (film) 3074, 2955, 
2931, 2895, 2857, 2740, 2713, 1728, 1592, 1568, 1472, 1411, 1350, 1250, 1168, 
1068, 938, 837, 776, 672 cm-1; 1H NMR (500 MHz, CDCl₃) -0.05 (s, 9H), -0.04 (s, 
3H), 0.03 (s, 3H), 0.04 (m, 15H), 0.21 (s, 3H), 0.22 (s, 6H), 0.23 (s, 3H), 0.76 (s, 9H), 
0.81 (s, 3H), 0.83 (m, 2H), 0.89 (m, 12H), 1.00 (s, 9H), 1.01 (s, 9H), 1.08 (m, 5H), 
1.62 (m, 1H), 1.67 (m, 1H), 1.74 (s, 3H),  1.77 (m, 1H) 1.95 (m, 1H), 2.13 (s, 3H) 
2.00 (m, 1H), 2.20 (m, 1H), 2.29 (dd, J = 9.5, 14.5 Hz, 1H), 2.86 (dd, J = 12.5, 16.0 
Hz, 1H), 3.05 (d, J = 15.5 Hz, 1H), 3.15 (d, J = 10.0 Hz, 1H), 3.27 (s, 3H), 3.34 (s, 
3H), 3.54 (m, 3H), 3.62 (m, 2H), 4.09 (m, 1H), 4.18 (m, 1H), 4.29 (m, 2H), 4.64 (m, 
2H), 4.76 (d, J = 11.5 Hz, 2H), 5.15 (d, J = 5.0 Hz, 1H), 5.64, (d, J = 5.0 Hz, 1H), 
6.29 (s, 1H); δ ¹³C  NMR (125 MHz, CDCl₃) δ -5.0, -4.9, -4.4, -4.3, -4.2, -4.2, -4.1, 
-3.3, -1.6, -1.5, -1.4, 1.0, 8.8, 11.9, 13.5, 13.5, 17.6, 18.0, 18.0, 18.1, 18.3, 18.6, 
21.9, 22.8, 24.0, 25.7, 25.8, 25.9, 26.0, 29.7, 29.9, 30.3, 34.9, 38.8, 39.0, 40.4, 56.6, 
58.1, 65.9, 66.1, 69.0, 72.7, 74.4, 75.3, 77.3, 79.6, 80.9, 95.8, 110.6, 110.8, 112.7, 
119.0, 141.9, 142.6, 154.3, 156.7, 158.19, 163.7, 174.6; MS (ESI+) for 
C67H129NO14Si6 [M+Na] calc 1362.7926 found 1362.7686.
(+)-Irciniastatin A (8) To a sample of fully protected (+)-irciniastatin A 246 (7.5 mg, 
0.006 mmol) in a polyethylene vial was added a prepared solution of TASF (23.1 mg, 
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0.084 mmol) in DMF (0.18 mL). The reaction was set in a 50 °C  sand bath and 
stirred for 36 h. The reaction was quenched with saturated aqueous NH₄Cl (2 mL) 
and diluted with EtOAc (2 mL). The layers were separated and the aqueous layer 
was extracted with EtOAc (5 x 2 mL). The combined organic layers were dried over 
Na₂SO₄, filtered, and concentrated. Purification by column chromatography (CH₂Cl₂ 
to 5% CH₂Cl₂/MeOH gradient) afforded (+)-irciniastatin A (8) (3.2 mg, 0.0052 mmol) 
94% yield as white solids. [α]22D = +27.3 (c = 0.22, MeOH); IR (film) 3370, 2965, 
2928, 2853, 1650, 1624, 1558, 1515, 1453, 1387, 1364, 1297, 1252, 1173, 1067, 
967 cm-1; ¹H NMR (500 MHz, MeOD) δ 0.89 (s, 3H), 0.96 (s, 3H), 1.09 (d, J = 7.0 
Hz, 3H), 1.72 (m, 6H), 1.89 (m, 1H), 2.00 (m, 1H), 2.06 (m, 4H), 2.34 (dd, J = 9.5, 
14.5 Hz, 1H), 2.85 (dd, J = 12.0, 17.0 Hz, 1H), 3.12 (dd, J = 3.0, 17.0 Hz, 1H), 3.19 
(s, 3H), 3.34 (s, 3H), 3.49 (m, 1H), 3.58 (dd, J = 4.5, 11.0 Hz, 1H), 3.66 (ddd, J = 3.0, 
3.0, 9.0 Hz, 1H), 3.93 (m, 2H), 4.34 (d, J = 2.5 Hz, 1H), 4.48 (ddd, J = 3.5, 6.0, 12.5 
Hz, 1H), 4.71 (d, J = 12.0  Hz, 2H), 5.38 (d, J = 8.0 Hz, 1H), 6.23 (s, 1H); ¹H NMR 
(500 MHz, CDCl₃) δ 0.90 (s, 3H), 0.94 (s, 3H), 1.08 (d, J = 7.0 Hz, 3H), 1.61 (m, 2H), 
1.73 (s, 3H), 1.81 (m, 2H), 1.98 (s, 3H), 2.05 (m, 1H), 2.16 (m, 1H), 2.38 (dd, J = 9.0, 
14.5 Hz, 1H), 2.78 (m, 2H), 3.36 (s, 6H), 3.52 (m, 1H), 3.66 (m, 1H), 3.74 (m, 1H), 
3.88 (m, 1H), 3.92 (m, 1H), 4.43 (m, 1H), 4.51 (m, 1H), 4.78 (s, 2H), 5.43 (t, J = 9.5 
Hz, 1H), 6.33 (s, 1H), 7.12 (m, 1H), 11.03 (brs, 1H); ¹³C NMR (125 MHz, CDCl₃) δ 
9.0, 10.5, 13.7, 22.7, 23.0, 28.5, 29.6, 32.3, 37.6, 38.8, 42.6, 56.3, 57.8, 71.3, 72.9, 
74.3, 78.4, 79.6, 80.6, 81.9, 100.8, 101.2, 113.1, 113.7, 139.5, 142.0, 162.0, 162.2, 
170.7, 173.9; MS (ESI+) for C31H47NO11 [M+Cs] calc 742.2203 found 742.2197.
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(+)-Alcohol 255 To a -78 °C solution of N-acetyl thiazolidinethione 254 (1.50 g, 5.97 
mmol) in CH₂Cl₂ (19.1 mL) was added TiCl₄ (0.65 mL, 5.97 mmol) dropwise over 4 
min. The orange solution was stirred for 20 min at -78 °C becoming an orange slurry. 
The reaction mixture was then treated with i-Pr2NEt (2.1 mL, 11.9 mmol) dropwise 
over 5 min becoming purple in color. The thick purple solution stirred for 45 min at 
-78 °C and was then treated with a room temperature solution of the aldehyde 253 
(878 mg, 8.95 mmol) in CH₂Cl₂ (4.1 mL), dropwise over 20 min. The purple reaction 
mixture was stirred at -78 °C for 2 h. The reaction was quenched with half-saturated 
aqueous NH₄Cl (20 mL) and warmed to room temperature. The layers were 
separated and the aqueous layer was extracted with CH₂Cl₂ (3 x 5 mL). The 
combined organic layers were dried over Na₂SO₄, filtered and concentrated to green 
oil. Purification by column chromatography (15% EtOAc/Hexanes) afforded the 
desired (+)-alcohol diastereomer 255 (1.76 g, 5.04 mmol) in 85% isolated yield as 
well as the undesired diastereomer (240 mg, 0.69 mmol) in 12% isolated yield, 
giving an overall yield of 97% yield with 7.5:1 dr. [α]22D = +179.9 (c = 0.29, CH2Cl2); 
IR (film) 3544, 2965, 1693, 1455, 1436, 1364, 1341, 1318, 1293, 1264, 1192, 1165, 
1136, 1043, 916, 746, 702 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.07 (s, 6H), 2.63 (br 
s, 1H), 2.87 (d, J = 11.5 Hz, 1H), 3.03 (dd, J = 10.3, 12.6 Hz, 1H), 3.20 (m, 2H), 3.38 
(dd, J = 6.9, 11.5 Hz, 1H), 3.55 (dd, J = 1.4, 17.6 Hz, 1H), 3.96 (dd J = 1.4, 10.3 Hz, 
1H), 5.08 (m, 2H), 5.37 (m, 1H), 5.87 (dd, J = 11.0, 17.6 Hz, 1H), 7.28 (m, 5H); ¹³C 
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NMR (100 MHz, CDCl₃) δ 22.6, 23.2, 32.2, 36.9, 41.0, 41.6, 68.5, 74.2, 77.3, 113.5, 
127.3, 128.9, 129.5, 136.5, 144.6, 173.7, 201.4; MS (ESI+) for C18H23NO2S2 [M+Na] 
calc 372.10 found 372.10.
(+)-TBS Ether To a yellow solution of (+)-alcohol (240 mg, 0.687 mmol) and 2,6-
lutidine (0.32 mL, 2.47 mmol) in CH₂Cl₂ (1.7 mL) at 0 °C was added TBSOTf (0.32 
mL, 1.37 mmol) dropwise over 3 min. The yellow solution was stirred at 0 °C  for 30 
min and the yellow solution was quenched with saturated aqueous NaHCO₃  (1.5 mL) 
and the layers were separated. The aqueous layer was extracted with CH₂Cl₂ (2 x 1 
mL) and the combined organic layers were dried over Na₂SO₄, filtered, and 
concentrated. Purification by  column chromatography (Hexanes to 3% EtOAc/
Hexanes) gave (+)-TBS ether (299 mg, 0.647 mmol) in 94% yield. [α]23D +191.5 (c = 
0.25, CH2Cl2); IR (film) 2596, 2929, 2856, 1697, 1365, 1293, 1262, 1166, 1091, 
1043, 835, 775, 701 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.01 (s, 3H), 0.13 (s, 3H), 
0.87, (s, 9H), 1.03 (s, 3H), 1.04 (s, 3H), 2.88 (d, J = 11.5 Hz, 1H), 3.04 (d, J = 10.7, 
13.1 Hz, 1H), 3.33 (dd, J = 3.3, 13.1 Hz, 1H), 3.32 (dd, J = 7.7, 11.5 Hz, 1H), 3.36 
(m, 2H), 4.24 (dd, J = 3.5, 6.3 Hz, 1H), 5.04 (m, 2H), 5.30 (m, 1H), 5.86 (dd, J = 
10.8, 17.6 Hz, 1H), 7.29 (m, 5H); ¹³C NMR (100 MHz, CDCl₃) δ -4.6, -4.2, 18.4, 21.5, 
24.7, 26.1, 32.1, 36.4, 42.3, 43.9, 68.7, 75.4, 112.6, 127.2, 128.9, 129.5, 136.6, 
145.5, 173.0, 201.0; MS (ESI+) for C24H37NO2S2Si [M+Na] calc 486.19 found 
486.19.
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Aldehyde 249 To a green -78 °C  solution of N-acyl thiazolidinethione (300 mg, 
0.647 mmol) in CH₂Cl₂ (6.2 mL) was added a 1.0 M solution of diisobutylaluminum 
hydride in hexanes (1.30 mL, 1.30 mmol) dropwise over 10 min, giving a colorless 
solution. The reaction mixture was quenched with saturated aqueous Rochelleʼs salt 
(6 mL) and the reaction mixture was warmed to room temperature and stirred 
vigorously for 2 h. The layers were separated and the aqueous layer was extracted 
with CH₂Cl₂ (3 x 5 mL). The combined organic layers were washed with brine (5 mL), 
dried over Na₂SO₄, filtered and concentrated. Purification by column chromatography 
(4% EtOAc/Hexanes) afforded aldehyde 249 (133 mg, 0.519 mmol) in 80% yield. 
The identity of the aldehyde product was confirmed by 1H and immediately  taken on 
to the next step.¹H NMR (400 MHz, CDCl₃) δ 0.00 (s, 3H) 0.04 (s, 3H), 0.89 (s, 9H), 
0.99 (s, 3H), 1.00 (s, 3H), 2.43 (m, 1H), 2.59 (m, 1H), 3.98 (m, 1H), 5.02 (m, 2H), 
5.82 (dd, J = 10.9, 17.5 Hz, 1H) 9.79 (s, 1H).
Aldehyde 259 To a 0 °C  solution of 2,2-dimethyl-1,3-propane diol (98) (21.0 g, 201.6 
mmol) in CH₂Cl₂ (129 mL) was added Et₃N (42.2 mL, 302.4 mmol) followed by a 1:1 
v/v solution of acetic anhydride (21.9 mL, 231.8 mmol) and CH₂Cl₂ (21.9 mL) 
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dropwise over 60 min. The reaction stirred for 1 h at 0 °C and was warmed to room 
temperature and  stirred for 1 h. The reaction was quenched with saturated aqueous 
NaHCO₃  (100 mL) giving pH 8 aqueous phase, and the layers were separated. The 
aqueous layer was extracted with CH₂Cl₂  (3 x 25 mL) and the organic layers were 
combined, washed with brine (100 mL), dried over Na₂SO₄, filtered, and 
concentrated to crude oil (23.8 g).
! A separate flask containing CH₂Cl₂ (521 mL) at -78 °C was charged with 
oxalyl chloride (20.8 mL, 244 mmol) followed by dropwise addition a solution of 
DMSO (34.6 mL, 488 mmol) in CH₂Cl₂ (35 mL) over 20 min. The resultant solution 
evolved gas and stirred at -78 °C for 30 min. A sample of the above crude alcohol 
(23.8 g)was dissolved in CH₂Cl₂ (73 mL) and added dropwise to the reaction mixture 
at -78 °C over 30 min, followed by a rinse with CH₂Cl₂ (5 mL). The reaction formed a 
cloudy white solution and stirred at -78 °C  for 30 min and was then treated with 
triethylamine (85 mL, 610 mmol) over 20 min at -78 °C. The reaction became thick 
and white slurry and was then warmed to 0 °C  and was stirred for 30 min while 
additional CH₂Cl₂ (100 mL) was added to facilitate stirring. The reaction was warmed 
to room temperature for 30 min and quenched with saturated aqueous NaHCO₃  (100 
mL), stirred for 5 min, diluted with water (100 mL) and the layers were separated. 
The aqueous layer was extracted with CH₂Cl₂  (3 x 50 mL) and the combined 
organics were dried with Na₂SO₄, filtered and concentrated. The crude material was 
diluted with ether (200 mL) and washed with copper(II) sulfate (200 mL), forming a 
light blue suspension. The layers were separated and the aqueous washed with 
ether (3 x 50 mL) and the combined organic layers were washed with brine (50 mL), 
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dried over Na₂SO₄, filtered and concentrated to orange oil. The product was vacuum 
distilled using a short path equipped with a vigreaux column under full vacuum at 80 
°C  to give aldehyde 259 (17.6 g, 122 mmol) in 61% yield over 2 steps. The identity 
of the aldehyde product was confirmed by 1H NMR and taken forward immediately 
due to potential enone formation. ¹H NMR (300 MHz, CDCl₃) δ 1.12 (s, 6H), 2.05 (s, 
3H), 4.11 (s, 2H), 9.53 (s, 1H).
Enoate To a 0 °C slurry of NaH 60% oil dispersion (4.9 g, 123.1 mmol) in THF (125 
mL) was added phosphonate (20.4 mL, 102.5 mmol) over 20 min, gradually  giving a 
clear solution that stirred for 20 min at 0 °C. The clear solution was then treated with 
an orange solution of aldehyde (17.7 g, 123.1 mmol) in THF (83 mL) over 10 min. 
The reaction was stirred vigorously at 0 °C  for 5 min then warmed to room 
temperature and stirred in a room temperature ultrasonic bath for 4 h. The reaction 
was quenched with saturated aqueous NH₄Cl and the layers were separated. The 
aqueous layer was extracted with EtOAc (3 x 100 mL) and the combined organic 
layers were washed with water (100 mL) and brine (100 mL) then dried over Na₂SO₄, 
filtered, and concentrated to yellow oil. The oil was purified by plug column 
chromatography (Hexanes to 10% EtOAc/Hexanes) to give pure enone (22.0 g, 
102.6 mmol) in quantitative yield. IR (film) 2974, 1744, 1719, 1651, 1375, 1311, 
1271, 1242, 1182, 1041 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.08 (s, 6H), 1.27 (t, J = 
7.1 Hz, 3H), 2.03 (s, 3H), 3.88 (s, 2H), 4.17 (q, J = 7.1 Hz, 2H), 5.78 (d, J = 16.0 Hz, 
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1H), 6.90 (d, J = 16.0 Hz, 1H); ¹³C  NMR (100 MHz, CDCl₃) δ 14.2, 20.7, 23.7, 37.1, 
60.3, 71.2, 119.5, 153.8, 166.6, 170.7; MS (ESI+) for C11H18O4 [M+Na] calc 
237.1103 found 237.11.
Alcohol  A solution of enoate (22.0 g, 102 mmol) in reagent grade 99.5% absolute 
ethanol (203 mL) was treated with K₂CO₃  (42.5 g, 308 mmol) and stirred vigorously 
for 16 h. The reaction mixture was acidified to pH = 4 with 1 M HCl and diluted with 
CH₂Cl₂ (600 mL). The layers were separated and the aqueous layer was extracted 
with CH₂Cl₂ (5 x 200 mL). The combined organic layers were dried over Na₂SO₄, 
filtered and concentrated. Purification by column chromatography  (10% EtOAc/Hex) 
gave alcohol (15.9 g, 92.3 mmol) in 90% yield. IR (film) 3458, 2964, 2872, 1714, 
1650, 1469, 1392, 1367, 1311, 1272, 1181, 1042, 998, 982, 912, 863, 727 cm-1; ¹H 
NMR (400 MHz, CDCl₃) δ 0.99 (s, 6H), 1.21 (t, J = 7.1 Hz, 3H), 2.99 (br s, 1H), 3.33 
(s, 2H), 4.09 (q, J = 7.1 Hz, 2H), 5.73 (d, J = 16.1 Hz, 1H), 6.86 (d, J = 16.1 Hz, 1H); 
¹³C NMR (100 MHz, CDCl₃) δ 14.1, 23.1, 39.0, 60.2, 70.6, 119.3, 155.4, 167.0; MS 
(ESI+) for C9H16O3 [M+Na] calc 195.0997 found 195.1001
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Aldehyde 260 A -78 °C solution of oxalyl chloride (5.9 mL, 69.6 mmol) in CH₂Cl₂ 
(300 mL) was treated dropwise with a solution of DMSO (9.9 mL, 139 mmol) in 
CH₂Cl₂ (10 mL). The resultant solution evolved gas and stirred at -78 °C for 20 min. 
A solution of alcohol (8.0 g, 46.4 mmol) was dissolved in CH₂Cl₂  (3 mL) and added 
dropwise to the reaction -78 °C over 5 min. The reaction mixture became a cloudy 
white solution and stirred at -78 °C  for 45 min. The reaction mixture was then treated 
with triethylamine (19 mL, 139 mmol) and stirred for 15 min at -78 °C  and was then 
allowed to warm to 0 °C and stirred for 40 min. The reaction mixture was quenched 
with saturated aqueous NaHCO₃  (50 mL), stirred 5 min diluted with water (50 mL) 
and the layers were separated. The aqueous layer was extracted with CH₂Cl₂ (3 x 50 
mL) and the combined organic layers were washed with water (100 mL), brine (100 
mL), dried over Na₂SO₄, filtered and concentrated. Purification by plug column 
chromatography (20% Et₂O/Hexanes) afforded the aldehyde 260 (7.5 g, 44.0 mmol) 
in 95% yield. The identity of aldehyde 260 was confirmed by 1H NMR and 
immediately taken on to the next step. ¹H NMR (400 MHz, CDCl₃) δ .1.29 (m, 9 H), 
4.21 (q, J = 7.2 Hz, 2H), 5.89 (d, J = 15.9 Hz, 1H), 6.96 (d, J = 15.9 Hz, 1H), 9.45 (s, 
1H).
(+)-Alcohol 261 To a -78 °C  solution of N-acetyl thiazolidinethione 254 (9.0 g, 35.1 
mmol) in CH₂Cl₂  (114 mL) was added TiCl₄ (3.9 mL, 35.1 mmol) dropwise over 4 min. 
The orange solution was stirred for 15 min at -78 °C  becoming an orange slurry. The 
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reaction mixture was then treated with i-Pr2NEt (12.5 mL, 71.6 mmol) dropwise over 
5 min becoming an opaque purple solution. The thick purple solution stirred for 40 
min at -78 °C  and was treated with a -78 °C solution of the aldehyde 260 (7.3 g, 43.0 
mmol) in CH₂Cl₂ (22.9 mL), dropwise over 1 h. The purple solution was stirred at -78 
°C  for 1.5 h and the reaction was then quenched with half saturated NH₄Cl (100 mL)
and warmed to room temperature. The layers were separated and the aqueous layer 
was extracted with CH₂Cl₂ (3 x 10 mL). The combined organic layers were dried over 
Na₂SO₄, filtered and concentrated to yellow/green oil. Purification by  column 
chromatography (10% to 20% EtOAc/Hexanes) afforded the desired isomer (+)-
alcohol 261 (11.2 g, 24.8 mmol) in 75% yield as well as the undesired isomer (2.2 g, 
5.2 mmol) in 15% yield for a total yield of 90% with 5:1 dr. [α]24D +109.1 (c = 0.24, 
CH2Cl2); IR (film) 3493, 2970, 1712, 1649, 1367, 1342, 1311, 1265, 1192, 1166, 
1137, 1041, 747, 702 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 1.10 (s, 6H), 1.26 (t, J = 7.1 
Hz, 3H), 2.85 (d, J = 9.4 Hz, 1H), 3.00 (m, 1H), 3.14 (m, 3H), 3.36 (dd, J = 7.3, 11.4 
Hz, 1H), 3.53 (d, J = 17.8 Hz, 1H), 4.00 (d, J = 9.4 Hz, 1H), 4.15 (q, J = 7.1, 14.2 Hz, 
2H), 5.32 (ddd, J = 4.0, 7.0, 10.6, 1H), 5.82 (d, J = 16.0 Hz, 1H), 7.00 (d, J = 16.0 
Hz, 1H) 7.26 (m, 3H), 7.30 (m, 2H); ¹³C NMR (100 MHz, CDCl₃) δ 14.3, 22.5, 23.0, 
32.2, 36.9, 41.1, 41.6, 60.3, 68.4, 73.8, 77.4, 119.9, 127.3, 128.9, 129.1, 129.4, 
136.4, 154.4, 166.7, 173.3, 201.5; MS (ESI+) for C21H27NO4S2Si [M+Na] calc 444.12 
found 444.12.
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(+)-TBS ether To a yellow solution of (+)-261 alcohol (5.29 g, 12.55) and 2,6-lutidine 
(3.21 mL, 27.61 mmol) in CH₂Cl₂ (24.1 mL) at 0 °C was added TBSOTf (3.2 mL, 13.8 
mmol) dropwise over 3 min. The yellow solution was stirred at 0 °C for 10 min and 
then warmed to room temperature and stirred for 2 h. The reaction mixture was 
quenched with saturated aqueous NaHCO₃  (20 mL) and the layers were separated. 
The aqueous layer was extracted with CH₂Cl₂ (3 x 10 mL) and the combined organic 
layers were washed with water (10 mL) and brine (10 mL) then dried over Na₂SO₄, 
filtered, and concentrated. Purification by column chromatography (Hexanes to 8% 
EtOAc/Hexanes) gave (+)-TBS ether (5.73 g, 10.7 mmol) in 85% yield.[α]23D = 
+148.7 (c = 0.27, CH2Cl2); IR (film) 2956, 2929, 2895, 2856, 1715, 1650, 1294, 
1259, 1191, 1166, 1092, 1041, 835, 777, 702 cm-1; ¹H NMR (400 
MHz, CDCl₃) δ -0.03 (s, 3H), -0.10 (s, 3H), 0.84 (s, 9H), 1.05 (s, 3H), 1.07 (s, 3H), 
1.26 (t, J = 7.2 Hz, 3H), 2.86 (d, J = 11.6 Hz, 1H), 3.00, (dd, J = 10.8, 13.1 Hz, 1H), 
3.19 (dd, J = 3.2 Hz, 13.1 Hz, 1H), 3.32 (m, 3H), 4.15 (q, J = 7.2 Hz, 14.1 Hz, 2H), 
4.30 (dd, J = 3.2, 6.8 Hz, 1H), 5.27 (ddd, J = 3.7, 6.8, 10.8 Hz, 1H), 5.80 (d, J = 16.0 
Hz, 1H), 6.98 (d, J = 16.0 Hz, 1H), 7.31 (m, 5H); ¹³C NMR (100 MHz, CDCl₃) δ -4.8, 
-4.2, 14.3, 18.3, 22.0, 23.5, 26.0, 32.1, 36.4, 42.4, 43.7, 60.2, 68.6, 74.8, 77.3, 
119.5, 120.1, 127.2, 128.9, 129.4, 136.5, 155.3, 157.6, 166.7, 172.3, 201.1; MS (ESI
+) for C27H41NO4S2Si [M+Na] calc 558.21 found 558.21.
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(+)-Alcohol To a solution of N-acylthiazolidinethione (5.65 g, 10.54 mmol) in ether 
(55 mL) and MeOH (0.51 mL, 12.65 mmol) at -15 °C was added 2.0 M LiBH4 
solution in THF (6.32 mL, 12.65 mmol) over 5 min. The yellow solution stirred for 1.5 
h at -15 °C. The reaction mixture was quenched with saturated aqueous Rochelleʼs 
salt at -15 °C (25 mL) and warmed to 0 °C  over 30 min. then warmed to room 
temperature and stirred for 2 h. The layers were separated and the aqueous layer 
was extracted with ether (4 x 10 mL). The combined organic layers were washed 
with brine (10 mL), dried over Na₂SO₄, filtered, and concentrated. Purification by 
column chromatography (CH₂Cl₂ to 5% CH₂Cl₂/EtOAc) afforded the product (+)-
alcohol (2.60 g, 7.89 mmol) in 75% yield. [α]22D = +20.8 (c = 0.25, CH2Cl2); IR (film) 
3444, 2957, 2931, 2884, 2857, 1720, 1649, 1472, 1386, 1366, 1310, 1257, 1190, 
1095, 1034, 1310, 1257, 1190, 1095, 1034, 836 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 
0.03 (s, 3H), 0.06 (s, 3H), 0.87 (s, 9H), 1.01 (s, 3H), 1.02 (s, 3H), 1.25 (t, J = 7.1 Hz, 
3H), 1.58 (m, 1H), 1.72 (m, 1H), 1.90 (br s, 1H), 3.59 (m, 2H), 3.65 (m, 1H) 4.14 (q, J 
= 7.1 Hz, 2H), 7.73 (d, J = 16.1 Hz, 1H), 6.99 (d, J = 16.1 Hz, 1H) ; ¹³C  NMR (100 
MHz, CDCl₃) δ -4.1, -3.9, 14.2, 18.3, 22.8, 23.5, 26.0, 36.6, 42.4, 59.9, 60.2, 75.8, 
118.7, 156.2, 167.0; MS (ESI+) for C17H34O4Si [M+Na] calc 353.21 found 353.21.
(+)-Aldehyde 262  To a -78 °C solution of oxalyl chloride (1.21 mL, 14.1 mmol) in 
CH₂Cl₂ (45 mL) was added a room temperature solution DMSO (2.0 mL, 28.3 mmol) 
in CH₂Cl₂ (2.0 mL). The resultant solution evolved gas and stirred at -78 °C  for 20 
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min. A solution of (+)-alcohol (2.60 g, 7.86 mmol) in CH₂Cl₂ (25 mL) was added 
dropwise to the reaction mixture at -78 °C  followed by a CH₂Cl₂ rinse (2 mL). The 
reaction formed a cloudy white solution and stirred at -78 °C for 30 min. The reaction 
mixture was treated with triethylamine (4.3 mL, 31.5 mmol) and stirred for 10 min at 
-78 °C, then warmed to 0 °C  and stirred for 60 min. The reaction mixture was 
quenched with saturated aqueous NaHCO₃  (10 mL), stirred for 5 min, diluted with 
water(10 mL), and the layers were separated. The aqueous layer was extracted with 
CH₂Cl₂ (3 x 10 mL) and the combined organic layers were dried over Na₂SO₄, filtered 
and concentrated. Purification by column chromatography (20% ether/hexanes) 
gave aldehyde 262 (2.54 g, 7.73 mmol) in 98%. The identity of aldehyde 262 was 
confirmed by 1H NMR and taken on immediately to the next step.
(-)-Alcohol 263 To a clear solution of methoxyglycolate 253 (1.45 g, 4.46 mmol) in 
CH₂Cl₂ (105 mL) at -78 °C was added TiCl4 (0.72 mL, 6.56 mmol) over 3 min. and 
stirred for 15 min becoming and orange solution. The orange solution was then 
treated with (-)-sparteine (1.50 mL, 6.56 mmol) becoming an opaque purple solution 
and stirred for 45 min at -78 °C. The purple solution was treated with TiCl4 (1.32 mL, 
12.0 mmol) over 1 min and was immediately charged with a -78 °C  solution of 
aldehyde (1.97 g, 6.00 mmol) in CH₂Cl₂ (14 mL). The reaction mixture stirred for 30 
min and was quenched with saturated aqueous NH₄Cl and warmed to 0 °C. The 
layers were separated and the aqueous layer was extracted with CH₂Cl₂ (2 x 20 mL). 
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The combined organic layers were washed with saturated aqueous NaHCO₃  (20 mL) 
and brine (20 mL) and then were dried over Na₂SO₄, filtered, and concentrated. 
HPLC analysis of the crude reaction product showed a 3.5/1.0/0.74 ratio of desired /
undesired/undesired isomers. Purification by column chromatography (35% ether/
hexanes) afforded the desired (-)-alcohol 263 (1.90 g, 3.20 mmol) in 59% isolated 
yield. [α]23D = -115.2 (c = 0.25, CH2Cl2); IR (film) 3438, 2956, 2930, 2856, 1713, 
1367, 1325, 1199, 836, 776, 732 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.06 (s, 3H), 
0.12 (s, 3H), 0.88 (s, 9H), 1.03 (s, 3H), 1.04 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H), 1.70 (m, 
1H), 2.06 (m, 1H), 2.77 (m, 2H), 3.26 (m, 1H), 3.35 (s, 3H), 3.80 (m, 1H), 3.93 (m, 
1H) 4.13 (q, J = 7.1, Hz, 2H), 4.35 (m, 2H), 5.00 (m, 1H), 5.74 (d, J = 16.0 Hz, 1H), 
5.85 (d, J = 6.28 Hz, 1H), 7.04 (d, J = 6.28 Hz, 1H), 7.28 (m, 5H); ¹³C  NMR (100 
MHz, CDCl₃) δ -4.5, -3.6, 14.3, 18.2, 22.7, 23.2, 26.0, 37.5, 39.4, 42.9, 58.4, 60.2, 
60.4, 71.2, 72.2, 75.7, 77.4, 82.1, 119.1, 127.5, 129.0, 129.2, 129.4, 155.8, 166.76, 
172.5, 186.2; MS (ESI+) for C30H47NO7SSi [M+Na] calc 616.2740 found 616.2749.
(+)-Dioxanone 248  To a solution of (-)-alcohol 248 (105 mg, 0.177 mmol) and 
pyridine (0.014 mL, 0.177 mmol) in CH₂Cl₂ (3.4 mL) at -78 °C  was bubbled ozone @ 
1 L/min for 0.5 min and the reaction stirred for 3 min. Ozone was bubbled again 
through the reaction mixture @ 1 L/min for 0.5 min and then the reaction mixture 
stirred for 3 min. Again, ozone was bubbled through the reaction mixture @ 1 L/min 
for 10 sec and the reaction mixture stirred for 5 min. Solid triphenylphosphine (139 
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mg, 0.530 mmol) was added to the reaction mixture at -78 °C  and stirred for 10 min. 
The reaction mixture was warmed room temperature, purged with argon, and stirred 
for 2 h under inert atmosphere. The reaction mixture was then treated with imidazole 
(36 mg, 0.530 mmol) and stirred at room temperature for 18 h. The reaction mixture 
was concentrated and purification by column chromatography (Hexanes to 10% 
EtOAc/Hexanes) gave (+)-dioxanone 248 (22 mg, 0.0666) for a 38% yield.[α]20D = 
-82.5 (c = 0.28, CH2Cl2); IR (film) 2954, 2930, 2886, 2857, 1737, 1462, 1362, 1257, 
1244, 1109, 1097, 984, 971, 880, 840, 774 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.02 
(s, 6H), 0.86 (s, 9H), 0.97 (s, 3H), 1.03 (s, 1H), 1.72 (dd, J = 5.2, 13.6 Hz, 1H), 2.09 
(ddd, J = 6.2, 13.6, 13.6 Hz, 1H), 3.51 (m, 1H), 3.53 (s, 3H), 3.62 (dd, J = 5.2, 12.0 
Hz, 1H), 4.39 (d, J = 6.2 Hz, 1H), 5.26 (s, 1H) ; ¹³C NMR (100 MHz, CDCl₃) δ -5.0, 
-4.3, 17.1, 17.9, 23.0, 25.6, 33.4, 40.7, 58.5, 67.4, 74.6, 78.2, 106.9, 164.8; MS (ESI
+) for C16H30O5Si [2M+Cs] calc 683.3695 found 683.3695.
(-)-Benzyl Ester 278 To a solution of N-acyloxazolidinethione (215 mg, 0.36 mmol) 
in CH₂Cl₂ (0.83 mL) and BnOH (0.37 mL, 3.6 mmol) was added DMAP (11 mg, 0.09 
mmol) and imidazole (49 mg, 0.72 mmol) and the reaction mixture stirred for 2 h. 
The reaction mixture was concentrated and the crude material was purified by plug 
column chromatography  (15% EtOAc/Hexane) to remove the chiral auxiliary  and the 
amine bases. The material was then azeotroped with water at 55 °C until the 
remaining BnOH was gone and was purified again by  column chromatography (15% 
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EtOAc/Hexanes) to give (-)-benzyl ester 278 (128 mg, 0.25 mmol) in 70% yield. [α]
20D = -17.4 (c = 0.25, CH2Cl2); IR (film) 3499, 2956, 2931, 2893, 2856, 1749, 1718, 
1258, 1186, 1094, 837, 776 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.04 (s, 3H), 0.06 (s, 
3H), 0.87 (s, 9H), 0.94 (s, 3H), 0.96 (s, 3H), 1.26 (t, J = 7.0 Hz, 3H), 1.56 (m, 1H), 
1.74 (m, 1H), 3.40 (s, 3H), 3.65 (t, J = 5.6 Hz, 1H), 3.75 (d, J = 4.4 Hz, 1H), 3.92 (m, 
1H), 4.16 (q, J = 7.0 Hz, 2H), 5.20 (s, 2H), 5.70 (d, J = 16.0 Hz, 1H), 6.99 (d, J = 
16.0 Hz, 1H), 7.34 (m, 5H); ¹³C NMR (100 MHz, CDCl₃) δ -4.4, -3.8, 14.2, 18.2, 22.7, 
22.9, 26.0, 26.1, 37.1, 42.7, 58.7, 60.1, 66.7, 70.6, 76.3, 77.3, 84.0, 118.9, 128.5, 
128.5, 128.6, 135.4, 155.9, 166.8, 170.2; MS (ESI+) for C27H44O7Si [M+Na] calc 
531.2754 found 531.2746
(-)-Lactol-Acetate 275 To a -78 °C solution of (-)-enoate 278 (120 mg, 0.24 mmol) in 
CH₂Cl₂ (2.26 mL) was bubbled ozone gas at 1L/min until the solution gave a 
persistent blue color (~ 1 min). The blue solution solution stirred at -78 °C for 2 min 
and was then charged with Et₃N (0.99 ml, 0.708 mmol), dropwise, producing a white 
plume of smoke and giving a clear solution immediately, The solution stirred at - 78 
°C  for 5 min and was connected to an argon line, purged over 5 min, then warmed to 
room temperature. After 1 h at room temperature the reaction was treated with 
pyridine (0.11 mL, 1.41 mmol), Ac₂O (0.067 mL, 0.71 mmol) and DMAP (2.9 mg, 
0.024 mmol). The reaction stirred for 15 h and was quenched with saturated 
aqueous NaHCO₃  (2 mL). The layers were separated and the aqueous layer was 
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extracted with CH₂Cl₂ (3 x 3 mL), dried over Na₂SO₄, filtered and concentrated. 
Purification by plug column chromatography (8% EtOAc/Hexanes) gave (-)-lactol-
acetate 275 (98 mg, 0.20 mmol) in 86% yield. [α]20D = -38.9 (c = 0.25, CH2Cl2); IR 
(film) 2955, 2930, 2885, 2857, 1753, 1462, 1390, 1371, 1228, 1186, 1148, 1085, 
1059, 776 cm-1; ¹H NMR (400 MHz, CDCl₃) δ 0.03 (s, 3H), 0.03 (s, 3H), 0.87 (m, 
12H), 0.97 (s, 3H), 1.34 (m, 1H), 2.08 (s, 3H), 2.16 (m, 1H), 3.45 (s, 3H), 3.66 (m, 
1H), 4.01 (m, 1H), 4.32 (m, 1H), 5.05 (d, J = 12.2 Hz, 1H), 5.29 (d, J = 12.2 Hz, 1H), 
5.79 (s, 1H), 7.35 (m, 5H); ¹³C NMR (100 MHz, CDCl₃) δ -5.0, -4.5, 18.0, 18.6, 21.0, 
21.5, 25.7, 25.8, 25.8, 29.6, 38.5, 58.9, 66.8, 72.7, 74.8, 82.8, 96.1, 128.3, 128.5, 
135.4, 170.1, 169.4; MS (ESI+) for C25H40O7Si [M+Na] calc 503.2441 found 
503.2482.
4.3 NMR Spectra
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